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Abstract  
 
Fibrocyte degeneration in the cochlear lateral wall is one possible pathology of age-related 
metabolic hearing loss (presbyacusis). Fibrocytes play a role in potassium recycling and 
maintenance of the endocochlear potential (EP). It has been proposed that a cell replacement 
therapy could prevent fibrocyte degeneration in the CD/1 mouse model of hearing loss. One 
source of replacement cells is cultured spiral ligament fibrocytes (SLFs) as they do not require 
significant differentiation or development so may integrate into the cochlea better than stem 
cells. This research employs the techniques of whole-cell voltage clamping and 
immunolabelling to examine and compare the characteristics of native and cultured 
fibrocytes. The aim to see whether the cultured SLFs display similar features and 
characteristics to that of native SLFs, in aid of building the case of these cells being a suitable 
cell replacement to treat age-related hearing loss. 
Fibrocytes cultured as monolayers or on 3-D collagen I gels were compared with fibrocytes in 
cochlear slices or micro-dissected spiral ligament (SL) from ~P7 cochlea of CD/1 mice. 
Fibrocytes successfully grown for short periods on a 3-D collagen I matrix exhibited rounded 
cell bodies with extending processes, compared to a flatter morphology when grown in a 
monolayer. Immunofluorescence showed expression of aquaporin 1 (AQP1) which, in the 
cochlea, is confined to type III fibrocytes and to a lesser extent for S-100 found in several 
fibrocyte types. The cultured cells also expressed the inwardly-rectifying potassium channel 
Kir5.1, as well as labelling for the gap junction proteins connexin 26 and 31. Finally, whole-
cell voltage clamp recordings in both the cultured and putative native fibrocytes revealed 
outwardly- rectifying potassium currents on depolarisation. There was also a large group of 
linear response recordings, and a subset showing both inward and outward-rectification. 
There was no significant difference in the resting membrane potentials between the native and 
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cultured cells in any of the linear or outwardly-rectifying group recordings. Thus 3-D cultured 
fibrocytes show morphology that more closely resembles that in vivo compared to monolayer 
cultures and appear to possess functional potassium channels. Thus far, this research indicates 
that these cells are suitable for transplantation into the lateral wall of the cochlea in a cell 
therapy to treat age-related metabolic presbyacusis. 
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1. Chapter 1- General Introduction 
 
Hearing impairments are one of the biggest health-related problems reported worldwide. 
Indeed, Whe WoUld HealWh OUganiVaWion eVWimaWeV WhaW oYeU 5% of Whe ZoUld¶V popXlaWion 
(~466 million people) have debilitating hearing loss with approximately 11 million people in 
the UK alone diagnosed as being deaf or hard of hearing, making it the second most common 
disability in the UK (Actiononhearingloss.org.uk). It affects more people than epilepsy, 
mXlWiple VcleUoViV, Vpinal injXU\, VWUoke, HXnWingWon¶V and PaUkinVon¶V diVeases combined 
(Hudspeth, 1997).  
Presbycusis is a form of hearing loss associated with normal ageing, with 71% of individuals 
over the age of 70 in the UK reporting some form of age-related hearing loss 
(Actiononhearingloss.org.uk). Schuknecht (1974) identified the four types of human 
presbycusis: (1) sensory, affecting hair and sensory cells; (2) neural, loss of spiral ganglion 
neurons; (3) metabolic, deficits in processes maintaining ionic gradients, caused mainly by 
degeneration of the stria vascularis cells and SLFs; and (4) mechanical, stiffening of the 
basilar membrane and organ of Corti therefore affecting its movement. Animal models have 
been used extensively to predict patterns of hearing loss associated with human cochlear 
pathology. The outbred CD/1 mouse model is commonly used and shows accelerated 
presbycusis (Shone et al, 1991) with hearing loss occurs at about 4 weeks (Le Calvez et al, 
1998).  
Indeed, audiograms and other advanced measures of auditory function (including, auditory 
brainstem responses, otoacoustic emissions) have been used in rodents to provide compelling 
evidence for metabolic, sensory and a mixed metabolic/sensory phenotype of presbycusis 
(Schuknecht, 1964). Schuknecht and Gacek (1993) later revised his earlier classification to: 
(1) sensory cell losses are least important type of loss in the aged ear; (2) neuronal losses are a 
constant pathology of aging; (3) lateral wall pathology is the main lesion in the aging ear.  
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Therefore, they established the main cause of age-related hearing loss to be the degeneration 
of the cochlear lateral wall with sensory cell loss being of secondary importance.  In order to 
understand the structures implicated in different forms of presbycusis, a review of the 
anatomy and functions of the cochlea is required. 
 
1.1 Functional Anatomy of the Cochlea 
 
The human cochlea is the auditory portion of the inner ear and is a ~35mm long coiled bony 
tube containing three compartments: the scala tympani, the scala vestibuli, and the scala 
media (Mills & Weber, 2001; fig. 1.1). The scalae tympani and vestibuli contain perilymph, 
whilst the scala media contains endolymph. The boundaries of the scala media are at the top 
surface of the Organ of Corti, the reticular lamina, which separates it from the scala tympani; 
ReiVVneU¶V membUane, VepaUaWing fUom Whe scala vestibuli; and the stria vascularis (fig. 1.1). 
Beneath the tectorial membrane are interdental cells connected to each other to form a comb-
shaped cellular network in the spiral limbus, also containing fibrocytes (Shodo et al, 2017).  
 
The perilymph contains typical extracellular ion concentrations and the endolymph contains a 
high potassium concentration of 150 mM and an 80 mV EP (Wangemann & Schacht, 1996; 
Wangemann, 2006; Hibino & Kurachi, 2006). The EP is at a positive voltage of 80-100mV 
seen in the cochlear endolymphatic spaces and is the main driving force for sensory 
transduction (Wangemann & Schacht, 1996). Another driving force for this transduction is 
provided by the large potential difference across the apical membrane of the hair cell 
(membrane potential), the sensory receptors for the auditory and vestibular system within the 
organ of Corti. There are two types of hair cells: inner hair cells (IHC) and outer hair cells 
(OHC). 
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The hair cells have a membrane potential of ±70 mV thereby producing a total driving force 
across the hair cell apex of 150 mV; these both increase the driving of K+ recycling. The 
influx of potassium into the hair cells is driven strongly by the highly positive EP, and this 
potential is the result of the unique electrical properties of the cochlear lateral wall. 
 
Figure 1. 1 Schematic cross section of the cochlea and Organ of Corti 
 
 
 
 
 
 
 
 
 
 
 
1.2 Structure and Function of the Organ of Corti 
 
The mammalian cochlea contains the transduction organ, the organ of Corti, comprising the 
two types of sensory hair cells receptors. Acoustic energy that enters the cochlea causes a 
pressure gradient between the scala vestibuli and scala tympani, causing movement of the 
Figure 1.1 Cross-section of the cochlea. Schematic drawing of the cochlear cross-section 
showing turns of the cochlea. Surrounding structures of the scala media. Potassium is taken 
up by hair cells and passed through either the epithelial gap junction system or into the 
perilymph before being taken up by fibrocytes at the bottom of the spiral ligament where it is 
passed through to the connective tissue gap junction network and back into the endolymph. 
This potassium recycling maintains the EP crucial to hearing. Arrows indicate potassium 
transport routes. Image provided by Prof David Furness. 
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basilar membrane and a traveling wave which propagates towards the apex of the cochlea. 
The precise location along the basilar membrane that the traveling wave reaches its maximum 
vibration depends on the frequency of the stimulus, low frequencies are detected at apex and 
high frequencies detected at base, the principle of tonopic organisation of the cochlea. Basilar 
membrane displacement induces deflection of the hair cell stereocilia which sit on this 
membrane, and this deflection modulates OHC current.  The removal of the EP removes the 
power driving OHC motility (Ruggero & Rich, 1991). The importance of maintaining the EP 
has been shown in the development of a young gerbil model of metabolic presbycusis through 
use of furosemide, a loop directic used to treat heart failure and edema, into the round window 
of the cochlea inducing damage or injury to the lateral wall (Lang et al, 2010). K+ cycling is 
essential for hearing as it converts the hair cell sensitivity to mechanical stimulation 
(reviewed in Hibino & Kurachi, 2006). Essentially, the re-establishment of the K+ recycling 
route following damage or injury may result in the normalization of the EP and the recovery 
of hearing.  
 
IHCs are the sensory cells which convert mechanical stimulation into electrical signals and 
synaptic activity which is transmitted to the brain. The OHCs are key in the amplification of 
the basilar membrane motion, which is needed to detect sounds at low sound pressures. 
Cochlear hair cell bodies are bathed in perilymph and possess stereocilary cell bundles. The 
bundles of sensory OHCs project up to the tectorial membrane. The vibration of the basilar 
membrane induced by sound causes hair cell bundle displacement which causes stereocillia 
deflection, this causes mechanoelectrical transducer channels to open. Tip links seem to 
couple stereocillia displacement to channel gating (opening) (Corey & Hudspeth, 1983; 
Pickles et al, 1984; Assad et al, 1991). This then allows Ca2+ and predominantly K+ from the 
endolymph to enter the hair cells and ultimately leads to the excitation of the auditory nerve 
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(Hudspeth, 1989). The hair cells then send their signal via neurotransmitter to the primary 
auditory neurons of the spiral ganglion. One IHC is innervated by 10-15 type I spiral ganglion 
neurons, and numerous OHCs are innervated by a single type II spiral ganglion neuron. 
Approximately 90-95% of the spiral ganglion neurons are type I that send peripheral 
processes to IHCs (Spoendlin, 1985), and are the source of nerve fibres to the brain. The 
remaining 5-10 % are type II whose functions are still not clear.  
 
1.3 Lateral Wall Structure and Function 
 
The cochlear lateral wall consists of the stria vascularis which is located medially and the 
spiral ligament located laterally (fig. 1.1). The EP is generated by a process of K+ movement 
provided by a number of cell types in the lateral wall (Mizuta et al, 1997; Crouch et al, 1997; 
Takeuchi et al, 2000; Marcus et al, 2002), which may be highly susceptible to aging due to the 
high metabolic activities of these cells (Gruber et al, 2008). The stria vascularis is a secretory 
epithelium lining the lateral wall of the scala media and it is composed of three cell layers: 
marginal cells, intermediate cells and basal cells (fig. 1.2). The spiral ligament is composed of 
fibrocytes, of which there are five types.  
 
1.3.1 Spiral Ligament Structure 
 
A function of the spiral ligament is maintaining the ionic balance in the cochlea. Supported by 
gap junctions and Na+ K+ ATPase pumps, the spiral ligament, alongside the stria vascularis, is 
believed to transport K+ out of the perilymph, and back into the endolymph maintaining its 
high K+ concentration (Spicer & Schulte, 1991). The predominant cell types in this structure 
are SLFs which possess uptake mechanisms for K+ and contribute towards the generation of 
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the EP (Mizuta et al, 1997; Crouch et al, 1997). The cell bodies of root cells reside within  the 
outer sulcus and project into the spiral ligament (Galic and Giebel 1989; Spicer and 
Schulte 1996).The EP in the scala media (+80) is due to the actions of complex physiological 
mechanisms involving Na+ K+ ATPase pumps, NKCCs (Na+K+Cl transporter) and K+ 
channels along the cochlear lateral wall.   
 
 Figure 1. 2 Schematic of potassium transport through lateral wall 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Model of cochlear potassium circulation and formation of EP in the lateral wall. 
Ion-transport expressed in the stria vascularis and the spiral ligament involved in 
potassium circulation. Fibrocytes of the spiral ligament receive potassium from the outer 
sulcus cells and uptake by the Na+K+ATPase transporter and the Na+K+Cl- cotransporter 
(NKCC). They also contain Kir5.1 inwardly rectifying potassium channels. Gap junctions 
enable the transport of ions from the fibrocytes to the basal cells, then to the intermediate 
cells which expel the potassium into the intrastrial space via Kir4.1 potassium channels. It is 
then actively taken up by marginal cells by transporters cotransporters before being released 
back into the endolymph ready for use again. NKCC1, Na+K+Cl- cotransporter. TJ, tight 
junctions. ClC-K/Barttin, Barttin activated chloride channels. KCNQ1/KCNE1, voltage-
gated potassium ion channel complex. Taken from Hibino & Kurachi (2006). 
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Fibrocytes of the cochlear lateral wall are classified into different types based upon their 
ultrastructure, immunostaining patterns, and anatomical location (Spicer & Schulte, 1996). 
There are five types of highly specialised fibrocytes which vary in terms of their structural 
and functional roles (reviewed in Berrocal et al, 2008). Type II and V have been found to 
have higher levels of Na+ K+ ATPase so are believed to be involved in homeostasis 
(Mahendrasingam et al, 2011); type III are involved in water regulation and tension of the 
cochlea basilar membrane (Henson et al, 1984; Kuhn & Vater, 1997; Naidu & Mountain, 
2007). These type III cells are most numerous in the basal region of the cochlea (Henson & 
Henson, 1988), and here they possess strong acto-myosin cytoskeletal elements. Type IV are 
primarily structural but also have some role in K+ recycling, as do type I. Aiding their K+ 
recycling function are the proteins they have been found to express (figure 1.2): the two 
transporters Na+K+ATPase (Schulte & Adams, 1989); Na+K+2Cl- (Crouch et al, 1997); and 
the Kir5.1 channel (Hibino et al, 2004). There are numerous other proteins and channels 
found to be expressed by SLFs. 
Type I fibrocytes are lateral to the stria vascularis, type II below the stria vascularis, type III 
along the external edge of spiral ligament and are most prevalent in the most basal region of 
the cochlea (high frequency coding), type IV lateral to the basilar membrane and type V are 
above the stria vascularis (figure 1.3) (Spicer & Schulte, 1991; 2002; Weber et al, 2001). 
Type I, II and V fibrocytes, the intermediate and basal cells of the stria vascularis, are 
interconnected by gap junctions (reviewed in Berrocal et al, 2008). Type I fibrocytes connect 
via gap junctions to the basal cells of the stria vascularis and contain mitochondria in their 
membrane believed to provide energy required for ion transport. Type II exhibit Na+-K+-
ATPase in their elongated cell body, where they take up K+ ions from the roots which they 
release to type I fibrocytes through these gap junctions.  
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The use of the three marker proteins (AQP1, S-100 and Į1Na-K-ATPase) can distinguish 
between all fibrocyte types, except II and V (Mahendrasingam et al, 2011a). S-100 is a 
calcium-binding protein present in a variety of tissues (Haimoto et al, 1987) and believed to 
be involved in the regulation of diffusion of cations across membranes, modulating 
membranes, and in regulation of phosphorylation of several proteins (Donato, 1986). It has 
been indicated that S-100 positive cells may have special functions as type I, II and V SLFs 
are strongly S-100 positive (Shi et al, 1992; Suko et al, 2000; Mahendrasingam et al, 2011a). 
AQP1 is a water-transporting channel protein involved in water and ion homeostasis (Carbrey 
& Agre, 2009), and is associated with the plasma membranes and cytoplasm. Aquaporin is 
expressed in all cells but six times stronger in type III cells than any other (Mahendrasingam 
et al, 2011a). The VodiXm poWaVViXm pXmp, Į1Na, K-ATPase (Jorgensen, 1985), is highest in 
type II and V cells. This pump is membrane associated, however, despite the moderate 
expression in type III, it was indicated that there was also cytoplasmic labelling which was 
more evident in type III SLFs (Mahendrasingam et al, 2011a). It could be that the type III 
cells may be recruited to express this protein and function when other fibrocytes degenerate, 
as shown in some mouse models (Wu & Marcus, 2003; Mahendrasingam et al, 2011a).  
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Figure 1. 3 Spiral ligament and areas the five types of SLFs reside 
 
 
 
 
 
 
      
 
 
 
 
 
 
 
1.3.2 Stria Vascularis Structure  
 
The stria vascularis is composed of three cell layers, from medial to lateral: marginal cells, 
intermediate cells and basal cells (fig. 1.2). Basal cells are joined via gap junctions to 
intermediate cells and fibrocytes; however, unlike most sheets or epithelial cells, strial 
marginal cells are not coupled to each other or other cells by gap junctions (Kikuchi et al, 
2000). As basal cells are connected to fibrocytes via gap junctions, all of these cells are 
involved in the connective-tissue gap junction network (CG-JN) which transports K+ from 
type II and IV fibrocytes to intermediate and basal cells (figure 1.2) (Wangemann, 2002).  
 
Figure 1.3 Transmitted 
light microscopy of spiral 
ligament in a midmodiolar 
plane. The locations of the 
different fibrocyte types (I-
V), the Reissner membrane 
(RM), and stria vascularis 
are shown. Scale bar= 50 
µm. Taken from 
Mahendrasingam et al, 
2011. 
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1.4 Role of Fibrocytes in maintaining the Endocochlear Potential  
 
The difference in electrical potential between the interior and exterior of the fibrocyte network 
enables the movement of ions; normally this membrane potential difference is maintained 
between +5 and +12 mV in vivo (Nin et al, 2008; Adachi et al, 2013; Yoshida et al, 2015; 
2016). The atypical characteristics of fibrocytes are crucial for maintaining the EP as their 
highly-positive resting membrane potential underlies a Kir4.1-mediated inwardly-rectifying 
potassium current that sets the EP to a highly positive value required for hearing. Both the EP 
and hair cell membrane potentials are driving forces in sensory transduction as the EP is 
essentially a potassium equilibrium potential generated by the potassium channel, Kir4.1, in 
the intermediate cells of the stria vascularis in conjunction with the low concentration of 
potassium of the intrastrial fluid and high concentration in the intermediate cells (Takeuchi et 
al, 2000; Marcus et al, 2002). Spiral ligament fibrocytes, which contain potassium uptake 
mechanisms, assist with the EP generation by the maintenance of a high concentration of 
potassium inside the intermediate cells (Schulte & Adams, 1989; Crouch et al, 1997; Mizuta 
et al, 1997). 
 
1.5 Gap Junction Systems 
 
There are two independent cell systems distinguished by interconnecting gap junctions which 
function in the recirculation of K+ (figure 1.4). The first system is the epithelial cell gap 
junction system (EG-JS), consisting of organ of Corti supporting cells, interdental cells in the 
spiral limbus and root cells in the SL. The second system is the connective-tissue cell gap-
junction network composed of the strial intermediate cells; strial basal cells, SLFs and 
mesenchymal cells (figure 1.2).  
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For the EG-JS, membUaneV of DeiWeUV¶ cellV facing Whe hair cells express K+-Cl- 
cotransporters. The voltage-gated Kv7.4 K+ channel is a major pathway for K+ to exit through 
OHCs which are predominantly present at the basolateral membrane of the hair cells 
(Kharkovets et al, 2006), and a BK Ca2+-activated K+ channel (RȨWWigeU eW al, 2004; 
Navaratnam et al, 1997). The K+ must be immediately removed from the hair cell 
surroundings as it would cause continuous depolarisation and affect normal excitability. From 
the hair cells the K+ ions are expelled basolaterally and enter cochlear supporting cells, which 
once inside the supporting cells, move through the EG-JS network. 
The CG-JN is expressed by fibrocytes which mediate the K+ circulation from perilymph to 
endolymph (reviewed in Kikuchi et al, 2000). There is no cellular connection between outer 
sulcus cells and type II or IV fibrocytes, therefore K+ exiting hair cells, is picked up by 
DeiWeU¶V cellV and moYeV doZn iWV elecWUochemical gradient, passing through the CG-JN. It is 
at this point released to perilymph by the outer sulcus cells (Santos-Sacchi, 2000) and actively 
up taken by nearby type II and IV fibrocytes which are situated around the root cells within 
the lower region of the SL. Then this K+ moves down its electrochemical gradient through 
type II and type I SLFs, and intermediate cells where it is released through K+ channels 
directed into the endolymph (Shen et al, 2004), where they become available to the sensory 
hair cells again for sensory transduction, thereby maintaining the endolymph K+ 
concentration. 
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Figure 1. 4 K+ recycling pathways within the cochlea 
 
 
 
 
 
 
 
 
 
Figure 1.4 Endocochlear K+ 
recycling routes. a proposed K+ 
recycling routes in the medial 
(continuous black line: medial 
route) and lateral parts of the 
cochlear duct (dashed line: 
lateral route; dotted line: 
extraepithelial route). b 
Proposed K+ uptake by 
epithelial supporting cells c 
Proposed K+ release by the 
ISC-oc, the IPhC and the IPC. d 
Alternatively, K+ ions in the 
ISC-oc, IPhC and IPC may be 
funnelled into the inner sulcus 
cells of the spiral limbus (ISC-
sl) via GJs. e The proposed K+ 
uptake by epithelial supporting 
cells that are adjacent to the 
OHC. f The proposed volume-
equilibrated K+ release. g The 
concept of an intraepithelial 
lateral K+ recycling route 
postulates K+ flux into outer 
sulcus cells (OSC) via gap-
junctions. Taken from Eckhard 
et al (2012). 
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1.6 Relationship between Types of Hearing Loss and Cochlear Structures 
 
Schuknecht and Gacek (1993) described atrophy of the cochlea lateral wall as the main lesion 
in human temporal bones. However, SchuknechW and Gacek¶V (1993) WempoUal bone VWXdieV 
did not focus specifically in SL, since, more in-depth spiral ligament degenerative changes 
were investigated which revealed that degeneration of the stria vascularis, due to ageing, 
appears to be slower than that of the spiral ligament (Kusunoki et al, 2004).   
 
1.6.1 Cochlear Conductive Hearing Loss 
 
Conductive hearing loss is usually attributed to external or middle ear abnormalities. 
Computed tomography scans of the inner ear shows widened internal auditory canal with an 
incomplete separation of the basal turn of the cochlea from the internal auditory canal, and 
these inner ear abnormalities are believed to partly cause the conductive hearing loss in X-
linked deafness type 3. When the increments of a threshold loss (reduced sensitivity to sound) 
present a gradually decreasing linear distribution pattern on the audiometric scale and have no 
pathologic correlate, it is thought the hearing loss is caused by alterations in the physical 
characteristics of the cochlear duct, and this hearing loss is cochlear conductive presbycusis 
(Schuknecht and Gacek, 1993). 
 
1.6.2 Sensorineural Hearing Loss 
 
Sensory neural hearing loss (SNHL) is defined by damage to the cochlear hair cells (the 
sensory hearing organ) or damage to the hearing pathways (nerves). It is not always possible 
to distinguish which part is damaged with this hearing loss, so is usually stated together as 
SNHL. Degeneration of the organ of Corti implies sensory presbycusis and loss of word 
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discrimination indicates neural presbycusis. SNHL results from lesions of the cochlea, VIII 
cranial nerve, and central auditory pathway.  
1.6.2.1 Hair Cell Loss 
 
The loss of sensory cells, supporting cells and neurons in the mammalian cochlea was 
generally believed to lead to permanent hearing loss as these cells are made only during 
embryonic development and not regenerated if lost from the mature inner ear so must last an 
entire lifetime (Ruben, 1967; Michaels, 1987). However, it was found in a guinea pig model 
that hair cells were replaced after loss induced by amino-glycoside treatment (gentamicin) as 
by 4 to 7 days most hair cells had been completely replaced by expanded surfaces of 
supporting cells and only a few degenerating hair cells remained (Forge, 1993). However this 
was not in the cochlea but the utricle and in very low numbers as after 4 weeks at the end of 
the treatment, immature hair bundles at different development stages were found in the 
utricle. These and other similar findings showed that in vivo hair cell regeneration in the 
mature mammalian ear can take place (Lowenheim et al, 1999).  
 
1.6.2.2 Spiral Ganglion Neuron Loss 
 
It has also been found in the CD/1 mouse that acoustic overexposure induces significant 
degeneration of the cochlear nerve despite the survival of hair cells (Riva et al, 2005; 2007; 
Kujawa & Liberman, 2009; Makary et al, 2011). Indeed, even where cochlear thresholds have 
returned to normal there can be up to a 50% loss of spiral ganglion neurons. Large neural 
degeneration appears to be a primary result of acoustic overexposure and not secondary to 
hair cell loss. Nevertheless, studies of outbred CD/1 mice displaying accelerated presbycusis 
have shown different possible causes of this hearing loss (Shone et al, 1991): one suggestion 
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being that spiral ligament damage precedes hair cell loss, with an endolymphatic K+ 
concentration reduction (Wu & Marcus, 2003). It is predicted that fibrocyte degeneration 
could cause the organ of Corti pathology, later inducing hair cell and spiral ganglion damage 
(Mahendrasingam et al, 2011b). This damage due to spiral ligament degeneration and 
consequently stria vascularis degeneration could be the cause of K+ recycling breakdown 
from the perilymph which surrounds the base of the hair cells, leading to hair cell death 
(Nouvian et al, 2003). This outcome is only avoided by the process of K+ being continuously 
being pumped out of the perilymph, which is dependent upon fibrocytes and cells of the stria 
vascularis. 
 
1.6.2.3 Hidden hearing loss 
 
There are cases of hearing disabilities which display a normal audiogram, and animal 
experiments which show that noise exposure can cause cochlear neuropathy without affecting 
sensitivity to weak sounds. This selective neural loss is termed hidden hearing loss (Schaette 
& McAlpine, 2011). It is likely that individuals with an audiometric hearing loss due to noise 
exposure or aging have a hidden cochlear pathology. It was long thought that once hearing 
thresholds return to normal that the ear also would, however this is not the case. Causes of 
temporary threshold rises can induce irreversible damage to the auditory nerve fibres, which 
transmit sound information to the brain. This damage might not affect tone detection but the 
ability to process more complex signals, therefore may allow someone to detect sound but not 
make out what the person is saying (Liberman, 2015). 
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1.6.3 Strial/Metabolic Hearing Loss pathology 
 
Strial/metabolic hearing loss is characterised by a decline of EP (Pauler et al, 1988; Gates et 
al, 2002). Kusunoki et al (2004) conducted a temporal bone study exploring the age-related 
histopathologic changes in the human cochlea, where compared to Schuknecht & Gacek 
(1993), they explored these changes in the lateral wall in more detail. Using 39 temporal 
bones from 24 subjects they found significant degenerative changes of the spiral ligament in 
the 9-18 year group compared to the 0-2 year group, but decreased areas of the stria 
vascularis only significant in 64-86 year group compared to the 0-2 year group.  
In support of Schuknecht and Gacek (1993), work on hearing difficulties in the aging have 
shown that fibrocytes are progressively lost from the SL, a major pathology in presbycusis, 
suggesting their importance for auditory capacity (Wu & Marcus, 2003; Adams, 2009). The 
loss of function of these cells in the cochlear lateral wall can result in disruption of the ion and 
fluid homeostasis, causing a decline in the EP (Schmiedt, 1996). In this EP maintenance 
system, a collapse of the endolymphatic compartments occurs if the EP threshold point is not 
met and a failure of its generation follows (Schulte and Schmiedt, 1992; Friedmann et al, 
1966; Wang et al, 2002).    
 
Findings from quiet-aged and furosemide-exposed gerbils (reduced Na+-K+-Cl- co-transport) 
demonstrated specific contributions of EP loss (Schmiedt et al. 2002) and was key in 
classifying audiograms and characterizing evidence for metabolic presbycusis (Schulte & 
Schmiedt, 1992; Gratton et al, 1997; Schmiedt et al, 2002; Schmiedt 1996; 2010). Audiogram 
patterns from OHC losses due to exposure to noise and drugs are different from those due to 
chronic EP decline in metabolic presbycusis. 
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A model of cochlear lateral wall degeneration was performed by applying furosemide as 
described previously (Lang et al, 2010). This caused a loss of strial intermediate cells and 
cochlea lateral wall oedema, hence a chronic reduction in EP (Schmiedt et al, 2000). 
However, this model did not show the characteristic pathological alterations in hair cells and 
neurons that occur with age as their morphology appeared normal. It was found spontaneous 
activity of auditory neurons was significantly lower in the furosemide-treated gerbil models, 
similar to aged gerbils raised in a quiet environment which show a decline in EP and elevated 
auditory nerve compound action potential (Lang et al, 2010). This suggests that the chronic 
reduction in the EP induced by cochlear lateral wall dysfunction has a direct effect on the 
activity of primary auditory neurons similar to that seen in aged gerbils and therefore 
responsible for much of the hearing loss in metabolic presbycusis.  
 
Nevertheless, some mice strains, such as SAMP1 and C57BL/6 (B6) mice are found to 
undergo age-related strial and spiral ligament degeneration that is not linked to EP reduction 
(Ichimiya et al, 2000; Di Girolamo et al, 2001; Hequembourg & Liberman, 2001; Lang et al, 
2002). These studies find little changes in EP in aged animals in contrast to other studies, as 
well as significant degeneration of SLFs prior to that of cochlea hair cells and neurons and 
this evidence will be explored later in this chapter. It is possible these fibrocytes in the spiral 
ligament have more to do with trophic factors or K+ recycling associated with the generation 
of the silent current than they do with the production of the EP. 
 
Metabolic hearing loss in animals is not necessarily a sensory loss, but results in raised pure-
tone thresholds as the gain of the cochlear amplifier is reduced, particularly at higher 
frequencies. Differences have been found in the lower frequency thresholds for metabolic and 
sensory phenotypes which averaged 16.5 dB better for sensory than metabolic phenotypes 
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(Dubno et al, 2013). A hypothesis for the differences is in sensory losses OHC loss cause the 
reduction of transduction currents (Salt & Konishi, 1979), which reduces the load on the EP 
generator causing a higher cochlear EP. Additionally, it has been found that the cochlear base 
is where the EP is most efficiently generated (Wu & Hoshino, 1999) consistent with OHC 
lesions location in the sensory phenotype. This suggests sensory loss could disguise metabolic 
loss until significant strial degeneration. 
 
1.7 Evidence of Fibrocyte Involvement in Presbycusis 
 
Wright and Schuknecht (1972) studied spiral ligament morphology in 151 human temporal 
bones and found age related changes in all samples, which were most significant in the middle 
and apical turns. Furthermore, a decreased hearing threshold was found in 15 ears with spiral 
ligament atrophy (shrinking), and in these individuals, the hearing loss was more severe than 
expected when compared to the limited amount of hair cell and ganglion cell loss. Later, 
Schuknecht et al (1974) affirmed that four pathologic types of presbycusis are valid, finding 
out of 101 individuals with presbycusis: 12 had sensory hearing loss, 31 neural, 35 strial 
(metabolic), and 23 mechanical, therefore proving a significant number of cases of human 
hearing loss are metabolic. Based on findings, is it reported that many individual cases do not 
separate into a specific type but possess a mixture of these pathologic types and are termed 
mixed presbycusis, hence why some believe SNHL is considered most common (Schuknecht 
& Gacek, 1993). It was then proposed that noise-damaged ears do not µage¶ aW Whe Vame UaWe 
as ears without evidence of noise damage, therefore, the effect of age is overestimated to do 
with sensory (Gates et al, 2000). 
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It has been found that in a C57BL/6 inbred mouse model of presbycusis, that fibrocyte loss 
precedes significant hair cell loss (Hequembourg & Liberman, 2001). In two cochlear spiral 
ligament locations, (part of the upper basal turn and the middle of the second turn) there was 
severe type IV cell loss by just 3 months of age. The SLFs loss extended further apically than 
the OHC loss, and even up to 7 months of age there was a scarce amount of hair cell loss. The 
auditory brain stem response (ABR) is an auditory evoked potential in the brain recorded by 
elecWUodeV and XVed Wo deWeUmine Whe abiliW\ of one¶V heaUing. It has been shown that fibrocyte 
loss with age reflects the ABR threshold loss with age, therefore the ABR threshold shift up 
to 7 month cannot be the result of a loss of hair cells as this loss was minimal (fig. 1.5). The 
timeline of the decreasing ABR threshold closely resembles that of the degeneration of type 
IV fibrocytes (fig. 1.5); this could mean the threshold shift could be due to the reduction in EP 
caused by the loss of these fibrocytes (Hequembourg & Liberman, 2001).   
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Figure 1. 5 Graph showing the age-related changes in cochlea structures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significantly, this research suggests that as the early-onset degeneration of the type IV 
fibrocytes occurs, cochlear ion homeostasis is disrupted (stria vascularis K+ recycling), 
causing an EP reduction. The reduction in EP reduces both the sensitivity and frequency 
selectivity of hair cells and auditory nerve fibre tuning curves (Evans & Klinke, 1982; Brown 
et al, 1983; Nouvian et al, 2003). These findings were later supported where the relative time 
course of degeneration of different cochlear structures in the CD/1 mouse model of 
Figure 1.5 Age-related changes in structures of the cochlea C57BL/6 inbred mouse strain. 
Changes seen in the upper basal turn  to about 21kHz(A) or middle of the second turn to 
about 7kHz(C) compared with the age-related threshold shift at the test frequencies for each 
region (B and D). Type IV fibrocyte loss after 3 month and no hair cell loss until after 7 
month (A and C). Type IV fibrocytes decrease by ~90%, OHC by ~70% and IHC by ~30% 
in region A. In region B type IV fibrocytes decrease by ~70%, OHC is minimal (~2%) and 
IHC by ~20%. Changes in ABR thresholds most closely mimic the degeneration patterns of 
type IV fibrocytes. Taken from Hequembourg & Liberman (2001).  
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accelerated ageing were investigated (Mahendrasingam et al, 2011b). The outbred CD/1 
mouse strain exhibits hearing loss at about 4 weeks, prior to hair cell loss, and display an age-
dependent high frequency sloping loss that progresses to a total hearing loss at all frequencies 
by 24 weeks of age (Shone et al, 1991, Le Calvez et al, 1998, Riva et al, 2005). It was shown 
that SLFs consistently begin to degenerate and show mitochondrial changes before 3 weeks 
postnatal, with type II and IV fibrocytes being the most likely to degenerate 
(Mahendrasingam et al, 2011b). They suggest mitochondrial degeneration could cause 
functional loss before actual loss of fibrocytes; therefore, the fate of the hair cells is dependent 
on the fibrocytes that regulate the removal of K+ from the perilymph highlighting the 
importance of fibrocytes in auditory transduction (Mahendrasingam et al, 2011b). Together 
these findings show fibrocyte loss precedes hair cells and/or neuron loss and may be 
accountable for the loss of sensory cell degeneration and consequently reduced hearing levels.  
 
An important and interesting property of cochlear fibrocytes is that they are present in the 
mesenchymal nonsensory regions of the cochlea therefore have the capacity for self-renewal 
whilst maintaining their multipotency. After damage caused by either noise or drug exposure 
in the inner ear, SLFs are able to repopulate themselves unlike sensory cells (Hirose & 
Liberman, 2003), although the continuous production of these cells is not sufficient to prevent 
presbycusis in CD1 mice where the hearing loss is caused by a decrease in EP (Lang et al, 
2002). However, loss of fibrocytes from the spiral ligament of humans starts at a young age 
and progressively increases with age. The replacement or regeneration of mesenchymal cells 
and fibrocytes of the inner ear is an ideal target for a new therapeutic strategy, an area which 
has been neglected.  
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There is some research that links the natural repopulation of fibrocytes and hearing recovery. 
One example is from a fairly recent study that found, when comparing 15 P6 mice to 6 noise-
exposed P28 mice, that noise-damaged mice the number of type III SLFs did not alter, in 
comparison to the loss of the other fibrocyte subtypes, and these type III fibrocytes increased 
from day 1 to 14 after noise exposure, (Li et al, 2017). Also the cells repopulating in the type I 
area, where the cells diminished profoundly after the noise damage, were positive for type III 
markers and a marker for proliferation. This study suggests type III SLFs possess the 
regeneration capacity as opposed to other fibrocyte types and may contribute to endogenous 
regeneration of the lateral wall SL. Therefore, type III cells may potentially be the key to 
regenerative therapies.  
Other research has investigated changes in the EP using a mouse model of acute cochlear 
energy failure, comprising severe cochlea lateral wall damage by 3-NP (Kitao et al, 2016). 
They detected recovery of the EP and hearing function at lower frequencies after damage of 
cochlea lateral wall fibrocytes as they observed the re-expression of Na+K+ATPase-ȕ1 in 
regenerated fibrocytes. The results indicate a mechanism for late-phase hearing recovery after 
severe deafness, often observed in the clinical setting. This is consistent with previous work 
that found histological analysis indicated that after 3-NP-treated ear damage, the lateral wall 
fibrocytes spontaneously recover and the re-expression of Na+K+ATPase-ȕ1 occXUV in WheVe 
cells in the cochlea 2 month after 3-NP treatment (Mizutari et al, 2011). 
Mechanisms underlying the decline of SLFs remain poorly understood. There may be a 
potential correspondence between mitochondrial damage and susceptibility of SLFs. Their 
degeneration is believed to be caused by features of energy depletion, shared by 
mitochondrial dysfunction, oxidative stress and ischemia (Fujinami et al, 2010). There are 
animal models in which fibrocyte degeneration is due to a molecular defect involving 
primarily fibrocytes showing severe ultrastructural alterations, with relatively few structural 
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alterations in the neurosensory epithelium (Minowa et al, 1999, Xia et al, 2002, 
Mahendrasingam et al, 2011b). The lack of mitochondrial damage seen in hair cells, and weak 
levels detected in spiral ganglion neurons suggests there is a tissue-specific difference as well 
as a genetic susceptibility. It could be that in the spiral ligament, the higher energy demands 
result in greater damage to susceptible mitochondria through generation of large amounts of 
free radicals (Seo et al, 2010).  
1.8 Treatments for Hearing Loss 
 
The options currently available for the treatment of presbyacusis are limited and consist 
mainly of prosthetic devices such as hearing aids and cochlear implants (Jongkamonwiwat et 
al, 2010).  For hearing impairments, especially presbycusis, hearing aids can offer significant 
improvements; however there is no universal benefit. For those with severe hearing loss a 
better therapeutic option may be cochlear implantation (reviewed in Hildebrand et al, 2008). 
1.8.1 Cochlear Implant 
 
Cochlear implants are devices that bypass the organ of Corti and supply electrical stimulation 
directly to the auditory nerve to mimic the functional properties of the cochlea (Kral & 
Sharma, 2012). There has been great success with the use of cochlear implantation as 200,000 
hearing impaired individuals use them worldwide with most being able to differentiate speech 
and inWeUpUeW UXdimenWaU\ aXdiWoU\ inpXW (KUal & O¶DonoghXe, 2010). However, despite the 
success of cochlear implantation, they have some limitations. Outcome differences across 
subjects in terms of accuracy of auditory cues transmitted by these implants (Brown et al, 
1990; Zeng, 2004), as well as electrode placement impact upon the success of cochlear 
implant outcomes (Finely & Skinner, 2009). The role of electrode placement as a contributor 
to the differences in the outcomes in cochlear implant was examined and found the location 
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positioning and depth of the electrode were contributory to the success as lower outcome 
scores in word recognition task were associated with greater insertion depth and number of 
contacts being located in the scala vestibuli (Finely & Skinner, 2009).   
Critical periods in the development of the auditory system also play a role in the success of 
the implants. Cochlear implantation during the first 3-4 years of life is the most optimal for 
treating hearing impairments as this is when central auditory pathways show maximal 
plasticity in response to auditory stimulation. If cochlear implantation is conducted at the end 
of this critical period, around 6.5-7 years, it results in the reorganisation of cortical areas and 
pathways (Kral & Sharma, 2012). It was also found that implantation after this critical period 
caused abnormalities in cortical auditory evoked potentials (CAEPs) thought to result from 
the functional re-organisation of the cortex (Gilley et al, 2008). One drawback of this is that 
introducing a new sensory stimulus also introduces new competition for cortical resources, 
another is the suggestion that the activity in cortical areas observed in children with late 
implants may have lasting implications for multisensory processing; although this functional 
relationship is still not clear (Gilley et al, 2008). It was suggested that sensory deprivation 
compromises learning, which adds to the concept of a sensitive period for recovery in the 
auditory system within the first 4 years of life (Kral & Eggermont, 2007). Essentially this 
means that cochlear implantation would be less effective for treating presbycusis as this 
occurs mainly in older individuals.  
An additional problem with this approach is that during cochlear implantation surgery, an 
electrode is inserted into the scala tympani which can often cause mechanical trauma due to 
disruption of delicate cochlear structures. The mechanisms behind this trauma and residual 
hearing loss are uncertain, but are thought likely to involve changes in EP that could be the 
result of spiral ligament and stria vascularis injury or due to perilymph and endolymph 
mixing (Takeuchi et al, 2000; Hequembourg & Liberman, 2001; Wangemann et al, 2004). A 
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characteristic pattern of cochlear lateral wall and basilar membrane damage in the upper basal 
turn of the cochlea in individuals who received implants has thought to be related to electrode 
trauma (Nadol, 1997). Furthermore, it is suggested that mechanical injury to the spiral 
ligament may cause degeneration of fibrocytes (Bas et al, 2012), and that the loss of these 
cells may alter the EP and lead to auditory hair cell death (Hequembourg & Liberman, 2001).  
1.8.2 Gene Replacement Therapy 
 
Gene therapy has been advocated as a possible way to treat hearing loss. This is where a gene 
is introduced and used to replace a faulty gene or activate a gene that is switched-off.  It was 
found that inhibiting caspase proteins that play a central role in the apoptosis of cells 
promotes hair cell survival after treatment with streptomycin, a cochleotoxic and 
vestibulotoxic aminoglycoside, a molecule that inhibits protein synthesis (Matsui et al, 2003). 
This followed on from earlier work which found that in the gerbil cochlea the suppression of 
the expression of the bcl-2 protein may cause apoptosis-induced presbycusis by caspase-3 
activation (Alam et al, 2001). These findings suggest inhibiting apoptosis may protect cells 
affected in presbycusis.  
The first gene found to induce age related hearing loss-like pathology was ahl in C57 mice 
(Willott et al, 1998; Hequembourg & Liberman, 2001). It was revealed this ahl gene codes for 
cadherin 23, a protein part of the tip link in the stereocilia of hair cells (Di Palma et al, 2001). 
It was later shown to be a primary determinant of presbycusis (Noben-Trauth et al, 2003). 
However, it was shown only to increase susceptibility and not be the only cause as other 
genetic factors are believed to be inYolYed. If a peUVon¶V geneV ma\ pUediVpoVe Whem Wo 
presbycusis it suggests a model that can be explored using cell-based therapies. 
The development and differentiation of hair cells in the developing cochlea is regulated by the 
expression of a gene called Atoh1. Knockout mice lacking this gene fail to produce hair cells 
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during development (Chen et al, 2002). It was found that cellular and functional repair of the 
organ of Corti in a mature deaf mammal occurred following the delivery of the Atoh1 gene to 
the inner ear by virus-mediated gene therapy (Izumikawa et al, 2005). This technique 
provides the ability of a virus carrying a gene to attach and enter a target cell, successful 
transfer to the nucleus, enabling stable expression in the nucleus, and a lack of toxicity 
(Izumikawa et al, 2005). Their findings showed that treatment with Atoh1 results in the 
generation of new hair cells and significant improvement of auditory brain stem responses by 
restoring their functional thresholds.  
However, one of the major limitations of virus-mediated gene therapy is the delivery of the 
virus to all cochlear spiral regions as this would require multiple injections at many different 
locations and increase the risk of additional damage. Also other supporting cells outside of the 
organ of Corti took up the Atoh1 gene causing ectopic hair cells to develop which would not 
be effective in re-establishing auditory function (reviewed in Cotanche, 2008).  
The presence of ectopic hair cells has been found to be associated with severe hearing 
loss (Chen et al, 2003). Overall, this delivery of Atoh1 in an adenovirus to the adult damaged 
cochlea revealed some hair cell differentiation, but the number of was unclear and the new 
hair cells could not be traced from their precursors which caused difficulty in identifying 
³neZ´ hair cells and those recovered from damage due to toxin or noise. 
Later, significant hair cell regeneration was demonstrated in a mammal by y-secretase 
inhibitor treatment in a damaged cochlea (Mizutari et al, 2013). Their approach of a caspase-3 
mouse allowed a model in which hair cells could be killed without damaging other cells so 
new hair cells could be quantified.  This in vivo treatment produced partial recovery after 
noise-induced hearing loss. Labelling revealed hair cell regeneration that resulted from 
transdifferentation of supporting cells. This finding of transdifferentation has led to the 
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development of a gene therapy consisting of virus-delivered Atoh1, tested in a clinical trial, 
the goal being to assess if inner ear fusion of CGF166 is safe and effective as a treatment for 
hearing loss. This therapy will not help those with inherited hearing loss where there is 
damage to the auditory nerve or missing structures, but it might help those with acquired 
hearing loss through drug and noise damage and aging (Actiononhearingloss.org.uk).  
1.8.3 Stem Cell Therapy 
 
Another experimental approach for inducing regeneration in the mammalian cochlea is to 
introduce cells to replace dead or dysfunctional ones and integrate them into the damaged 
sensory epithelium (reviewed in Cotanche, 2008). Using stem cells to replace hair cells or 
spiral ganglion neurons is less advanced, though it is still being explored (Liu et al, 2012; Su 
et al, 2014; Atkinson et al, 2015; Burns & Stone, 2017; Samarajeewa et al, 2018). Although 
work on the development of stem cell replacement has been significant, the research is still in 
its infancy and strategies to examine longer survival times or ways to direct stem cells to the 
cochlea still need to be determined. The main obstacles related to the use of stem cells are: 1) 
finding a suitable area of the cochlea to access; 2) ensuring that the transplanted cells survive, 
integrate and mature properly; and 3) finding ways to ensure that the stem cells do not 
become tumours (Oshima et al, 2010).  The superficial location of fibrocytes within the lateral 
wall makes them suitable to replacement by cellular transplantation 
Transplanted neural stem cells into the scala tympani of mice and guinea pigs 2 days after 
noise exposure produced fewer stem cells in the cochlea than in the nerve (Parker et al, 2007). 
Interestingly, cells that penetrated the cochlear lateral wall showed morphological, protein and 
genetic characteristics of cochlear-specific cells, such as IHCs and OHCs, pillar cells, DeiWeU¶V 
cells, fibrocytes and stria vascularis cells. Neural stem cells normally express myosin 7a (a 
mechanochemical protein and specific cochlear hair cell marker) when they are cultured in 
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differentiating conditions in vitro. Neural stem cells localised to the spiral ganglion, spiral 
ligament and spiral limbus expressed myosin 7a, while in these areas endogenous cells do not 
express it. This could be due to the limited ability of the neural stem cells to completely 
differentiate into cochlear-specific cells types and therefore form ectopic cells.  
Since then, human embryonic stem cells (hESCs) have been used to develop a cell-based 
therapy for deafness (Chen et al, 2012). Two types of otic progenitors were attained, capable 
of differentiating into hair cells and auditory neurons in vitro that exhibited the 
electrophysiological properties expected. The differentiation potential of otic epithelial 
progenitors (OEPs) and otic neural progenitors (ONPV) ZeUe WeVWed XVing µneXWUalising¶ and 
µhaiU-cell¶ cXlWXUe condiWionV. The OEPV pUodXced haiU-cell-like cells which expressed an 
outward K+ current, inwardly rectifying K+ current and inward Ca2+ current. The ONPs 
produced neurons showing a delayed-rectifier K+ current and Na+ current and provoked single 
action potentials. To explore properties of ONPs in vivo a toxic model of neuropathic 
deafness was used where these cells were transplanted into ouabain-treated gerbils (Chen et 
al, 2012). Ouabain was applied directly to the round window which selectively damages type 
1 spiral ganglion neurons and preserves hair cells and the organ of Corti. Once the ONPs were 
transplanted, after 2-3 weeks, five out of six animals had surviving transplanted cells grafted 
in the modiolus, forming an ectopic spiral ganglion and after 10 weeks it was still present but 
cells had also migrated into the RoVenWhal¶V canal. The pUojecWionV Ueaching Whe oUgan of CoUWi 
were targeting hair cells and in the transplanted animals there was a significant functional 
improvement in ABR thresholds of 46%. The cells were able to survive at least 3 weeks after 
transplantation; however, their impact on hearing was not assessed. The replacement of hair 
cells may not be an effective method for combating presbycusis. Despite the findings 
described, it was suggested that even though hair cells are functional, age-related metabolic 
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degenerations in the cochlear lateral wall can result in significant declines in cochlear 
responses (Saremi & Stenfelt, 2013).  
A rat animal model of hearing loss caused by cochlear energy failure through the application 
of the mitochondrial toxin 3-nitropropionic acid (3NP-an inhibitor of an enzyme of the 
mitochondrial electron transport chain) revealed pathological changes in fibrocytes in the 
lateral wall and spiral limbus initially (Kamiya et al, 2007). There were no signs of significant 
organ or Corti or spiral ganglion damage, indicating pathology of metabolic hearing loss. 
They used levels of 3NP that would induce a temporary threshold shift to explore the result of 
transplanted mesenchymal stem cells (MSCs) into the semi-circular canals and revealed 
significantly enhanced hearing recovery. The outcome was complete hearing recovery at low 
frequencies, but residual hearing loss remained at higher frequencies. The MSC in the 
cochlear lateral wall showed connexin 26 and connexin 30 immunostaining indicative of gap 
junctions; however, connexin 30 staining was very weak in the apical region of the lateral 
wall and the cells did not show the staining pattern at contact sites with neighbouring 
fibrocytes that would indicate gap junction connections. This contact site staining pattern was 
also not clearly seen in connexin26 staining (Kamiya et al, 2007).  
Moreover, the nuclei of some of the MSCs were small and irregular, and the cells were found 
to express connexins in the nucleus and cytoplasm as well as in the cell membrane. These 
connexin proteins were not expressed in the nuclei of normal cochlear fibrocytes which 
suggest they were not completely differentiated as cochlear fibrocytes or were an artefact due 
to the procedure or mitochondrial toxin model. This toxin model represents artificial damage 
to the lateral wall and does not represent any known ageing cochlear pathologies. This may 
mean that the hearing recovery could be due to the natural regeneration capacity of fibrocytes 
and not the MSCs, therefore it is questionable whether this model represents the natural 
ageing process of fibrocyte loss.   
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Additionally, the uptake of these cells was limited and they were dispersed throughout 
multiple locations and were not contained within the spiral ligament as they would be 
natively. More recently a study examined MSC transplantation into the semi-circular canals in 
mice with the intention to stop/delay hearing loss by transplanting before hearing ability and 
auditory pathways are fully mature (Kasagi et al, 2013). They found through the use of 
immunofluorescence for connexin26 that in young mice (of 2 to 3 weeks), engrafted MSCs 
migrated towards the cochlear lateral wall and differentiated into suspected type II and V 
fibrocyte-like cells due to the intense connexin26 labelling in the regions of the spiral 
ligament where these fibrocyte types reside (fig. 1.6). Interestingly this had no effect on 
auditory function. Moreover, in the adult mice (24-26 weeks) there was no detected migration 
or differentiation in transplanted cells (fig. 1.6).  
ThiV ZaV Whe fiUVW Wime µW\peV¶ of fibUoc\WeV diffeUenWiaWed fUom MSCV WUanVplanWaWion ZeUe 
identified. However, major a limitation of these studies is that the immunostaining for 
connexins (26 and 30) were the only markers used which they believed to represent SLFs. 
Although Connexin 26 is expressed mainly by type I fibrocytes in the cochlear lateral wall 
(Kikuchi et al, 1995) both connexin26 and connexin30 are widely expressed in the supporting 
cells of the sensory epithelium as well as fibrocytes of the SL, spiral limbus and stria 
vascularis (Kikuchi et al, 1995; Lauterman et al, 1998; Ahmad et al, 2003). This means the 
staining found in this study may not only represent SLFs but cells of the organ of Corti. 
Additionally, the immunostaining for these connexins were mainly detected in the cytoplasm 
and surrounding cells where MSCs attached to the cochlea, therefore where not detected in 
the membrane of the cells as they would be natively. Collectively, these findings are not 
conclusive in the differentiation of MSCs into SLFs after transplantation into the semi-
circular canals due to an inaccurate representation of cochlear degeneration pathology or 
indefinite detection of SLFs due to unspecific immunostaining.   
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Figure 1. 6 Immunohistochemistry of the connexin26 gap junction protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To identify the mechanism of SLF repair and the impact of transplanted MSCs the mutual 
effects on differentiation and proliferation between the two in a co-culture system was 
examined (Sun et al, 2012). Under typical culture conditions MSCs did not express markers 
for SLFs, but when they were plated on collagen-coated dishes a small group of the MSCs 
differentiated into SLF-like cells. In the initial MSC cultures, no cells were positive for Na+ 
Figure 1.6 Immunohistochemical analysis of gap junction protein Cx26. (A-1) one week 
after transplantation Cx26 was expressed in the cytoplasm and surrounding cells, where 
MSCs attached to the cochlea in the young group. (A-2) 2 weeks after transplantation 
Cx26 was expressed in the cytoplasm and surrounding cells, where MSCs attached to the 
cochlea in the young group. (B) Cx26 was not detected in the adult group. Stria 
vascularis: scala vestibuli; CD: cochlear duct; ST: scala tympani; LW: lateral wall. Taken 
from Kasagi et al (2013). 
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K+ ATPaVe ȕ1 e[pUeVVion. When Whe cellV ZeUe plaWed on collagen-coated dishes, SLF 
condition medium addition increased this Na+ K+ ATPaVe ȕ1 e[pUeVVion compaUed Wo cXlWXUeV 
without the conditioned medium.  
This suggests that transplanted MSCs in the damaged spiral ligament may induce regeneration 
of SLFs, and consequently promote hearing recovery (Sun et al, 2012). Whilst it has yet to be 
shown whether transplanted MSCs in vivo transdifferentiate into SLF-like cells, the results 
suggest hearing recovery following inner ear MSCs transplantation occurs by two 
mechanisms which contribute to damaged SLF functional recovery. Firstly MSCs 
transdifferentiate into SLF-like cells that attempt to replace the lost SLFs and secondly 
transplanted MSCs induce the proliferation and regeneration of host SLFs.  
1.9 Problems with Cell Replacement Strategies  
 
Cell therapies such as stem cell replacement have many advantages over drug and gene 
therapies. It is generally understood that replacement, repair and restoration of function is 
achieved best by cells that fulfil the most appropriate physiological/metabolic role better than 
any mechanical device, recombinant protein therapeutic or chemical compound (reviewed in 
Fodor, 2003). The most advanced and successful cell replacement strategies are autologous 
cell therapies such as those involved in the treatment of burns with autologous cultured 
keratinocytes (Carsin et al, 2000). Use of autologous retinal pigment epithelial cells for 
treating age-related macular degeneration is an area explored and it has been demonstrated 
that transplantation of these cells improved visual acuity in 57% of patients with age-related 
macular degeneration (Binder et al, 2002; Semkova et al, 2002). Such success provides proof-
of-principle of cell replacement therapies in age-related cellular degeneration processes. 
Although cell replacement strategies- at least superficially- seem very persuasive they still 
have limitations, the obvious one being that a surgical procedure is required to collect host 
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cells, and this introduces the possibility of secondary complications. Ideally this damage 
would be minimal or reduced to a much lesser extent than the pre-intervention disorder 
(reviewed in Fodor, 2003). In a clinical setting these cells could be taken from the same 
patient avoiding the rejection of the foreign cells after transplantation. In other models of 
hearing loss, transplantation has accelerated natural repair after ototoxic insult (Kamiya et al, 
2007; Sullivan et al, 2011), but this has not been done in models of presbycusis. 
Many studies have shown viability and survival of ESC cells in the inner ear, but few 
demonstrate the differentiation and regeneration of endogenous cell types. It has been found 
that the survival rate of pre-differentiated cells (13.6%) was greater than that of 
undifferentiated cell types, suggesting the pre-differentiation and targeted delivery of 
progenitor cells is a more successful cell-based therapy for treating hearing loss (Corrales et 
al, 2006).  
Moreover, during the initial cell culture period, some cultured cells can become senescent or 
even de-differentiated (reviewed in Fodor, 2003). But since fibrocytes are mesenchymal in 
origin and possess the innate ability to differentiate, this allows the functional characteristics 
of fibrocytes to be identified in order to determine whether they would be suitable candidates 
for transplantation.  
For a cell replacement therapy to achieve functional restoration a number of criteria needs to 
be fulfilled: generation of a sufficient number of cells to reverse the defect; the correct 
differentiation of cell phenotype; three-dimensional structure formation; cells produced that 
are mechanically and structurally the same as the native cells; and transplanted tissue 
integration with native tissue without rejection (Vats et al, 2002). Fibrocytes are ideal for cell 
replacement strategies given their critical role in the hearing process by maintaining the EP. 
In order for hearing restoration to be possible, the transplanted cells need to possess all of the 
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functional characteristics of the native cells they will replace, specifically, transplanted cells 
must mimic native fibrocytes. 
1.10 Established spiral ligament fibrocyte cultures 
 
In vitro culture studying is a useful and effective technique in the search for factors that cause 
disruption of SLFs. Critically inner ear spiral ligament cells can be isolated and maintained in 
secondary culture whilst retaining many of their in vivo characteristics (Gratton et al, 1996). 
Cochlear fibrocytes can be successfully cultured in vitro where the most common fibrocyte 
type to be identified in culture is type I (Gratton et al, 1996; Suko et al, 2000; Ichimiya et al, 
2000; Liang et al, 2003; Shen et al, 2004) enabling the exploration of certain protein 
expression and ion channel physiology (Liang et al, 2004; Shen et al, 2004; Liang et al, 2005). 
Also cultures of type III (Kelly et al, 2012) and type IV (Qu et al, 2007) fibrocytes have been 
identified. However, issues related to the identity of the type I cultures have surfaced from 
Gratton eW al¶V (1996) iniWial chaUacWeUiVaWion of fibUoc\WeV gUoZn in cXlWXUe. Man\ UeVeaUcheUV 
based their identification of type I fibrocyte-containing cultures on these early observations 
and incorrectly showed negative labelling for the Na+ K+ ATPase. Indeed, the presence of the 
Na+ K+ ATPase is now believed to be a characteristic of type I fibrocytes, though not to as 
great an extent as type II fibrocytes (Mahendrasingam et al, 2011a).  
There are a range of proteins that have been identified in cultured fibrocytes, including gap 
junction connexins (Kasagi et al, 2013; Yamaguchi et al, 2015), BK channels (Liang et al, 
2003; Shen et al, 2004), Ca1.2 calcium channels (Liang et al, 2004), chloride channels (Que et 
al, 2007), glutamate-aspartate transporters (Furness & Mahendrasingam, unpublished) and 
otospiralins (Zhuo et al, 2008). However, there is some discrepancy between the complement 
of proteins expressed in native SLFs and those expressed in cultured fibrocytes, as well as the 
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ionic conductance properties involved in potassium recycling in the cochlea that require these 
key proteins.  
1.10.1 Expression profile 
 
Numerous proteins and transporters have been identified in native and cultured SLFs. 
Otospiralin (Otos) is found to be involved in the functionality of fibrocytes (Delprat et al, 
2005), using a mouse model with Otos deletion indicated that a lack of otospiralin causes 
fibrocyte alterations and hearing impairment. Damage to the mesenchymal spiral ligament 
and spiral limbus fibrocytes was the only histological abnormality observed in the 21 day old 
Otos-/-mice as histopathology revealed degeneration of type II and IV fibrocytes, whilst the 
hair cells and stria vascularis appeared normal establishing that fibrocyte degeneration 
precedes hair cell degeneration (Delprat et al, 2005). Also since cytoplasmic alterations 
predominate in the fibrocytes that produce otospiralin, being type II in the spiral ligament and 
some spiral limbus fibrocytes, this suggests the lack of otospiralin has a direct effect on these 
fibrocytes, and consequently cochlear physiology contributing to age-related hearing loss.  
GLAST (glutamate aspartate transporter) is a transporter protein found to be localised in 
lateral wall fibrocytes and has been localised to types of fibrocytes (Hakuba et al, 2000; Jin et 
al, 2003). In vivo GLAST undertakes the function of transport of glutamic and aspartic acid. 
Type II and V are involved in cochlear glutamate homeostasis with type V containing the 
most glutamate in the lateral wall. The lateral wall of a CD/1 mouse expressed most GLAST 
(38%) compared to the SG (35%) and organ of Corti (27%) (Furness et al, 2009). These 
findings suggest that a functional mechanism for glutamate transport exists in lateral wall 
fibrocytes (Furness et al, 2009). Immunocytochemistry and electrophysiology was used to 
assesses D-aspartate (a glutamate analogue) uptake and GLAST expression where D-Aspartate 
accumulated into GLAST expressing fibrocytes in vitro and evoked currents blockable by the 
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GLAST inhibitor D,L-threo-ȕ-benzyloxyaspartate (TBOA, Furness et al, 2009). The currents 
were strongest in spiral limbus fibrocytes, lower in type V and type II, and negligible in type I 
fibrocytes consistent with GLAST expression levels. Hair cells are sensitive to glutamate 
induced damage therefore the importance of the role of fibrocytes in the transport of 
glutamate is crucial to cochlear functioning. Since then, the presence of GLAST in the human 
cochlea has been demonstrated in SLFs (Ahmed et al, 2013). 
Cultured SLFs have also been found to express connexins, gap junction proteins, as do native 
SLFs. Connexin26 (Kasagi et al, 2013), connexin30, and connexin43 have been detected in 
cultures, with connexin43 having the highest level (Yamaguchi et al, 2015).  
Moreover, potassium channels have been identified in cultured SLFs as it has been reported 
that cultured type I SLFs have a dominant K+ membrane conduction mediated by BK 
channels (Shen et al, 2004). They reported that the averaged half-maximal voltage-dependent 
membrane potential for whole-cell currents was 70+/-1.2mV at 1nM intracellular free Ca2+ 
and shifted to 38+/-0.2mV at 20 mM intracellular free Ca2+. This BK channels activity 
imparts to neurons biophysical properties similar to those of potassium inward rectifiers in 
cardiac myocytes, enabling the cells to maintain their membrane potential whilst conserving 
intracellular K+ (McManus et al, 1995; Wallner et al, 1999; Brenner et al, 2000). This 
suggests that BK channels are involved in the maintenance of the membrane potential of type 
I SLFs and points towards them possessing a crucial role in the generation and regulation of 
the electrochemical gradient in the lateral wall, known to be vital to K+ recycling 
(Wangemann, 2002). 
Intracellular free Ca2+ levels are critical to the activity of BK channels in type I SLFs of the 
inner ear. The voltage dependent L-type Ca channel present in type I SLFs (Cav1.2 channel) 
has also been found in type I SLF cultures using the patch-clamp technique with the peak 
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current ranging from 50 to 274 pA and average of 132.4±76.2 pA (Liang et al, 2004). Steady 
inward currents were elicited with little inactivation of membrane depolarization and turned 
off quickly with membrane repolarisation (Liang et al, 2004). 
Another potassium channel found in native SLFs is the Kir5.1 channel. Kir5.1 is an inwardly 
rectifying potassium channel (Hibino et al, 2004; Pan et al, 2016) and this channel was found 
to be expressed in type II and IV SLFs in C57/BL/6J mice but not in type I or III where its 
expression is downregulated in the ageing cochlea (Pan et al, 2016). The Kir5.1 channel has 
not yet been detected in cultured SLFs.   
Moreover, ClC-2 and ClC-K2 chloride channels have been identified in cultured rat type IV 
SLFs (Qu et al, 2007). The presence of these channels was confirmed through reverse 
transcriptase -PCR and western blot analysis. For the recording of the ClC-K2-like and ClC-2 
like whole cell Cl- currents in cultured cells, tetraethylammonium (TEA) was used to block 
simultaneous K+ activity and to study Cl- currents in isolation. The recordings identified two 
Cl- currents in cultured cells; an inwardly rectifying Cl- current activated by hyperpolarisation 
or decreased extracellular pH, which resembles ClC-2. The second, a weak outwardly 
rectifying Cl- current regulated by extracellular pH, Cl- and Ca2+ indicating ClC-K2 
characteristics. The findings suggest two functionally distinct Cl- channels are involved in the 
regulation of membrane anion conductance in cultured type IV SLFs. Due to the low and 
variable level of ClC-2 expression; it seems ClC-K2 is the dominant Cl channel in cultured 
type IV fibrocytes. However, it cannot be ruled out that a small portion of the current could be 
carried by the ClC-2, suggested by opposite regulatory effects of extracellular pH. Moreover, 
even though ClC-2 and ClC-K2 are likely co-expressed, there was difficulty in recording ClC-
2 currents in this study as a result of the experimental conditions. 
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Table 1.1 summarises the properties used to distinguish between the various types of 
fibrocytes that enable them to carry out their highly-specialised cochlear functions involved 
with maintenance of the EP and hearing function.   
 
1.11 Electrophysiological properties of spiral ligament fibrocytes 
 
In vivo, fibrocyte membranes have been found to have a positive potential of +5 to +12 mV 
relative to the perilymph (Nin et al, 2008; Adachi et al, 2013; Yoshida et al, 2015). A recent 
study has shown that the resting membrane potential of fibrocytes is around +9 mV, in vivo 
(Yoshida et al, 2016). The experiments involved the simultaneous insertion of electrodes into 
the cochlea, as well as the use of a potassium-sensitive microelectrode inserted from the 
perilymph towards the endolymph to record the potential and the concentration of potassium 
of the lateral cochlear wall in guinea pigs. Results showed that fibrocyte membranes are 
significantly more permeable to sodium than to either potassium or chloride. They concluded 
that this unique profile and sodium concentration gradient contributes to the positive resting 
membrane potential of fibrocytes (Yoshida et al, 2016). 
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The atypical characteristics of fibrocytes are believed to be crucial for maintaining the EP. 
Both the EP and hair cell membrane potentials are driving forces in sensory transduction as 
the EP is essentially a potassium equilibrium potential generated by the potassium channel, 
Kir4.1, in the intermediate cells of the stria vascularis in conjunction with the low 
concentration of potassium of the intrastrial fluid and high concentration in the intermediate 
cells (Takeuchi et al, 2000; Marcus et al, 2002). SLFs, containing potassium uptake 
mechanisms, assist with the EP generation by the maintenance of a high concentration of 
potassium inside the intermediate cells (Schulte & Adams, 1989; Crouch et al, 1997; Mizuta 
et al, 1997). Therefore, these K+ uptake mechanisms are critical to the functioning of the 
cochlea and should be a focus for a potential treatment for metabolic age-related hearing loss.  
 
1.12 Study objectives 
 
A way to prevent presbycusis is to maintain the EP well into old age in order to preserve 
sensitive hearing. In principle, this could be accomplished by replacing dysfunctional 
fibrocytes as a means of maintaining optimal potassium recycling. Since fibrocytes are 
mesenchymal, it is possible that the re-introduction of healthy fibrocytes into the spiral 
ligament using a cell replacement therapy may ameliorate the symptoms of presbycusis. The 
general premise of a transplantation therapy like this would be to restore the function lost as a 
result of the normal aging process by replacing dysfunctional cells with new healthy ones that 
possess the same specialised features and characteristics (Lindvall & BjÖrklund, 2004). 
Previous inner ear transplantation strategies have involved injecting stem cells directly into 
the semi-circular canals in order to promote migration to functional sites in the cochlea, 
including the cochlear lateral wall. Whether these stem cells differentiate sufficiently to 
become highl\ VpecialiVed oU µfibUoc\We-like¶ iV XnceUWain. SXch differentiation is essential to 
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the success of any possible functional restoration. An exciting alternative would be to 
WUanVplanW cellV WhaW aUe alUead\ VpecialiVed and diffeUenWiaWed; ³deVigneU´ cellV gUoZn Volel\ Wo 
fulfil a specific function in a specific structure. If the cultured fibrocytes mimic the native by 
showing similarities in their morphology, protein expression and ionic conductance then this 
would strengthen the argument for their transplantation as they would possess the features 
that would enable their potassium recycling capacity. Indeed, if fibrocytes can be cultured to 
show the functional characteristics as the native cells they intend to replace then this would 
make them a more robust cell group to transplant compared to stem cells whose fate is 
uncertain following transplantation in terms of migration and differentiation. It may also be 
possible to identify critical factors to direct the fate of cultured cells from one type to another 
and grow a specific kind of fibrocyte. Most of the cell replacement therapies or cell 
regeneration strategies in this area have focused on the regeneration of hair cells or spiral 
ganglion neurons, but as discussed above loss of SLFs precedes the loss of hair cells in some 
circumstances (Hequembourg & Liberman, 2001; Mahendrasingam et al, 2011b). 
The aim of this research is to attempt to grow fully-fXncWional ³deVigneU´ fibUoc\WeV in 
culture, as well as to develop a method to transplant these cultured fibrocytes into the inner 
ear in an attempt to prevent some forms of presbycusis. Fibrocytes are ideal targets for 
transplantation because the lateral wall is easily accessible when compared to deeper internal 
targets within the cochlea. It is believed that cells transplanted into the lateral wall are more 
likely to survive transplantation due to the abundance of tissue and vascular irrigation in the 
structure, as well as a low likelihood of infiltration into other cochlear regions (Zhang et al, 
2013). Fibrocyte transplantation has not been explored as a potential treatment for presbycusis 
and it may represent an exciting new therapeutic approach to help individuals suffering from 
age-related hearing loss. 
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1.12.1 Comparison of the morphology of native and cultured fibrocytes 
 
The gross morphology of cultured and native fibrocytes was assessed and classification of 
various fibrocyte types in culture. Growing fibrocytes in 3-D transplantable collagen gel 
matrices provides an optimal environment for the fibrocytes to develop their morphology in a 
manner that mimics conditions in vivo. Specifically, the gel is permissive in allowing the 
cultured cells to grow in more spatial planes and interact with other cells and their 
surroundings when compared to 2-D growth. Cells grown in 3-D matrices display marked 
improvements in overall cell numbers, viability, morphology, proliferation, differentiation, 
response to stimuli, migration, general cell function and in vivo relevance meaning that they 
function as they would in the in vivo environment (Antoni et al, 2015). 
 
1.12.2 Comparison of the electrophysiological properties of cultured and 
native fibrocytes 
 
The electrophysiological signature of native and cultured fibrocytes was assessed using the 
whole-cell voltage-patch clamp technique to measure the intrinsic conductances involved in 
the generation of the EP. Pharmacological agents were applied to both cultured and native 
SLFs to isolate and characterise the contributions of potassium channels. 
 
1.12.3 Comparison of the expression of key proteins in native and cultured 
fibrocytes 
 
The project utilises immunolabelling methods, which enable further identification of fibrocyte 
types and their key protein expression profiles, including targets such as S-100, AQP1 and the 
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Į1Na+ K+ pump. By labelling with combinations of these antibodies, this technique 
distinguished between each type of fibrocyte except type II and type V fibrocytes. It is 
therefore feasible to apply this technique to characterise cultured or native fibrocytes, or cells 
that have been transplanted into the lateral wall where multiple comparisons can be made to 
distinguish the fibrocyte types (Mahendrasingam, et al, 2011a). Also, immunocytochemistry 
was used to identify other channels or transporters involved in potassium transport and the 
generation of the EP in fibrocyte cultures.   
1.12.4 Development and validation of a novel cell replacement therapy 
 
The three methodological approaches described above were performed on fibrocytes grown in 
culture, as well as in native fibrocytes prepared from cochlear slices obtained from CD/1 
mice. Such a comparative analysis enabled Whe deWeUminaWion of ZheWheU Whe ³deVigneU´ 
fibrocytes grown in 3-D collagen matrices possess the key physiological characteristics of 
native fibrocytes. As noted above, the unique morphology, complement of membrane proteins 
and electrophysiological features inherent in lateral wall fibrocytes are crucial to their 
involvement in potassium recycling and in the maintenance of the EP, and thus general 
cochlear function. If the cultured fibrocytes display similar features to those of native 
fibrocytes then this would provide significant justification for their use in transplantation 
experiments as opposed to more traditional approaches, such as the use of stem cells. 
Transplantation strategies and spiral ligament repopulation experiments will be another aspect 
explored in this research project.  
It is hypothesised that the fibrocytes cultured in 3-D collagen gels will retain their native-like 
morphology; it is further hypothesised that they will possess a similar protein expression 
profile as certain types of native fibrocytes; and they will also show a similar 
electrophysiological signature to native fibrocytes. This will then provide suitable justification 
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supporting the use of these cultured fibrocytes as a potential cell replacement strategy to inject 
them directly into the lateral wall of experimental animals in vivo and assess whether they 
have a restorative affect upon ABR thresholds in the CD/1 mouse model of presbycusis. This 
project utilises a combination of powerful techniques made possible at Keele University such 
as cell culture, intracellular electrophysiology and immunocytochemistry. These approaches 
complement each other and will be used here in an innovative attempt to develop a possible 
cell replacement strategy to treat age-related hearing loss.  
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CKaSWHU 2 
CXlWXUing of SpiUal LigamenW FibUoc\WeV  
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2. Chapter 2- Culturing of Spiral Ligament Fibrocytes 
2.1 Introduction 
 
The majority of cell culture methods use traditional two-dimensional (2-D) monolayer cells 
cultured flat on rigid substrates. Although this 2-D approach has been a valuable method for 
cell-based studies, limitations of this approach have been noted. In the in vivo environment 
cells are surrounded by other cells and extracellular matrix in a 3-D setting, therefore 2-D cell 
culture does not entirely take the natural 3-D environment of cells into account. This 
sometimes means tests involving 2-D cell cultures can provide misleading data for in vivo cell 
characteristics due to their unnatural microenvironment (Birgersdotter et al, 2005). It has been 
shown that 3-D extracellular matrix and its receptors can dictate the phenotype of mammary 
epithelial cells (Weaver et al, 1997). 
It has been found that 3-D culture cells express different morphologies and physiology from 
2-D culture cells and 3-D cell responses are more similar to in vivo behaviour than 2-D 
culture cells (Langer & Peppas, 2003; Baharvand et al, 2006; Shield et al, 2009). A study 
examining the differentiating potential of hESCs into hepatocytes in 2-D and 3-D culture 
systems found the embryonic body of hESCs cultured in a 2-D environment displayed 
morphological characteristics of hepatocyte-like cells, binuclei and polyhedral contours. Cells 
in the 3-D culture system migrated out of aggregates and formed cordlike and multilayer 
structures which were not observed in the 2-D cultures (Baharvand et al, 2006). Moreover, 
cells in the 3-D environment showed in vivo-like ultrastructure with numerous mitochondria, 
lysosomes, prominent nucleoli, well-developed Golgi apparatus and rough and smooth 
endoplasmic reticuli (Baharvand et al, 2006). The differentiation of hESCs into hepatocyte-
like cells within the 3-D collagen scaffolds in comparison with 2-D culture also gave rise to 
cells displaying earlier and higher levels of gene expression patterns and metabolic activities 
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of hepatocytes (Baharvand et al, 2006). Another example is the transformation process of 
embryonic sensory neurons which, in vivo, express a bipolar morphology with two-opposite 
neurites, and then transform to pseudo-unipolar axonal arbour (Langer & Peppas, 2003). This 
transformation of these cells is delayed or disappears in cells cultured on flat 2-D substrates 
(Langer & Peppas, 2003). This suggests 3-D culture systems provide a microenvironment that 
is conducive to normal progenitor cell kinetics and enhanced cell differentiation. 
It is the dimensionality of the cultures that results in different cellular responses as it affects 
the spatial organisation of the cell surface receptors that engage with the surrounding cells, 
but also induces physical constraints to cells. This in turn affects the signal transduction from 
the inside to the outside of a cell, consequently influencing gene expression and cellular 
behaviour (Bettinger et al, 2009). It has been found that there is a significant variation 
between cell cultured as 2-D monolayers and those in 3-D constructs in mammalian cell 
responses including cell polarity and migration, cytoskeleton structure, distribution of 
receptors, hormone responses, growth factors and apoptotic factors (Tibbitt & Anseth, 2009; 
Kim et al, 2012). Cellular responses to pharmaceutical drugs in 3-D cultures from cells lines 
from malignant ovarian tumours have been demonstrated to be more similar to that in vivo 
than 2-D (Shield et al, 2009; Zietarska et al, 2007; Lee et al, 2008). Work has gone into 
developing 3-D culture systems in areas of drug discovery, cancer cell biology, stem cells and 
implantation strategies where the 3-D culture systems allow exploration of in vitro models 
resembling in vivo environments (Baharvand et al, 2006; Justice et al, 2009; Reininger-Mack 
et al, 2002; Sun et al, 2006).  
As stated, cells in a 3-D environment differ from 2-D cultures in terms of gene, protein, and 
cell receptor expression (Baharvand et al, 2006).This difference in gene and protein 
expression explains why cells cultured in 3-D behave differently in many cellular processes, 
including growth and proliferation, migration and invasion, and morphology (Gurski et al, 
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2010). A lot of the genes that promote rapid growth and proliferation, as well as those 
responding to factors in culture medium, are usually upregulated in cells in 2-D culture 
environments. In 2-D cell cultures the expression of genes that limit growth and proliferation 
are repressed when compared to tissue (Birgersdotter et al, 2005). This is consistent with the 
fact that 2-D cultured cells proliferate more rapidly than cells cultured in 3-D models. 
Therefore, 3-D models are crucial in maintaining gene and protein expression profiles and 
functions of cells ultimately making them behave similarly to how they would in vivo.  
Common cell culture techniques are traditional 2-D cultures (fig. 2.1a); and two typical 3-D 
cultures where cells are either grown on a scaffold/matrix (fig. 2.1b); or grown in a 
scaffold/matrix (fig. 2.1c). Most hydrogel-based scaffolds do not naturally adhere cells nor 
promote cell function. Collagen is an exception as it is rich in integrin-binding domains that 
enhance cell attachment and growth. The collagen molecule is a three-stranded structure 
which consists of three polypeptide chains twined around one another, with each chain having 
an individual twist in opposite directions (Lee et al, 2001). In the lattice structure the strands 
are held together by hydrogen and covalent bonds. Type I collagen is the most favourable for 
tissue engineering because it is a major extracellular matrix protein and fibroblasts naturally 
reside in collagen-rich matrices. Cells delivered in 3-D collagen gels have been used as a 
potential and promising treatment for neurons damaged due to injury/ disease (Lindvall et al, 
2004; Thompson & BjÖrklund, 2015). 
 
SLFs (specifically type I and IV) have previously been cultured primarily in 2-D monolayers 
(Gratton et al, 1996; Suko et al, 2000; Ichimiya et al, 2000; Liang et al, 2003; 2005; Shen et 
al, 2004; Qu et al, 2007). However, one study has demonstrated 3-D culturing of type III 
µWenVion¶ SLFV ZiWhin a type I collagen gel demonstrating that these fibrocytes can impart 
myosin-dependent contractile force on a collagenous substrate (Kelly et al, 2012). This work 
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provided support for the tension regulation function hypothesis in the spiral ligament-basilar 
membrane, and therefore their role in determining auditory sensitivity (Kelly et al, 2012). In 
this present study a successful culture of SLFs was established and cultured on a collagen 
matrix, providing not only a representative environment that more closely mimics the in vivo 
environment in terms of cells morphology, proliferation rates and gene/protein expression but 
also made it feasible to perform electrophysiology in the cells as they could be accessed at the 
top of the gels.  
 
In vivo, SLFs are typically spindle-shaped with long parallel processes (Liang et al, 2003). 
The significance of fibrocyte morphology to hearing is that their characteristic spindle-like 
shape and long processes may be a key factor in the transport of potassium as these 
processes/projections enable the formation of gap junctions between other cells which utilise 
this transport system. Without these features their ability to participate in potassium recycling 
would be affected and thus so would the EP. Fibrocyte ultrastructure is shown to be crucial to 
hearing since the severe ultrastructural alterations in knockout mice lacking the Brn-4 
transcription factor has been shown to result in severe deafness (Minowa et al, 1999). Brn-4 is 
the gene responsible for human DFN3, an X chromosome linked non-syndromic hearing loss 
(de Kok et al, 1995). Brn-4 deficient mice exhibit a reduced EP and hearing loss, as well as 
markedly fewer cytoplasmic extensions and a dramatically reduced volume of cytoplasm and 
number of mitochondria (Minowa et al, 1999).  The purpose here is that if the cells are grown 
in a 3-D matrix as opposed to a monolayer, the morphology and associated functions in 
hearing may possibly provide a restorative effect if transplanted.  
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Figure 2. 1 Schematic of cell culture systems 
 
 
 
 
 
 
 
There have been previous attempts for transplantation to restore degenerated SLFs using 
mesenchymal stem cells which were met with partial success however suffered issues with 
migration and differentiation of the transplanted cells (Kamiya et al, 2007; Kasagi et al, 
2013). Alternative strategies for repopulating the spiral ligament would be either transplanting 
a cell-laden gel or a decelluarised tissue which has been re-cellularised.  
A particularly appealing approach to engineer tissues or organs uses a combination of a 
paWienW¶V oZn cellV combined ZiWh pol\meU VcaffoldV.  The cells are harvested and 
incorporated into 3-D polymer scaffolds which act as the extracellular matrices found in 
tissues and enable delivery of the cells to the desired site in the body, provide space for new 
tissue formation, and potentially control the structure and function of the engineered tissue 
(Chen & Chen, 2019; Nishimure et al, 2019).  Hydrogels have been successfully used to 
improve post-transplantation survival of encapsulated stem and progenitor cells (Chang et al, 
2012; Ballios et al, 2015; Jha et al, 2015).  
Figure 2.1 Traditional 2-D monolayer culture (A) and typical 3-D cell culture 
systems: cell spheroids/aggregates grown on matrix (B) or cell embedded 
within matrix (C). (Modified fUom EdmondVon eW al, 2014). 
2-D mRnRla\eU 3-D VSheURidV 
gURZn Rn maWUi[ 
3-D VSheURidV 
gURZn ZiWhin 
maWUi[ 
CXlWXre media 
CXlWXre media CXlWXre media 
MaWri[ for 3-D 
cXlWXre 
MaWri[ for 3-D 
cXlWXre 
A B C 
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Another process is decellularisation, by which cells are discharged from tissues/organs, but all 
of the essential cues for cell preservation and homeostasis are retained in a three-dimensional 
structure of the organ and its extracellular matrix components (Badylak, 2007). For the 
recellularisation, the scaffold/matrix is seeded with cells with the goal being to form a 
practical organ/functioning tissue. This technique has been used in numerous other studies 
using different tissue and cell types providing successful approaches for insights into 
repopulation of decelluarised tissue for heart valve engineering and kidney regeneration 
(Roosens et al, 2017; Chani et al, 2017; Destefani et al, 2017). This could be a potential route 
for research into the degeneration of fibrocytes in the cochlea spiral ligament. 
The aim of this study was to develop from an initial 2-D culture system of SLF to a 
subsequent 3-D culture environment in which the cells can grow in a way that enables them to 
possess a native-like morphology, genetic and physiological functions that are crucial to their 
potassium recycling function, maintenance of the EP and ultimately hearing. The 
development of this 3-D transplantable matrix or scaffold could provide a potential cell 
replacement therapy to treat metabolic age-related hearing loss.  
 
2.2 Methods  
2.2.1 The experimental animal 
 
An oXWbUed VWUain of CD/1 mice (MahendUaVingam eW al, 2011) aged P9-30 ZaV XVed foU Whe 
e[peUimenWal ZoUk oXWlined beloZ. CD/1 mice ZeUe VelecWed foU XVe in WhiV VWXd\ becaXVe Whe\ 
VhoZ acceleUaWed age-UelaWed heaUing loVV and can be XVed foU ageing VWXdieV foU compaUiVon 
ZiWh oWheU UodenW VWUainV.  
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2.2.2 Preparation of the experimental animal 
 
CD/1 mice were bred and maintained in the Central Animal Facility at Keele University. All 
animals were treated in accordance with the UK Animal (Scientific Procedures) Act of 1986, 
and approved by the Animal Welfare and Ethical Review Board at Keele University. 4 to 5 
week old CD/1 mice were deeply anesthetized with sodium pentobarbitone (Vetalar) injected 
intraperitoneally at a dose of 0.1 ml for a 30 g mouse. After loss of the pedal withdrawal 
reflex, animals were decapitated. Pups were decapitated following schedule 1 killing 
guidelines.  
2.2.3 Cell culture 
2.2.3.1 Collagen I coating 
 
Before initiating any cell culture within plastic wells or flasks for monolayer cultures the 
bottom of these had to be coated with a dilute collagen I solution to better enable any future 
cells to adhere more efficiently. Stocks of rat tail collagen I (Corning, fisher scientific, UK) 
solutions were diluted to a 0.01% working solution using sterile tissue culture grade water. 
When coating coverslips within wells the coverslips were sterilised in 100% ethanol and dried 
in a laminar flow cabinet before use. The 0.01% collagen solution was added to the well or 
flask (200uL per 1cm2) and removed after 5-6 h and were incubated to dry out overnight 
@37.5ºC. Rinse with sterile tissue culture grade water twice before introducing cells (table 
2.1).  
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Table 2. 1 Collagen coating of culture dishes 
 
 
 
 
 
 
2.2.3.2 Reagents for cell culture 
 
Minimal Essential Media-Į (MEM-Į, FiVheU VcienWific, UK), AnWibioWic-Antimycotic (PSF, 
Sigma Aldrich, UK), 10% foetal calf serum (FCS,  Fisher scientific, UK) and 1% Insulin-
Transferrin-Selenium-G Supplement (ITS-G, Fisher scientific, UK) were combined to make 
medium for cell culture. Each 5 ml of medium consisted of 4.4 ml of MEM-Į, 500 l FCS, 50 
µl ITS-G, 50 µL PSF. Phosphate-buffered saline (PBS, Fisher scientific, UK) and PSF were 
combined to make the sterile wash used between medium changes. Each 5 ml of the wash 
solution contained 4.95 ml of PBS and 50 µl PSF. Trypsin-EDTA (Fisher scientific, UK) was 
used for the dissociation of cells for passaging. 
2.2.3.3 Tissue preparation and cell culture 
 
The cochlea ZaV caUefXll\ and qXickl\ diVVecWed fUom Whe VkXll. WiWh Whe VkXll facing Xp, Whe 
head ZaV biVecWed, bXllae UemoYed and opened Wo UeYeal Whe cochlea beneaWh Whe oWic capVXle 
(Whe WempoUal bone iV haUdeU Whe oldeU Whe animal). SXUUoXnding boneV ZeUe diVVecWed aZa\ 
and Whe cochlea ZaV When UemoYed and placed inWo a peWUi diVh in cold cXlWXUe mediXm (4 ஈC) 
until micro-dissection. 
Cell culture plate Area/well Volume Concentration Time todry 
24 well plate 2 cm2 200 µL 0.01% Overnight 
6 well plate 10cm2 2 mL 0.01% Overnight 
T25 flask 25 cm2 5 mL 0.01% Overnight 
Table 2.1 Scheme of pipetting for coating of culture dishes for monolayer culture with 
collagen I solution. 
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The lateral wall was dissected under a dissecting microscope using aseptic techniques (using 
forceps soaked in 100% ETOH) whilst immersed in 4 ஈC MEM-Į ZiWh PSF. A Vmall hole ZaV 
chipped through the bone at the apex of the cochlea using a sterile needle; sterile forceps were 
used to chip away the outer bone to reveal the turns of the inner spiral. Lengths of the lateral 
wall were detached and pulled away, the stria vascularis was then removed from the section 
of lateral wall leaving the spiral ligament remaining. These lengths of the spiral ligament were 
broken up into shorter length to then be used to initiate cultures,  
To increase the likelihood of attachment of the tissue to the collagen coated wells, 50 µl of 
culture medium consisting of MEM-Į VXpplemenWed ZiWh 10% FCS, 1[ PSF and 1% ITS-G 
supplement was added onto the collagen-coated 10 cm2 well (6-well plate). The spiral 
ligament tissue fragments were placed into the 50 µl of medium (strial side downwards) and 
covered with a 22mm x 22mm ½ oz. glass cover slip (smaller coverslips failed to generate 
cultures). A few drops of culture medium were added to the edges of the coverslips to prevent 
drying out. The well plates containing the ligament were placed in an incubator at 37 ஈC (5% 
CO2, 95% O2, BOC, UK) for 24 hours.  
Culture medium was then added to cause the coverslip to float and facilitate its removal. Once 
removed, 2 ml of culture medium was then slowly added to the wells containing the ligaments 
which were incubated further. The culture medium was changed every 2 to 3 days after 
rinsing twice with the washing buffer (sPBS with 1x Antibiotic-Antimycotic). 
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2.2.3.4 Passaging and freezing of cells 
 
Once cells in the primary culture had reached confluence (~2 weeks) they were passaged into 
T25 flasks. The cells were washed with sterile PBS (sPBS) and detached by the addition of 
0.02% trypsin/EDTA (1mL for 10cm2) being placed back into the incubator for ~10-15m. The 
action of trypsin was halted by the addition of medium to make a total volume of 10 ml. The 
detached cells were then centrifuged @270.5 G-force (1200 rpm) for 5 min, the supernatant 
was removed and the cell pellet was re-suspended in new culture medium and either seeded 
onto collagen coated T25 flasks and grown until confluence or the cells were then harvested 
and seeded onto gels. The medium was changed the next day after being passaged. Seeding 
densities guides are shown in table 2.2. 
Table 2. 2 Seeding density and volumes for culture dishes 
Cell culture plate Seeding density Volume Cells at confluency 
24 well plates 0.05x106 200 µL 0.24x106 
6 well plates 0.3x106 2 mL 1.2x106 
T25 flask 0.7x106 5 mL 2.8x106 
 
 
To freeze the cells the same protocol as passaging was followed, then once the cell pellet had 
been produced it was re-suspended in MEM medium with 10% DMSO (Sigma Aldrich, UK). 
Then this was transferred to a freezing tube and stored at -80ºC. To defrost and re-seed these 
cells the frozen tubes were slowly defrosted in hands and then 100µL of warmed medium 
added and re-suspended. The re-suspended cells were added to fresh medium in either a T25 
flask or 6-well plate, re-suspended and incubated at 37ºC for 24 hours. A medium change 
took place the following day to remove any dead cells. 
Table 2.2 The media volumes and density of cells for seeding. 
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2.2.3.5 Trypan blue live-dead test 
 
Cell viability and cell number of spiral ligament fibrocytes were assessed by the trypan blue 
exclusion test. This is based on the principle that live cells possess intact cell membranes and 
therefore exclude trypan blue as it cannot enter the cell (the live cells then appear golden), 
whereas dead cells do not as they lack intact cell membranes so the dye is able to penetrate 
causing the cells to appear blue.  
A haemocytometer was cleaned using 70% ethanol, and coverslip added using small volumes 
of sterile water to adhere it down. Before the cell suspension settled 10µL was taken out and 
added to an Eppendorf tube and incubated with 10µL of trypan blue solution (Thermofisher 
Scientific, UK) for 1 min at RT after being gently mixed. 10µL of the cell mixture was added 
to the haemocytometer by placing the tip at the end of the cover slip and expelling the 
solution until it filled the chamber. After, viable and dead cells were counted using a Fuch-
Rosenthal-Chamber by counting the cells within 16 square each (4x4) in each corner of the 
grid using X10 magnification and taking the average. The numbers of living and dead cells 
were used to calculate the viability, as well as the total number of cells. The total count from 4 
sets of 16 corners was divided by 4 (to get the average), and then multiplied by 2 to adjust for 
the 1:2 dilution in trypan blue (the two steps are equivalent to dividing the cell count by 2). 
The viability had to be greater than 85% for the cells to be used for further studies. 
Cells x 104 / mL = Cells Viable / 2   % (Viability) =        Cells Viable               100 
                        Cells Viable + Cells Dead 
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2.2.3.6 Preparation of collagen I gels 
 
Gels were made as instructed on Thermofisher Scientific, UK, website, a few hours prior to 
being seeded with cells (the gels set 30 min after preparation). The 3-D gels were made at a 
final concentration of 3 mg/mL collagen I from a stock solution of 9 mg/ml. A total volume of 
1 ml was made using 330 µL of the 9 mg/mL collagen solution, 100 µL 10XDMEM 
(Thermofisher scientific, UK, polymerised by addition of 18 µL 1N NaOH, and 552 µL of 
sterile H2O. All solutions were kept on ice and tubes were wiped with ethanol sprayed blue 
roll. In one chilled tube the 10XDMEM, NaOH and H2O were gently mixed using a pipette 
tip avoiding air bubbles. The collagen was transferred gently into another chilled vial to 
reduce air bubbles. Both tubes were transferred to the ice for 5 min. The 10XDMEM, NaOH 
+ H2O mixture was transferred into the collagen aliquot and stirred using a pipette tip until 
homogeneous and transferred to the ice until use. Initially 250 µL volumes were placed into 4 
wells of a 24 well plate; however this caused issues for electrode access during 
electrophysiology experiments. Thus, 250 µL was instead added to the centre of a 30 x 11 mm 
sterile petri dish, with the gels having a diameter of approximately 15.6 mm, and incubated at 
37 ஈC for a minimum of 30 min (fig. 2.2).  
Cells were seeded directly on top of the gels using 50µl of cell suspension containing a 
density of approximately 5x104 cells per sample where they were left to settle for ~2 h after 
which fresh culture medium (MEM-Į VXpplemenWed ZiWh 10% FCS, 1% ITS-G and PSF) was 
gently added to cover them overnight. The gels containing the cells were then used for 
electrophysiological experiments over the following few days and finally fixed for later 
immunocytochemistry. 
 
 59 
 
2.2.3.7 Fixation of cells or gels for immunolabelling 
 
Cells on coverslips or on gels were fixed in 4% paraformaldehyde (PFA) for 2 h for 
immunocytochemistry. 4% PFA was made using 2g PFA dissolved in 25mL of filtered H2O 
in a fume cupboard, whilst being stirred at 60ºC. 1 pellet of NaOH was added to aid this. The 
solution was then taken off the heat and 25mL of 0.2M PB was added and the pH of the 
solution was checked and amended to pH7.4. After the 2 h of fixation in 4% PFA the gels 
were kept in 0.4% PFA for longer storage. 
2.2.3.8 Trouble shooting and optimisation 
 
In the early trouble shooting period of the project, the cells (after initially being cultured in a 
2-D 6-well plate) were seeded onto collagen gels set within the wells of a 24-well plate. This 
caused numerous problems later on when it came to electrophysiology as the electrodes could 
not reach the cells due to the sides of the wells. It was then attempted to remove the gel and 
place it into the lip of a petri dish, this also raised problems of its own as it was very tricky to 
remove the gel and meant the gel was often damaged and mangled making it hard to locate 
and access the cells on the surface. Therefore it was established that the gels could be made 
directly onto the inside lid of a 30x11mm sterile petri dish. Once the solution for the gel was 
mixed, it was pipetted straight onto the petri dish in a central convex mass where it held its 
shape and set (fig. 2.2). This then enabled the cells that would later be seeded directly on top 
to be easily accessed by the electrodes to undertake the electrophysiology.    
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Figure 2. 2 Schematic of collagen gel 
 
 
 
 
 
 
 
2.2.3.9 Making antifade mountant 
 
Anti-bleaching agents are widely used for preserving signal for fluorescent dyes. Antifade is a 
custom made reagent used in our laboratory. It was freshly prepared just before the samples 
were ready to view on the confocal microscope. However the PVA/glycerol component of the 
antifade solution had to be made up in advance. The PVA/glycerol was made by dissolving 1g 
of polyvinyl alcohol (PVA) in 40mL of 0.1M PB (pH 8) @RT (stirred for 16 h). After this 
period 20mL of H2O free glycerol was added to the PVA solution and stirred for another 16 h. 
The PVA/glycerol mixture was then stored at 4ºC. 
The antifade was then freshly prepared by centrifuging the PVA/glycerol mixture for 15 min. 
0.01g of para-phenyldiamine (pPD) was dissolved in 1mL of 0.1M PB (pH8). The freshly 
dissolved pPD was diluted with the centrifuged PVA/glycerol mixture (1:10) before use. 
 
 
Figure 2.2 Collagen gel set up (not to scale). Gel pipetted into the centre of a sterile petri 
dish lid where it sets. Once set it was seeded with the cultured SLFs before being covered by 
medium. 
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2.2.3.10 Immunocytochemical labelling for cells on collagen gels 
 
For immunofluorescent labelling of the cultured cells, the gels were fixed in 4% 
paraformaldehyde for 2 h as described above, washed with PB X3 and PBS X1 before 
following similar immunolabelling procedures used previously (Mahendrasingam et al, 
2011a). In brief they were permeabilised with 0.25% Triton-X-100 in PBS with 1% goat-
serum for 30 min. The gel was then washed with PBS X3 and pre-blocked with 10% goat-
serum PBS for 30 min. Samples were then incubated overnight at 4 ஈC on a rotator with 
primary antibody (table 2.3). The following day the gel was washed with 1% goat-serum PBS 
X3 followed by application of the appropriate conjugated secondary antibodies (AlexaFluor 
488 green and 568 red) for 2 h at room temperature (table 2.3). After this the gels were 
washed in PBS X3 and mounted in antifade just prior to being observed using a confocal 
system (1024 two-photon, MRC-BioRad, UK).  
Trials of antibody concentrations were done using guides from the data sheet and other 
research using the antibody. Initial concentrations were used and modified until optimal 
labelling was achieved.  
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Table 2. 3 Antibody table 
Protein Primary antibody species and 
dilution 
Secondary antibody species and 
dilution 
AQP1 Rabbit 1:100 (MilliporeSigma, UK) Goat anti-rabbit 1:50 (Invitrogen 
Thermofisher Scientific, USA) 
S-100 Goat 1:100 (Santa Cruz, USA) Donkey anti-goat 1:50(Invitrogen 
Thermofisher Scientific, UK) 
Phalloidin  1:250 (Thermofisher Scientific, UK)  
 
 
2.2.3.11 Seeding of cultured SLFs onto dissected decellularised spiral 
ligament 
 
In this preliminary experiment the cochlea of a P29 CD/1 mouse was isolated and incubated 
for 5 days with the culture medium being changed every 2 to 3 days, so that the spiral 
ligament degeneration could occur (Kubikova & Furness, unpublished observations). The 
spiral ligament was micro-dissected after 5 days in culture and placed into 50µL of culture 
medium. The 50µL of medium was then replaced in the experimental samples with 50µL of 
cell suspension from cultures from a P9 mouse, cell count 8x105 live cells/mL. They were 
then placed back into the incubator for 24 h. 
After 24 h of incubation the cell suspension of medium was removed from surrounding the 
ligaments which were then fixed in 4% paraformaldehyde for 1 h and incubated with a 
fluorescent phalloidin and a goat-anti-rabbit TRITC antibody for background, before being 
prepared for confocal viewing with antifade Wo pUeVeUYe flXoUeVcence¶V (a custom made 
solution not commercially available). 
 
Table 2.3 A summary of the marker proteins with primary and secondary antibodies 
used with their dilution ratio. 
 
species and dilutions.   
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 2.2.4 Confocal fluorescence microscopy imaging 
 
A confocal laser scanning microscope (1024 two-photon, MRC-BioRad, UK) was used to 
observe cultured fibrocytes throughout collagen I gel construct. Fluorescence was detected 
using in-line filters for 510-530nm (green) and 565-600nm (red). Images were captured using 
either x20, x40 or x60 magnification. Three individual fluorescent images over the full z-axis 
range were captured with Lasersharp2000 software and merged into a single representative 
image using Adobe Photoshop (version 7.0).  
2.2.5 Statistics 
 
Data were analysed using GraphPad Prism statistical analysis software (version 5.0). All data 
are expressed as mean ± standard error of the mean (S.E.M.). Tests for normal distribution 
and equal variance were conducted to determine the suitable parametric or un-parametric test 
to be used. The analysis of variance and t-tests used to examine the significance of these data 
were calculated using GraphPad prism. Cell counts graphs used number of cells in 10 random 
areas within each well for each condition. Unless otherwise stated, significance was assessed 
at the 5% level (p< 0.05*); p<0.01**; p<0.001***; p<0.0001 indicate significance, shown 
across groups by bars.  
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2.3 Results  
2.3.1 Establishment of SLF culture 
2.3.1.1 Two Dimensional (monolayer) culturing 
 
In order to establish an isolated primary culture of SLFs, the spiral ligament from the cochlea 
of CD/1 mice was dissected using the approach described previously and stuck down on 
collagen coated 6-well plates where cells could then begin to grow. The cells were 
VXcceVVfXll\ cXlWXUed aV Whe\ ZeUe Veen Wo begin µcUaZling¶ oXW of Whe pieceV of ligamenW a day 
after being stuck down (fig. 2.3a & d). At this point the ligament was removed to allow the 
cells to grow until confluent (fig. 2.3c & f). After around 2 weeks of culturing the cells 
became confluent and were then either passaged into T25 flask to continue growing or seeded 
onto collagen gels. Cell viability was assessed by trypan blue dye and fibrocytes with >85% 
viability were seeded as described previously. 
The success rate of this was often quite low (usually less than 50%) therefore only 2 or 3 out 
of the 6 wells would grow cells. A way to improve WhiV ZaV Wo be UaWheU µUoXgh¶ Zhen 
dissecting the spiral ligament and break it up into smaller pieces. This was to allow the cells 
to be more exposed for culture initiation.    
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After becoming confluent in the 6-well plates the cells were either seeded onto 3-D collagen 
gels or passaged and split into T25 flasks to continuing growing. The cells seeded into and 
growing in T25 flasks in the 2-D environment appeared quickly and from day 3 to 9 (fig. 2.4) 
the density of cells significantly increased over time. Confluency was reached around day 10-
14 in culture.  Figure 2.5 shows the density of cells at day 3 in the cultures from P22 mice was 
significantly different from the density of cells at day 6 (12.22cells per mm2±3.894, n=3, 
verses 80.22 cells per mm2±12.64, n=3, respectively; p=0.0217). Moreover, the density of 
cells at day 6 in the cultures from P22 mice was significantly different to the density of cells 
at day 9 (257.2 cells per mm2±45.22, n=3; p=0.0441).  The density of cells at day 3 in the 
cultures from P22 mice was also significantly different to the density of cells at day 9 
(p=0.0273). 
 
Figure 2.4 Cells cultured on 2-D (monolayer) plastic collagen coated surface of T25 flasks 
on day 3, 6 and 9. 
 
 
 
 
 
 
 
 
 
 
FLJXUH 2.4 LighW micUoVcope imageV of cXlWXUed SLFV fUom P22 moXVe on da\ 3 (A ), 6 (B) and 
da\ 9 (C) afWeU Veeding inWo T25 flaVk. DenViW\ of cellV incUeaVeV fUom da\ 3 Wo da\ 9 XnWil Whe 
cellV in Whe T25 flaVk aUe conflXenW. Image A, B & C Waken aW [10 magnificaWion. Scale baU 
UepUeVenWV 25m. 
 
A B C 
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Figure 2.5 SLFs cultured in monolayer environment on day 3, 6 and 9. 
 
 
 
 
 
 
 
2.3.1.2 Preparation and use of collagen gel 
 
The collagen hydrogel was a critical factor to the quality and reproducibility of the assembled 
gels. Incorrectly measured components resulted in hydrogels that were too structurally weak 
to produce constructs after curing and not suitable to use in fluorescence microscopy. In this 
context, stock collagen concentrations at 3.5 mg/mL were used, which had a relatively low 
viscosity compared to higher concentration solutions at 10.2 mg/mL and were easier to 
accurately measure volumes and mix with the other hydrogel components. Additionally, the 
added handling difficulties inherent with the higher stock concentration resulted in the 
introduction of bubbles into the final collagen solution, which were transferred into the 
produced constructs and further impacted on the visualisation of cells. Thus the lower stock 
concentration was used to produce the solution. Furthermore, a rise in solution temperature 
increased the time constraints during production because the solution began to cure. Using 
compacted ice to chill both the hydrogel components and the neutralised hydrogel prevented 
the accumulation of air pockets within as it solidified over time and maintained the solution at 
Figure 2.5 Bar graph showing the density of cells in a 2-
D T25 flask on day 3, 6 and 9. Density of cells increase 
over time.  
* * 
* 
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a constant temperature. The effects of high ambient laboratory temperature were overcome by 
restricting the length of time the solution was out of ice to a maximum of five min and the 
effects of body heat mitigated by using a rack to place the final hydrogel (and the components 
during production) in the culture hood. 
The initial design of the gel later created more challenging methodological steps as gels were 
made within 24-well plates where electrode access was impossible and if the gel was removed 
it would become twisted and would break apart, again making later electrophysiology and 
labelling difficult. The new design of the gel set up in the petri dish enabled more optimal 
further assessment of the SLFs as electrodes could access the cells for electrophysiology. 
Moreover, seeding the SLFs on top of the collagen gels as opposed to within the gels made 
patch clamp electrophysiology possible as the patch electrode does not effectively penetrate 
the collagen matrix. 
2.3.1.3 Three-dimensional cultures of SLFs 
 
Once the cultured spiral ligament fibrocytes were confluent they were seeded onto collagen I 
gels, covered with medium and cultured for  up to1 week. After the initial seeding onto the 
gels, the cells appeared very round and isolated (fig. 2.6a & e) before beginning to move 
around, spread out and make connections within an hour after seeding (fig. 2.6). Within the 
first 24 h the cells appeared much fatter, elongated and interconnected. This continues over 
the next 4 days with the cells becoming more connected and cell clusters forming (fig. 2.6d & 
h, appendix 1). 
The numbers of cells appeared to slowly decrease over time period of 4 days and therefore 
seemed to have a cell death rate greater than the proliferation rate. Cells grown in a 3-D 
culturing environment seemed to have a lesser proliferation capacity. It could also be that the 
cells clumped together in large clusters so the cell density appears reduced. 
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2.3.2 Morphological characterisation of primary mice spiral ligament 
fibrocytes 
2.3.2.1 Morphological examinations of 2-D (monolayer) and 3-D cultures 
 
To mimic the spiral ligament environment, the cells where seeded onto collagen I gels in 
order to allow them to grown in a 3-D native-like environment. We examined the morphology 
of SLFs grown for up to 4 days in culture in 3mg/mL collagen gels. Light microscope images 
and time-lapse video microscopy (appendix 1) show that as cells proliferate in the hydrogels, 
they form connections and multicellular clusters (fig. 2.6). These resemble the morphology of 
fibrocytes within the spiral ligament. In comparison to the monolayer culturing where the 
cells remained more spherical and isolated. The cells in the monolayer were more spread out 
and had a more flattened morphology even when confluent, accompanied by an increase in 
the size of the nucleus (fig. 2.6b).  
 
After initial seeding, after trypsinization, the fibrocytes appeared very rounded with no 
processes or connections. Once the cells were settled on the 3-D collagen I gels compared to 
2-D collagen coated surfaces, the cells were more interconnected and rounder in terms of their 
3-D appearance (fig. 2.7). Cells were examined for morphological changes after seeding onto 
the gels, and within an hour after seeding the cells had already regained their polygonal shape 
and appeared to move around the gel starting to establish extensive cell-cell contacts with 
their processes appearing to form a network and also showing a decrease in cell size relative 
to the monolayer cells.  
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Figure 2. 7 2-D monolayer and 3-D cultured spiral ligament fibrocytes 
 
 
 
 
 
 
 
The 3-D cultured fibrocytes moved towards each other and built clusters of cells (shown and 
fig. 2.9 and appendix 1), expressing a more fibrocyte-like morphology by initially forming 
connections with the projections from the cell bodies before grouping together, shown in 
more detail through actin fibre labelling (fig. 2.7a & 2.8). In the time-lapse video (appendix 1) 
cells can be seed becoming more spindle-shaped from their initial circular appearance after 
seeding (fig. 2.9a). The cells begin to form processes and make connections with surrounding 
cells before forming clumps of cell bodies. Stills taken from different time-points of the 24-h 
time-lapse (fig. 2.9) show that after only 1 h after seeding onto the collagen gels the cells 
already appear to be forming processes and connections (fig. 2.9b) and by 6 h there is a large 
network between the cells (fig. 2.9c). At some point after this the cells begin to join and form 
clusters with the projections appearing to retract (fig 2.9d) and by 18-24 h there are just 
clumps of cells remaining (fig 2.9e & f). An individual cell can be seen (indicated by an 
arrow) forming connections and joining the masses of cell bodies and another cell can be seen 
dividing in figure 2.9b indicated by a circle. It also appears that the density of cells decrease 
Figure 2.7 Culturing lateral wall fibrocytes on 3-D collagen hydrogels. 
2-D cultured fibrocytes appear flatter (a). Fibrocytes exhibit a rounder 
morphology and have processes forming a network when on a 3-D 
collagen gel (b). Scale bar represents 25µm. 
B A 
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over time- this may be due to the cells joining the cell clumps or dying over longer time 
periods on the gels. 
 
Figure 2. 8 Phalloidin (actin) labelling in 3-D cultures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
FLJXUH 2.8 AcWin labelling fUom a flXoUeVcenW micUoVcope VhoZing confocal VWack 
imageV of cXlWXUed SLFV in a collagen I gel fUom P21 moXVe one da\ afWeU Veeding. 
ImageV A & B aW X10 magnificaWion. Scale baU UepUeVenWV 20m.  
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2.3.3 Age-dependent differences in growth rates 
 
When comparing different ages to initiate 2-D cultures; the speed of growth was significantly 
greater in the younger (P10) mice when compared to the older mice (P22, fig. 2.10). Cells are 
seen growing from the ligament by day 3 in cultures derived from both P22 (fig. 2.10a) and 
P10 (fig. 2.10c). By day 6 there are significantly more cells in the cultures derived from P10 
mice (fig. 2.10d) than those from P22 mice (fig. 2.10c). 
Figure 2. 10 Comparison of growth of spiral ligament fibrocytes from a P22 and P10 
mouse. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10 The initiation of cultures of spiral ligament fibrocytes from P10 and P22 
CD/1 mice. Images taken of the same wells at day 3 and 6. Images A (P22 culture) & C 
(P10 culture) at day 3 with the corresponding image of the same wells at day 6 in B & D. 
All images taken at X4 magnificaWion and scale bar represents 50µm. 
A 
C 
B 
D 
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As shown in the fig. 2.11 there was a significantly greater density of cells at both day 3 and 6 
from P10 mice when compared to day 3 and 6 from P22 mice. By day 6 the P10 mice cultures 
are almost confluent, halving the confluency time of the older mouse cultures. The density of 
cells at day 3 in the cultures from P10 mice was significantly greater than the density of cells 
at day 3 from P22 mice (189.8 cells per mm2±29.79, n=3 verses 12.22 cells per mm2±3.894, 
n=3, respectively; p=0.0041). The density of cells at day 6 in the cultures from P10 mice was 
significantly different to the density of cells at day 6 from P22 mice (400.4 cells per 
mm2±98.29 verses 80.22 cells per mm2±12.64, respectively; p=0.0319). There was no 
significant difference in the density of cells from the P10 mice at day 3 and day 6 (p=0.1497), 
however, there was a significant difference in the density of cells from the P22 mice at day 3 
and day 6 (p<0.0217).   
 
Figure 2. 11 Cell seeding/cell count graph for P10 and P22 mice cultures 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 Bar graph showing difference in cell proliferation rates 
between cultures derived from P10 and P22 mice at day 3 (n=3) and day 6 
(n=3). (Mean  SEM). 
* ** 
* 
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2.3.4 Aquaporin (AQP1) and S-100 spiral ligament fibrocyte marker 
labelling 
 
Results of immunolabelling experiments conducted on cultured fibrocytes in 2-D monolayers 
and 3-D gels (bright field of stained cells shown in fig. 2.12-D & 2.13-D) using antibodies 
against AQP1 and S-100 show expression of the water regulating membrane channel protein, 
AQP1 (fig. 2.12a & 2.13a) and the cytoplasmic calcium regulating protein, S-100 (fig. 2.12b 
& 2.13b). Merged confocal microscopic images show the cells expressing both AQP1 and S-
100 (fig. 2.12c & 2.13b). These images clearly show that AQP1 and S-100 proteins are 
expressed in these cultured fibrocytes and it appears that the AQP1 seems to be most 
concentrated in the cell bodies and nucleus and the S100 more so punctate and cytoplasmic. 
Figure 2. 12 AQP1 and S-100 marker protein expression in a monolayer culture of SLFs. 
 
 
 
 
 
 
 
 
 
 
C D 
AQP S-100 
C D 
Figure 2.12 2-D cultured SLFs express marker proteins. Immunolabelling for the water 
channel, aquaporin (AQP1; a), and for the calcium binding protein, S-100 (b), is high in the 
monolayer cultured fibrocytes. The merged image in c shows that AQP1 and S-100 are both 
expressed in the same fibrocytes. A bright field image of the cultured fibrocytes is shown in 
d. Scale bar represents 10µm. 
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2.3.5 Repopulation of degenerated spiral ligament using cultured fibrocytes 
 
As this was a preliminary study only two cochleae were used so labelling was conducted for 
the experimental and control conditions on pieces of ligament tissue from each. Nevertheless, 
the confocal results found through phalloidin labelling that the cultured SLFs were present in 
the decelluarised section of both ligament 1 and 2 from the experimental group seeded with a 
cell suspension of cultured SLFs (fig. 2.14a & e show light image and fig. 2.14b & f show 
corresponding confocal image) compared to the control group which was incubated with 
medium only where no cellular phalloidin labelling was present (fig. 2.14c & g show light 
image and fig. 2.14d & h show corresponding confocal image). Clear distinctive cell bodies 
can be seen in figure 2.14b& f with the morphology of the cells showing projections from the 
cell bodies making connections with other cells. In the control images (fig.2.14d& h) it 
appears fibrocytes are not present, however, blood vessels can be seen within the piece of 
spiral ligament with red blood cells in them.
 
 
 
meUge 
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Figure 2. 13 AQP1 and S-100 marker protein expression in cultured SLFs on 3-D collagen 
I gels  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
AQP1 S100 
meUge 
Figure 2.13 3-D cultured SLFs express marker proteins. Immunolabelling for 
the water channel, aquaporin (AQP1; a), and for the calcium binding protein, S-
100 (b), is high in cultured fibrocytes. The merged image in c shows that AQP1 
and S-100 are both expressed in the same fibrocytes. A bright field image of the 
cultured fibrocytes is shown in d. Scale bar represents 10µm. 
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Figure 2.14 C
onfocal im
ages show
ing actin labelling of cultured spiral ligam
ent fibrocytes in tw
o depopulated spiral ligam
ents, ligam
ent 1 A
 to 
D
 and ligam
ent 2 E to H
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, B
, E, F show
 light m
icroscope and confocal of spiral ligam
ent incubated w
ith spiral ligam
ent fibrocyte cell 
suspension (experim
ental). C
, D
, G
, H
 show
 light m
icroscope and confocal of spiral ligam
ent incubated w
ith cell m
edium
 containing no cells 
(control). Scale bar represents 50µm
. 
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2.4 Discussion 
 
When trying to determine the mechanisms underlying cochlear homeostasis the spiral 
ligament presents a significant challenge. The complexity in the cell types within the 
ligaments limits the access of investigation though recording techniques, such as patch clamp 
electrophysiology. Cultured-cell lines offer a more accessible approach to characterise these 
cells. Here, using an alternative approach, SLFs were successfully derived and cultured in a 2-
D and 3-D environment, to determine their characteristics as a prelude for supporting 
evidence in a potential cell replacement therapy. The cells in the 3-D environment were 
cultured within collagen as to mimic better the natural 3-D environment in which SLFs reside 
in vivo.  
The expression of collagen types I, II, III, IV, V, IX, and XI in the inner ear has been reported 
(Cosgrove et al, 1996; Tsuprun & Santi, 1997; Asamura et al, 2005). Among these, collagen 
II has been detected in the spiral ligament (Thalmann, 1993; Dreiling et al, 2002; Asamura et 
al, 2005). Here, collagen I was used instead of collagen II due to difficulty getting collagen II 
to set, therefore trial experiments were conducted mixing collagen I and II.  
Changes in substrate stiffness have been reported to cause a change in cell shape, where cells 
on compliant substrate retain a more rounded morphology and on a stiff substrate a flattened 
shaped, such as cells cultured on hard plastic in traditional 2-D techniques (Chen et al, 2008). 
Also, a compliant substrate directly reduces the stress at cell-matrix adhesions in an 
contracting cell which suppresses the normal maturation of focal adhesions and provides 
evidence that compliant substrates most likely supress certain types of signal while promoting 
others. Gel studies suggest that substrate stiffness can alter cellular functions such as 
migration, proliferation and differentiation (Lo et al, 2000; Peyton & Putnam, 2005; Leach et 
al, 2007; Li et al, 2007). Increasing substrate stiffness also appears to enhance proliferation of 
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cells and facilitates tumour progression (Paszek & Weaver, 2004; Wozniak et al., 2003; 
Georges & Janmey, 2005). MSCs differentiate into different lineage fates as a function of 
material stiffness, in a way that would promote tissue-specific healing (Engler et al., 2006). 
 
Preliminary attempts to introduce suspensions of fibrocytes in isolated cochleae were not very 
effective (Mahendrasingam & Furness, unpublished observations). The results of the study 
thus far indicate that it is possible to culture SLFs on a 3-D collagen matrix thus enabling 
them to have a more 3-D morphology compared to 2-D cultures. This allows the cells to 
possess an in vivo- like morphology do to the cells exhibiting a rounded cell body and a more 
interconnected network of cells as opposed to a flatter cell within the 2-D culture within no 
obvious processes forming connections. This then indicates the 3-D environment makes the 
cultures SLFs more suitable for transplantation than 2-D cultured SLFs.  
 
2.4.1 Optimisation of hydrogel construct for spiral ligament fibrocyte 
culture 
 
The new design of the gel enabled a middle ground where a comprehensive study could be 
undertaken as cells seeded on top of collagen I gels could be accessed for patch-clamp 
electrophysiology performed whilst still providing the cells a 3-D environment. It has 
previously been shown that it is possible to make patch clamp recordings from isolated 
neXUonV aW oU neaU Whe VXUface of collagen gelV (CoaWeV & NaWhan 1987; O¶ShaXghneVV\ eW al, 
2003).  
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2.4.2 Characterisation of 2-D monolayer cultured SLFs compared to 3-D gel 
cultured SLFs 
 
The interactions in 3-D spatial arrangement affect a range of cellular functions, such as cell 
proliferation, differentiation, morphology, gene and protein expression, and cellular responses 
to external stimuli (Baharvand et al, 2006; Gurski et al, 2010; Szot et al, 2011; Baker & Chen, 
2012; Price et al, 2012; Xu et al, 2012; Huang et al, 2013). The cell culture techniques in this 
study show that SLFs grown in a 3-D collagen environment possess a similar morphology to 
SLFs in vivo which, from in situ filled patch recordings in rat cochlea slice preparations, 
appear to be elongated with processes (Furness et al, 2009; Kelly et al, 2012). In contrast, 
those grown in a 2-D environment express a more flat and stretched out morphology as 
opposed to a more rounded 3-D appearance. The 3-D culture cells display processes 
appearing to form a network environment, therefore the 3-D environment enables the cells to 
make projections and cell-cell connections which more closely represents the native 
environment networks of cells forming gap junctions. It could be that putting the cells back 
into a 3-D environment, from the initial monolayer cultures, enables the cells to revert back to 
a more native-like morphology. If these 3-D cultured cells were used for transplantation back 
into the spiral ligament they would already possess the morphology require for function in 
addition to being embedded within a matrix that holds the cells within the specific area, where 
they can integrate back into the ligament.    
 
The growth rates of 3-D cultures are more consistent with that of cells in vivo than 2-D 
culture environments as findings show tumour cells cultured in the 3-D environments grow 
more compared to the same cells cultures in 2-D environments (Gorlach et al, 1994) and the 
growth rates in 3-D more closely reflects the mathematical models of tumours in vivo than the 
growth rates of the cells in 2-D (Chignola et al, 2000; Gurski et al, 2010; Chitcholtan et al, 
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2012). In traditional 2-D monolayer culture, cells adhere and grow on a flat surface enabling 
these cells to receive a homogenous amount of medium during growth (containing nutrients 
and growth factors; Huang et al, 2013). This monolayer mostly contains proliferating cells, as 
necrotic cells are usually detached and removed during medium changes. This is consistent 
with the unpublished findings by Furness et al that the endoplasmic reticulum of 2-D cultured 
SLFs appear like immature SLFs meaning they could have a faster proliferation capacity, then 
at P14 begin to look distinct and mature-like. The slower proliferation rates and slower 
decrease in density of SLFs in the 3-D environment could be due to the medium not being 
able to penetrate the clumps of cells that form after a period of days grown on the gels and 
therefore nutrients, oxygen and growth factors may not reach the cells inside the core causing 
them to become quiescent or hypoxic, whereas those in the outer layers are more exposed to 
the medium so are less challenged by the conditions. Current 3-D constructs still lack the 
complex in vivo vascular system that provides the tissues with oxygen, nutrients and waste 
removal. In the 3-D cultured cells these processes are only possible through diffusion.  
2.4.3 Faster growth of SLF cultures from younger aged mice 
 
The difference here between the growth rates of the P10 and P22 cultures show that the SLFs 
cultured from the younger mice grow at a significantly greater speed than the older mice 
cultures. It may be that the younger mouse and younger/immature fibrocytes have a greater 
regeneration capacity and thus may be more useful as a cell replacement when compared to 
older cultures. This finding in consistent with studies showing adult hematopoietic stem cells 
(HSCs) and adult MSCs which have a decreased ability to self-renew and differentiate (Lang 
et al, 2003; Roobrouck et al, 2008).  
A decrease in fibrocyte proliferation was found in the spiral ligament of an aged gerbil 
cochlea (35-37 month, when compared to a 6 month old young gerbil), significantly only in 
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type II and IV fibrocytes (Lang et al, 2003). This decrease in the turnover of type II and IV 
spiral ligament fibrocytes in aged cochleas may be related to the decrease of ion-transport 
enzymes found in the lateral wall of aged animals. For instance immunostaining of 
Na+K+ATPase is significantly reduced in type II and IV fibrocytes in aged cochleas (Schulte 
& Schmiedt, 1992; Spicer et al, 1997; Lang et al, 2003). A decreased cell turnover in type I 
and IV fibrocytes may lead to fewer surviving cells and potentially be responsible for the 
reduced immunostaining of Na+K+ATPase. Moreover, recently it has been found that most 
dividing cells in the lateral wall are located in the spiral ligament before P28 and cycle slowly 
as long as P72  days, and the number of dividing cells declines as the mice aged (from P13 to 
P72; Li et al, 2017; 2018). Therefore, this age-related decrease in cell proliferation may well 
be a causal factor in the loss of EP due to loss of function in the potassium recycling within 
the cochlea, and consequently a cause of associated metabolic presbyacusis. 
2.4.4 Marker protein expression in 2-D monolayer and 3-D cultured 
fibrocytes  
 
The identity of these 2-D monolayer and 3-D cultured cells could be verified 
immunocytochemically with marker proteins known to be expressed in different types of 
fibrocytes. The positive immunolabelling in both the 2-D and 3-D for AQP1 and S-100 show 
that in these cultures labelled for both but predominantly for AQP1. It therefore may be 
possible that these cultures are of a mixed phenotype with partial type III properties. AQP1is 
a marker for type III fibrocytes in mice (Li & Verkman 2001; Huang et al, 2002; Carbey & 
Age, 2009; Kelly et al, 2012) and the calcium binding protein S-100 (Donato, 2001) is 
strongly expressed in types I, II and V fibrocytes (Mahendrasingam et al, 2011a). The positive 
labelling for AQP1 and S-100 implies that the cultured cells still retain their functions of 
water regulation and calcium regulation. Aquaporins are proteins that facilitate water 
permeability for osmotic movement which is essential for fluid ionic transport and 
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homeostasis at their expression sites (Stankovic et al, 1995). It may also function in type III 
fibrocytes to regulate hydrostatic pressure within the spiral ligament, alongside its tension 
regulation of basilar membrane (Kelly et al, 2012).  
Additionally, type III fibrocytes have recently been found to possess a stem cell proliferation 
capacity as well as a protective capacity from degeneration that compensates for the other 
degenerating fibrocyte types. This aligns with the findings of a predominantly type III mixed 
phenotype culture aV Whe\ ma\ µWake oYeU¶ aV Whe oWheU W\peV die oXW and WhiV chaUacteristic 
may contribute to the endogenous regeneration of the lateral wall in vivo (Li et al, 2017; 
2018). It is possible that there may be redundant systems in the lateral wall for K+ recycling 
and EP generation, so that other fibrocyte subtypes can take over functionally when certain 
fibrocytes are damaged or degenerated. Thus type III fibrocytes may be the key target for 
future regenerative therapies to combat age related hearing loss alongside their established 
contractility function of regulating the tension of the basilar membrane (Kelly et al, 2012). 
2.4.5 Spiral ligament repopulated with cultured SLFs after decellularisation 
in vitro  
 
In this preliminary study we demonstrated that a decellularised spiral ligament could be 
repopulated with a cell suspension of cultured SLFs. The purpose of this was to investigate 
whether it is feasible to regenerate the ligament with these cultures as an approach to a cell 
replacement therapy. The cultured SLFs found to be present by actin labelling appeared to 
have migrated into the dissected spiral ligament. This confirms the repopulation and 
migration properties of these SLFs cultures strengthening the idea that they could be suitable 
for a cell-replacement therapy to treat age-related hearing loss. Previous in vivo studies have 
used toxin models to repopulate the spiral ligament by transplanting mesenchymal stem cells 
into the semi-circular canal of which a number where detected in the injured area of the lateral 
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wall (Kamiya et al, 2007; Kasagi et al, 2013). One group found significantly higher hearing 
recovery in the transplanted group compared to controls (Kamiya et al, 2007).  However, 
firstly these models were toxin models that do not reflect the process of natural circumstances 
of SLFs loss. Secondly, there were problems of migration and differentiation of the 
transplanted stem cells as some grew ectopically. Moreover, the differentiation of the MSCs 
into fibrocyte-like cells was demonstrated by connexin26 labelling, which although is 
expressed in SLFs, is also expressed in other cells in the inner ear, therefore is not a specific 
marker of SLFs.  
 
Although these studies were more developed than this preliminary experiment, it highlights 
the potential for using this decellularisation and recellularisation technique. This technique 
has been successful in the repopulation of decellularised tissue for heart valve engineering 
and kidney repopulation (Chani et al, 2017; Destefani et al, 2017; Roosens et al, 2017). Using 
differentiated cultured SLFs and transplanting them directly into their native area of the spiral 
ligament may be an optimal approach, thus removing any issues of migration or 
differentiation enabling maximal opportunity for them to fulfil their function in the 
maintenance of hearing.  
 
2.4.6 Conclusion 
 
To conclude, a mixed phenotype SLF culture with properties of partial type III has been 
successfully established and grown in a 3-D collagen I gel environment provides a native-like 
environment where SLFs develop a degree of native morphology and characteristics. The 
proliferation of these SLFs is faster in younger mice cultures compared to older mice cultures. 
The collagen gel 3-D environment here provides a transplantable matrix environment where 
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they could be easily manipulated and placed directly into the spiral ligament in vivo. The 
preliminary recellularisation experiment indicates it may be possible repopulate a degenerated 
ligament with cultures SLFs. These predominantly type III SLFs cultures can be used to be 
assessed further to determine whether they can be used as a therapeutic target for a cell 
replacement therapy to treat metabolic age-related hearing loss. The next chapters will build 
upon and explore further assessments of these cells to determine their functionality. To 
acquire deeper insights into the functionality of cultured spiral ligament fibrocytes, their 
protein profile and electrophysiological signature will be explored in the following chapters. 
. 
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3. Chapter 3- Immunolabelling of Spiral Ligament Fibrocytes 
 
3.1 Introduction 
 
SLFs function in cochlear homeostasis and in the maintenance of the EP through their 
involvement in K+ recycling. The degeneration of fibrocytes contributes to hearing loss 
(Okamoto et al, 2005; Antje et al, 2019), perhaps through loss of the EP. The functional 
characterisation of cochlear fibrocytes has been achieved by the discovery of the expression 
of proteins in the nonsensory regions in the cochlea involved in K+ transport in the lateral wall 
(Liang et al, 2003; 2004; Shen et al, 2004; Hibino et al, 2004; Pan et al, 2016). Fibrocytes 
express different combinations of water and ion channels, carbonic anhydrases II and III 
(Stankovic et al, 1995; Sakaguchi et al, 1998; Liang et al, 2003; Hibino et al, 2004; Shen et al, 
2004; Pan et al, 2016), and gap junction connexins 26, 30, 31 (Forge et al, 1999; Xia et al, 
2000), depending on their role in water and ionic transport.  
The inwardly rectifying K+ channel, Kir4.1 is distributed in the stria vascularis and critically 
contributes to the formation of a positive EP (Hibino et al, 1997; 2010;  Marcus et al, 2002). 
In renal epithelia (Tucker et al, 2000; Lourdel et al, 2002) and retinal Müller cells (Ishii et al, 
2003), heteromeric assembly of Kir4.1 and a Kir channel subunit, Kir5.1, occurs and forms a 
functional channel. It has previously been found that the Kir5.1 subunit is strongly expressed 
in type II, IV and V fibrocytes in the spiral ligament, whilst in the lateral wall Kir4.1 is 
expressed in the stria vascularis, the spiral ganglion area, and supporting cells in the organ of 
Corti (Hibino et al, 1997; Hibino et al, 1999; Ando & Takeuchi, 1999; Takeuchi et al, 2001).  
A difference in the time-course of developmental expression between Kir5.1 and Kir4.1 has 
also  observed as well as a decrease in Kir5.1 expression levels in cochlea of ageing 
C57BL/6J mice (Hibino et al, 2004; Pan et al, 2016), suggesting distinct and unique roles in 
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the K+ movement within the cochlea. In the spiral ligament, fibrocytes are bathed in 
perilymph and express Kir5.1 homomeric channels predominantly in the cytoplasm where it 
is believed not to form functional channels on the membrane surface of the cell (Grosse et al, 
2003; Hibino et al, 2004; 2010). Most of these channels appear to be localised in intracellular 
compartments. However, since perilymphatic perfusion of Ba2+ (Barium)  slightly increases 
the EP, it is possible that a small number of the Kir5.1 homomers on the ligament plasma 
membrane could negatively regulate K+ circulation and prevent the cochleas overshoot, as 
with the exit of K+ the cell overshoots the membrane potential and hyperpolarises (Hibino et 
al, 2004; Marcus, 1984). 
As opposed to a heteromeric Kir4.1/Kir5.1 channel that is stable and functional on the plasma 
membrane of various cells, homomeric Kir5.1 subunits believed to be endocytosed and 
internalised through the membrane surface and  do not carry any current (Tanemoto et al, 
2002). It is reported in PC12 cells, that high K+ solution activates protein-kinase A (Salvatore 
et al, 2001), the concentration of K+ in the extracellular solution surrounding fibrocytes could 
be a controlling factor in the functional expression of Kir5.1 on the plasma membrane. After 
cessation of the protein‐kinase A‐mediated signalling, unphosphorylated Kir5.1 in the 
cytoplasm would be recruited to the plasma membrane, where binding to the anchoring 
proteins could restore the negative control mechanism. The cochlea may use the two distinct 
Kir channel subunits, Kir4.1 and Kir5.1, in different ways to attain adequate K+ circulation for 
the EP formation in the lateral wall.  
Another potassium channel is the BK channel, a universally expressed large conductance 
calcium- and voltage-activated K+ channel (Meera et a, 1997) with the ability to integrate 
changes in intracellular calcium and membrane potential (Butler et al, 1993; Pallanck & 
Ganetzky, 1994). This makes the BK channel an important negative feedback system linking 
increases in intracellular calcium to outward hyperpolarizing potassium currents. Thus, the 
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channel has many important roles, including regulation of neurotransmitter release, neuronal 
excitability and smooth muscle tone (Salkoff et al, 2006). It has been shown that BK channels 
are also present in inner hair cells (Pattillo et al, 2001), the hair cells responsible for 
transducing sound to electrical impulses used in signaling to the central nervous system. 
These hair cells express a potassium current pharmacologically similar to BK channels, 
showing sensitivity to TEA (Kros & Crawford, 1990; Kros et al, 1998; Pyott et al, 2004; 
Skinner et al, 2003; Hafidi et al, 2005). 
The BK channel has been identified and characterised in cultured type I SLFs and freshly 
isolated type I SLFs, and these fibrocytes have been found to have a dominant K+ membrane 
conductance mediated by these BK channels (Liang et al, 2003; Shen et al, 2004). This, 
therefore, suggests that the cells have a crucial role in the K+ recycling and regulation of the 
electrochemical gradient in the lateral wall (Wangemann, 2002). 
Gap junction mediated intercellular communication is important in the maintenance of the 
unique ionic composition of the endolymph and intracellular ion content, both of which are 
essential for cochlear function. Connexins are transmembrane proteins which form the 
channels that enable transport of ions between cells, called gap junction proteins (reviewed in 
Kikuchi et al, 2000). Connexin26 is involved in anionic permeability and is key in 
intercellular signalling (Yamaguchi et al, 2014). It is associated with hereditary deafness in 
humans and hearing impairment in mice (Cohen-Salmon et al, 2002), and a mutation in the 
connexin26-encoding (GJB2) gene is predicted to cause 20-50% of human non-syndromic 
hereditary deafness cases (Yamaguchi et al, 2014). The proteins disruption in the spiral 
ligament is linked to be a causal and significant factor of presbycusis (Ichimiya et al, 2000). 
The expression pattern of connexin31 is detected in type I, III and IV SLFs and coincides 
with hearing loss mainly of higher frequencies (Xia et al, 1998; 2000; Lòpez-Bigas et al, 
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2002). Connexin30 is present in the lateral wall and connexin26 is observed in type I, II and 
V fibrocytes, and connexin30 detection is especially high in type II fibrocytes at the spiral 
prominence, and in type V fibrocytes at the apical tip of the spiral ligament (Kasagi et al, 
2013). It has also been found in an adult guinea pig that type III fibrocytes express 
connexin43, which are involved in the ion trafficking pathway (Kelly et al, 2012). 
Disruption of the connexin26 gap junction system complex adversely affects K+ recycling 
from the hair cells base through the supporting cells and cochlear SLFs (Lefebvre et al, 2002).  
Research using an in vivo model of hearing loss caused by intense noise exposure, as well as 
an in vitro system of SLF primary cultures, found that the prolonged decrease in levels of the 
gap junction proteins, connexin26 (in type I SLFs), connexin30, and Na+ K+- ATPase activity 
occurred in structures of the lateral wall prior to hearing loss caused by acoustic 
overstimulation. This also resulted in the dysfunction of the intracellular communication 
between SLFs.  Therefore a decrease in connexins and Na+ K+- ATPase activity causes a 
disruption of the ion-trafficking system in cochlear SLFs. Moreover it has also been found 
spiral ligament connexin26 density reduces with age despite no strial atrophy or Na-K-
ATPase reduction being detected (Ichimiya et al, 2000), which suggests that spiral ligament 
gap junction dysfunction could take place prior to stria vascularis dysfunction in an ageing 
organism.  
The aim of this part of the project was to identify and compare some of the relevant protein 
channels and transporters involved in the K+ transport function in the cultured and native 
SLFs, specifically connexin gap junction proteins, and specific potassium channel proteins. 
Building this protein profile will help to strengthen the case as to whether these cultured SLFs 
express the same proteins as native SLFs and therefore may be a potential cell replacement 
therapy to treat age-related hearing loss. 
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3.2 Methods  
3.2.1 Immunocytochemical labelling for cells on collagen gels 
 
Cells cultured on 3-D collagen I gels and native cells in cochlear wax sections were labelled 
for various channels following the protocol described in section 2.2.3.10 using the antibodies 
shown in table 3.1 below.  
Table 3. 1Antibody table 
Protein 
Primary antibody species 
and dilution 
Secondary antibody species 
and dilution 
Kir5.1 (Abcam, UK) Rabbit 1:100 Goat anti-rabbit 1:50 
BK (Alomone labs, Israel)  Rabbit 1:100 Goat anti-rabbit 1:50 
Connexin26 (Abcam, UK) Goat 1:100 Donkey anti-goat 1:50 
Connexin31 (Alpha 
diagnostics, USA) 
Rabbit 1:100 Goat anti-rabbit 1:50 
 
 
3.2.2 Cochlear fixation and embedding in paraffin wax for sectioning 
 
The cochlea was embedded in paraffin wax to allow sectioning to improve the access of dyes 
and antibodies and reduce the overlay of different cell layers. Wax embedding was also used 
due to it being the most optimal way to retrieve intact sections of the cochlea, as this bony 
structure would experience structural difficulties (crumbling) without embedding. CD/1 mice 
were deeply anesthetised following the same procedure as stated earlier (in section 2.2.2) in 
tissue preparation and cell culture. The bullae were opened and each cochlea was perfusion-
fixed in 4% paraformaldehyde in 0.1 M sodium phosphate buffer (PB), pH 7.4, through a 
small whole made in the apex and base of the cochlea, then immersed in the same fixative for 
2 h at room temperature. Next, the cochleae were washed in distilled water X3 for 10 min 
before being immersed and decalcified in 5.5% (5 mM) ethylene diamine tetra acetic acid 
Table 3.1 A summary of the marker proteins with primary and secondary antibodies used 
with their species and dilutions.   
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(EDTA) in 0.1% PFA solution for a minimum of 72 h. They were then dehydrated in a graded 
series of ethanol concentrations for 1.5 h each (50%, 70%, 80%, 90%, 100% and dry 100%). 
Each cochlea was then left in xylene for 1 h and again in fresh xylene for a further hour. The 
cochleae were then infiltrated through four changes of fresh molten paraffin wax (Agar 
Scientific, Stansted, UK) for 2 h each time at 75 ஈC before being mounted in a mould and 
embedded in fresh molten wax solidified by cooling in a refrigerator. The wax block was 
trimmed around the cochleae and sectioned at 10 µm using a Reichert-Jung 2040 wax 
microtome (Vienna, Austria). The sections were then mounted onto drops of water on glass 
slides and dried on a hot plate. 
 
3.2.3 Histological staining of cochlear wax sections 
 
Toluidine blue staining of wax sections of the section of cochlea were undertaken to review 
the histology of the spiral ligament before labelling to have an overview of the arrangement in 
that particular slice. Sections were deparaffinised and then stained. First xylene was used 
twice for 3 min each time and then slides were rehydrated using decreasing concentrations of 
ethanol first with xylene: ethanol 1:1 for 3 min, then 100% dry ethanol, 100% ethanol, 95% 
ethanol, 70%, 50% for 1 min each, then distilled water for 1 min. The sections were stained in 
toluidine blue 0.1% for 5 min then taken back through the solutions to xylene for the same 
times with the exception of the 95% ethanol in which they were left for 3 min. DPX 
(dibutylphthalate polystyrene xylene); a synthetic non-aqueous mounting medium was added 
followed by a coverslip.  
 
 
 95 
 
3.2.4 Immunolabelling of cochlear wax sections  
 
For immunofluorescence labelling, the same protocol as for histology staining was followed 
up to the distilled water step. After this was reached the sections were placed in a moist 
chamber and labelled using the same procedure as the immunolabelling of the gels.  
Quantifying the labelling intensity enabled analysis of labelled protein distribution across 
different structural compartments and the labelling intensity of those compartments. The 
samples were analysed using Photoshop 7.0 software on a cochlea section where a fixed circle 
was used to measure the mean pixel intensity at 5 random areas from each the apical, middle 
and basal spiral ligament and averaged for each region. 
3.2.5 Confocal fluorescence microscopy imaging 
 
Imaging was carried out as described in section 2.2.4. 
3.2.6 Statistics 
 
Data were analysed using GraphPad Prism statistical analysis software (version 5.0). All data 
are expressed as mean ± standard error of the mean (S.E.M.). Tests for normal distribution 
and equal variance were conducted to determine the suitable parametric or un-parametric test 
to be used. The analysis of variance and t-tests used to examine the significance of these data 
were calculated using GraphPad prism. Labelling intensity represents the pixels in 5 random 
areas within the labelled images. Unless otherwise stated, significance was assessed at the 5% 
level (p< 0.05*); p<0.01**; p<0.001***; and p<0.00001 indicate significance, shown across 
groups by bars. 
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3.3 Results 
 
3.3.1 Histological labelling of cochlea wax sections reveals turns of spiral 
ligament 
 
Whole-mount immunohistochemical examination of an adult mouse cochlea shows the 
orientation of the cochlea within the slices of wax sections (fig. 3.1). The apical, middle and 
basal spiral ligaments are easily seen in the turns of the cochlea (fig. 3.1). This histology 
labelling then set a guide for the following immunolabelling in the cochlea wax sections. 
 
Figure 3. 1 Toluidine blue histology staining  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Toluidine blue staining of a cochlea wax section 
clearly shows turns of the cochlea and reveals the apical, middle 
and basal spiral ligaments. SL- spiral ligament, SV- stria 
vascularis, BM- basilar membrane, TM- tectorial membrane, 
RM- reissners membrane, oC- organ of Corti.  Scale bar 
represents 50µm. 
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3.3.2 Kir5.1 channel protein expression in cultures 
 
An antibody was used to examine the expression of the inwardly rectifying Kir5.1 protein 
channel in mouse cultured fibrocytes on 3-D gels. Immunocytochemistry of the cultured 
fibrocytes was analysed using a confocal microscope, and revealed positive labelling for the 
Kir5.1 potassium channel (fig. 3.2). Kir5.1 immunoreactivity was found to be diffusely 
distributed within each fibrocyte. Expression of Kir5.1 was observed at in the membrane and 
also in the cell cytoplasm. 
Figure 3. 2 Cultured SLFs express the Kir5.1 potassium channel 
 
 
 
 
 
 
 
 
 
 
3.3.3 Kir5.1 channel protein expression in cochlear wax sections 
 
Kir5.1 immunoreactivity was detected in all turns of the cochlear lateral wall. The 
immunofluorescence technique showed the Kir5.1 immunoreactivity appeared in type III 
areas, along the back of the spiral ligament in the wax sections of the mouse cochlea (fig. 
Figure 3.2 Cultured fibrocytes express Kir5.1. Immunolabelling for the potassium 
channel Kir5.1. Bright field images shown in a and b shows the confocal image. 
Scale bars in a & b represent 10µm. 
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3.3b). It was expressed in most areas of the ligament indicating moderate expression in all 
types of fibrocytes. Labelling inWenViW\ ZaV VignificanWl\ gUeaWeU in Whe W\pe III aUea of Whe 
ligamenW compaUed Wo an\ of Whe oWheU aUeaV conWaining Whe oWheU fibUoc\WeV W\peV (fig. 3.4). 
Pi[el inWenViW\ ZaV VignificanWl\ gUeaWeU in Whe W\pe III aUea compaUed Wo Whe W\pe I aUea (175.3 
pi[elV 9.776, n=5 YeUVXV 29.18 pi[elV 2.883, n=5, UeVpecWiYel\, S<0.0001). IW ZaV alVo 
VignificanWl\ gUeaWeU compaUed Wo Whe W\pe II aUea (87.53 pi[elV9.983, n=5, S<0.0001) aV Zell 
aV Zhen compaUed Wo W\pe IV (71.30 pi[elV 6.714, n=5, S<0.0001) and W\pe V (44.99pi[elV 
8.026, n=5, S<0.0001). Labelling inWenViW\ ZaV alVo VignificanWl\ gUeaWeU in Whe W\pe II aUea 
Zhen compaUed Wo W\pe I (S<0.0001) and Wo W\pe V (S=0.0038). MoUeoYeU, labelling inWenViW\ 
in W\pe IV aUea ZaV VignificanWl\ gUeaWeU Whan in W\pe I aUea (S=0.0042). 
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Figure 3. 3 Immunohistochemical labelling for cochlea wax sections for Kir5.1 potassium 
channel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Immunohistochemical labelling of a cochlea wax section for Kir5.1. Kir5.1 
positively stained in most areas of the spiral ligament. A shows labelling in the type II area, 
B in the type III area, C in the type IV area and D in the type V area. Scale bar represents 
30µm. 
C D 
A B 
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Figure 3. 4 Cell fluorescence of Kir5.1 labelling in cochlea wax sections. 
 
 
 
 
 
 
 
 
 
 
3.3.4 BK protein channel expression in cultured SLFs 
 
A specific antibody against the big conductance voltage-gated BK protein channel was used 
to examine the expression of BK in cultured fibrocytes in 3-D gels. Immunocytochemistry of 
cultured fibrocytes obtained with a confocal microscope shows positive labelling for the Ca+-
activated potassium channel, BK (fig. 3.5). The expression appears to be more global and 
cytoplasmic as opposed to membrane specific. The bright spots in figure 3.5a could indicate 
some form of potential contamination of the gel or could be a UeflecWion of Whe µVWick\¶ naWXre 
of the gel.  
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Figure 3.4 Cell fluorescence pixel intensity in the different areas where 
types I to V fibrocytes reside. Mean ±SEM, n=5.  
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Figure 3. 5 Immunohistochemical labelling for BK potassium channel in cultured SLFs 
 
 
 
 
 
 
 
 
 
3.3.5 BK protein channel expression in native cochlea wax sections 
 
Immunolabelling for the Ca+ activated potassium channel in the wax sections was 
inconclusive (fig. 3.6). BK labelling was seen in all areas of the spiral ligament, but it was 
also observed in the rest of the lateral wall, stronger in the stria vascularis, and in all of the 
organ of Corti (fig. 3.6a). 
 
 
 
 
 
BK 
A B 
Figure 3.5 Immunolabelling in cultured SLFs for the large conductance calcium-
activated potassium channel, BK (a). Bright field image shown in (b). Scale bar 
represents 10µm. 
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Figure 3. 6 Immunohistochemical labelling for BK potassium channel in cochlea wax 
sections 
 
 
 
 
 
 
 
 
3.3.6 Connexin26 and connexin31 gap junction protein expression in 
cultures 
 
Positive immunocytochemical labelling for connexin26 and connexin31 was seen in the 
cultures (fig. 3.7). Some of the cultured cells were found to express both connexin26 and 
connexin31 (merged image in fig. 3.7c), some areas appeared to express more green 
fluorescence therefore may possess more connexin26, and some expressed more red 
fluorescence and may possess more connexin31. There were some cells that were unlabelled, 
suggesting they expressed neither connexin. 
Moreover, the same connexin26 and connexin31 labelling was seen in two cells connected by 
their projections and this labelling was more intense in this area of potential gap junctions 
where the cell projections join (fig 3.8). The mean pixel intensity (fig. 3.9) of the labelling of 
the cell body on the left was significantly different from that along the gap junctional area 
FLJXUH 3.6 ImmXnolabelling of laWeUal Zall Za[ cochlea VecWion foU Whe laUge condXcWance 
calciXm-acWiYaWed poWaVViXm channel, BK (a). BUighW field image VhoZn in (b). Scale  baU 
UepUeVenWV 500m. 
BK 
A B 
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(142.5 pixels ±12.27 and 206.9 pixels ±6.201, respectively, p=0.0016). The mean pixel 
intensity of the labelling of the cell body on the left was significantly different from that along 
the cell body on the right (142.5 pixels ±12.27 and 190.6 pixels ±18.41, respectively, 
p=0.0116). There was no significant difference in the mean pixel intensity between the gap 
junction area and the right cell body (p=0.1524). 
Figure 3. 7 Immunocytochemical labelling for gap junction proteins in cultured SLFs.  
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Figure 3.7 Cultured fibrocytes express connexin31 and 26. Immunolabelling for 
the gap junction proteins, Connexin31 (a) and Connexin26 (b) is high in cultured 
fibrocytes. The merged image in c shows that Connexin26 and Connexin31 are both 
expressed in the same fibrocytes. A bright field image of the cultured fibrocytes is 
shown in b. Scale bar indicates 10µm. 
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Figure 3. 8 Immunocytochemical labelling for gap junction proteins in cultured SLFs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Intense gap junction labelling in areas of possible gap junctions between 
cultured fibrocytes. Immunolabelling for the gap junction proteins, Connexin31 (a) and 
Connexin26 (b) is high in cultured fibrocytes. The merged image in c shows that 
Connexin26 and Connexin31 are both expressed in the same fibrocytes but also show 
certain areas of more expression of one connexin type than the other indicated by the 
green and red fluorescence. A bright field image of the cultured fibrocytes is shown in 
b. Scale bar indicates 10µm. 
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Figure 3. 9 Connexin fluorescent labelling intensity in cultured SLFs  
 
 
 
 
 
 
 
 
 
3.3.7 Connexin26 & connexin31 labelling in cochlear wax sections 
 
Connexin26 and Connexin31 labelling was also found in the spiral ligament of cochlear wax 
sections (fig. 3.10) and at varying intensities in the different ligaments of the different 
cochlear turns (apical, middle and basal). Their concentrations appeared greater in the basal 
turn and decreased towards the apex where the thickness of the ligament decreases. The 
fluorescence (using the pixel concentration) was compared at the 3 different sites of ligament 
for both the connexin31 and connexin26 (fig. 3.11). There was no significant difference in the 
pixel intensity of connexin31 between the apical and middle spiral ligament turn (27.25 pixel 
±1.613 and 25.21 pixel ±1.111, respectively, p=0.3281). There was no significant difference 
in the pixel intensity of connexin31 between the middle and basal spiral ligament turn (25.21 
pixel ±1.11 and 29.78 pixel ±1.818, respectively, p=0.064), or between the apical and basal 
spiral ligament (p=0.327). 
Figure 3. 9 Bar graph showing the merged fluorescent labelling pixel 
intensity of connexin26 and connexin31 comparing this in a gap junction 
area to the cell bodies to the left and right of this projection. (mean± SEM, 
n=5). 
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In contrast there was a significant difference in the pixel intensity of connexin26 between the 
middle and basal spiral ligament turn (78.70 pixel ±2.623 and 110.6 pixel ±1.876, 
respectively, p<0.0001) and between the apical and basal spiral ligament turn (p<0.0001). 
However, there was no significant difference in the pixel intensity of connexin26 between the 
apical and middle spiral ligament turn (72.59pixel ±1.258 and 78.70pixel ±2.623, 
respectively, p=0.0689). Moreover, there was a significant difference in the pixel intensity of 
connexin31 and connexin26 in the apical turn (p<0.0001). Also, there was a significant 
difference in the pixel intensity of connexin31 and connexin26 in the middle turn (p<0.0001). 
Finally, there was a significant difference in the pixel intensity of connexin31 and connexin26 
in the basal turn (p<0.0001).  
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Figure 3. 10 Connexin31 and Connexin26 labelling in turns of the spiral ligament 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 Immunohistochemical labelling of a cochlear wax section for 
Connexin26 and Connexin31. Cross section shows three areas of spiral ligament. 
Panel A shows labelling for Connexin31, B Connexin26 and C shows a merged 
panel. In the merged panel (C) the left arrow shows the apical, the top arrow 
indicating the middle turn and the right arrow the basal turn, D shows bright field 
image. Scale bar represents 50µm. 
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Figure 3. 11 Connexin fluorescent labelling intensity in the native SL 
 
 
 
 
 
 
 
 
 
 
 
3.3.8 Immunolabelling controls 
 
Secondary antibody controls were used to show that the labelling observed was due to binding 
of the secondary antibody to the primary antibody. This was done by eliminating the primary 
antibodies, therefore with no primary antibody to bind the secondary antibody; no labelling 
should be seen (fig. 3.12 & 3.13). A very small amount of background labelling can be seen, 
this could be due to the sticky nature of the collagen gels or interference of the wax.  
 
 
 
Figure 3.11 Bar graph showing the fluorescent labelling pixel intensity of connexin26 
and connexin31 in the spiral ligament comparing this in the ligament in the apical, 
middle and basal turn. (Mean± SEM, n=5). 
**** 
**** 
**** 
**** 
**** 
C
el
l F
lu
or
es
ce
nc
e 
 
 109 
 
Figure 3. 12 Immunolabelling controls for cultured SLFs 
 
 
 
 
 
 
 
 
 
Figure 3. 13 Immunolabelling controls for native SLFs 
 
 
 
 
 
 
 
 
 
A B 
Figure 3.12 Immunolabelling controls for cultured SLFs on gels. (a) shows a bight field 
of the cells on the gels and (b) shows the confocal image. Scale bar represents 20µm. 
A B 
Figure 3.13 Immunolabelling controls for the native wax section slices. (a) shows a 
bight field of the cochlea slice and turns of the spiral ligament (b) shows the confocal 
image. Scale bar represents 20µm. 
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3.4 Discussion 
 
3.4.1 Inwardly-rectifying potassium channels, Kir5.1, expressed in native 
and cultured SLFs 
 
Findings using immunohistochemistry and immunogold electron microscopy have shown 
previously that Kir5.1 immunoreactivity was detected in the lower part of the spiral ligament 
and in the suprastrial zone of the ligament, the location in which type II, IV and V fibrocytes 
are found (Hibino et al, 2004). Further examination of the lower part of the ligament 
confirmed this as the cells that showed Kir5.1 labelling were found to be spindle and slender 
shaped; morphological features indicative of these specific fibrocyte types (Spicer & Schulte, 
1996; 2002).  This has also been confirmed recently by the discovery that Kir5.1 is expressed 
in type II and IV SLFs in the cochlea of C57BL/6J mice, but not in type I or III fibrocytes, in 
which expression is typically downregulated in the aging cochlea (Pan et al, 2016). Type II 
and IV fibrocytes may play a crucial role in potassium transport as they take up potassium 
from the perilymph and supply it to the stria vascularis. Sodium-potassium pumps and Na+ 
K+ Cl- cotransporters are also highly expressed in type II and IV fibrocytes and are thought to 
play an important role assisting in this potassium uptake (Spicer & Schulte, 1996; Xia et al, 
1999). Kir5.1 channels are also believed to be involved in potassium transport in the spiral 
ligament by forming a pathway required for either potassium recycling or potassium extrusion 
from the spiral ligament to the connective tissue gap junction network.  
The EP starts to rise at around P8 and reaches adults levels two weeks after birth (Anniko, 
1985). In the stria vascularis, Na+K+ATPase and Na+K+2Cl- cotransporter are expressed at P1 
and increase to adult levels at P10 and P12 (Sakaguchi et al, 1998; Xia et al, 1999). Moreover, 
Kir5.1 becomes detectable around P10 and its expression increases and plateaus at P15-P16 
(Hibino et al, 2004), the time-course for which almost parallels that of the Na+K+ATPase, 
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Na+K+2Cl- cotransporter, and connexin26 in the spiral ligament. Kir4.1 is detected in the stria 
vascularis at P8 as the EP starts to become positive and increases between P10 and P14 
(Hibino et al, 1997). Therefore, these molecules might possibly be involved in the rapid phase 
of elevation of the EP. The two Kir channel subunits, Kir4.1 and Kir5.1, may be used by the 
cochlea in different ways to efficiently circulate K+ circulation for the generation of the EP in 
the cochlea lateral wall. However, this present study is the first finding that cultured SLFs of a 
predominantly type III mixed phenotype express Kir5.1 suggesting they are possibly involved 
in the K+ transport in the cochlea. Type III SLFs line the space between type I and II 
fibrocytes and the optic capsule, and are more frequent in the basal region of the cochlea 
(Henson & Henson, 1998), therefore these cells could be connected potentially through 
connexin channels to the type I and II fibrocytes and involved in potassium recycling through 
this Kir5.1 expression. 
Heteromeric Kir4.1/Kir5.1 channels have been found to be stable and functional on the 
plasma membrane, and homomeric Kir5.1 subunit channels endocytosed and internalised 
through the membrane surface whilst generating no current (Tanemoto et al, 2002).  Previous 
findings have found Kir5.1 to be slightly expressed on the membrane surface but abundantly 
distributed in the cytoplasm, presumably on the transport vesicles (Hibino et al, 2004). A 
possible explanation for this could be that Kir5.1 is actively recycled between the cytoplasm 
and membrane surface, and this recycling system could dynamically regulate the activity of 
Kir5.1 in the fibrocytes. It could also bind to anchoring proteins, to restore the negative 
regulatory control mechanisms and therefore show expression not only in the membrane. 
Kir6.1 has been found subcellular in the mitochondria in rat skeletal muscle and liver cells, 
located on the inner membrane (Suzuki et al, 1997). Also, when Kir2.1 was expressed in 
cultured cells, it is distributed mainly in the Golgi complex with little expression on the cell 
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surface (Hofherr et al, 2005). This suggests that Kir subunits might possess functions 
intracellularly, as well as in the plasma membrane. 
Here Kir5.1 expression was detected in native SLFs of cochlear wax sections and in the 
cultures of SLFs. The native labelling is consistent with previous research of Kir5.1 being 
expressed in SLFs (Hibino et al, 2004; Pan et al, 2016), although it cannot be confirmed here 
whether this channel is formed homomerically or heteromerically as Kir4.1 research has 
clearly shown that Kir5.1 and Kir4.1 subunits are found in different types of cells in the 
cochlea (Hibino et al, 2004). It is therefore highly possible that Kir5.1 expression in cochlear 
fibrocytes assembles homomerically. This homomeric assembly could mean this channel 
subunit could remain non-functional, consistent with a lack of inward rectification in these 
cells in this study. 
Moreover, the detection of Kir5.1 expression in the cultured SLFs is the first of this finding, 
the cultures of which we believe to be of a predominantly type III mixed phenotype. This is 
also consistent with the labelling of wax sections which found greater expression in the type 
III area when compared to other areas. This labelling strongly points towards type III SLFs 
possessing a potassium transport function, alongside its known established tension regulation 
function. This fibrocyte type has also been found to possess a regeneration capacity within the 
spiral ligament (Li et al, 2017; 2018), therefore could be a target for a cell replacement 
therapy to restore the loss of these cells that occurs in ageing organism, a promising treatment 
for metabolic presbycusis.  
3.4.2 Weak BK potassium channel expression in native and cultured SLFs 
 
Large Ca2+-activated K+ channels, BK, have a high unitary conductance and are activated by 
both membrane depolarisation and intracellular Ca2+ (reviewed in Vergara et al, 1998). BK 
channels are known to play a prominent role in hair cell function in lower vertebrates 
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(Fettiplace & Fuch, 1999). However, the role of BK channels in mammalian cochlear hair 
cells remains more obscure since these hair cells do not display electrical resonance. The BK 
channel has previously only been found in cultured type I SLFs (Liang et al, 2003; Shen et al, 
2004). In this current study, the cultured SLFs of a potential type III mixed phenotype, 
displayed weak expression for the BK channel. The non-specific labelling in the native SLFs 
could be due to a developmental effect as the sections were from a cochlea of a P7 mouse, 
whereas the cultures, although from a P9 mouse, may not be a same maturity from age of 
culture initiation due to the continuation of cell culture over a period of weeks. These cultured 
cells may have reverted back to immature fibrocytes or fully matured therefore may be a 
possible cause for limited BK expression. Strong membranous labelling for BK in inner hair 
cells is not seen until P12 to adult (Hafidi et al, 2005), an age at which the auditory system 
becomes functional. The age and fibrocyte type could therefore explain the lack of BK 
expression in the cultures and native SLFs, or alternatively, may not be present in these SLFs, 
as most of the research in this area has identified this BK channel in cultured type I SLFs. 
Therefore, differences in initial cell subtypes in addition to differences in unstable 
characteristics in cells that change over time in continuous culture could explain these 
differences in findings.   
3.4.3 Connexin gap junction protein expressed in native and cultured SLFs 
 
It has been reported previously that connexin26 and connexin31 are expressed in spiral 
ligament fibrocytes (Xia et al, 2000; López-Bigas et al, 2002).  Connexin26 is found in type I, 
II and V fibrocytes, as expression is especially intense in type II at the spiral prominence and 
in type V at the apical tip of the spiral ligament (Liu & Zhao, 2008; Kada et al, 2009; Kasagi 
et al, 2013). Connexin31 has also been found to be expressed in type I, II and IV SLFs of the 
lateral wall (Xia et al, 2000; 2002; Liu & Zhao, 2008).  
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In the current study, both native and cultured SLFs expressed the gap junction proteins 
connexin26 and connexin31. The cultured SLFs showed more intense labelling at connecting 
processes, however, this level of detail could not be determined in the native SLFs. These 
proteins were also more concentrated at sites of potential gap junction connections between 
cell projections, suggesting that the cultured fibrocytes retain gap junctional features provided 
by these connexins as they do in the native cochlea. Findings that connexin expression 
labelling appears more intense in areas where cell projections join together further suggest the 
presence of gap junctions (Kikuchi et al, 2000). The presence of the connective-tissue gap 
junction network between fibrocytes of the spiral ligament and the basal and intermediate 
cells of the stria vascularis are required for the recycling of potassium ions (Kikuchi et al, 
2000; Liu & Zhao, 2008). Further labelling for connexin 43 would have been beneficial as 
secondary marker to confirm a type III phenotype in the cultures (Kelly et al, 2012). 
Moreover, the results from the positive connexin labelling in the cochlear wax sections 
regarding the difference in expression between the spiral ligaments of the different turns of 
the cochlear were not found to be significantly different for the connexin31 but was 
significant for connexin26 when comparing the basal turn to the middle and apical, with basal 
expressing a greater amount. The apical and middle, in contrast, were not significantly 
different from each other. It may indicate that there could be more connexin26 per fibrocyte 
in the basal spiral ligament compared to the apical. This is consistent with the fact that 
presbycusis is characterised by an initial loss of high frequency sound detection associated 
with the base of the cochlea and that connexin26 disruption in the spiral ligament is linked to 
be a causal and most significant factor of presbycusis (Ichimiya et al, 2000).  
The use of paraffin wax embedding is a technique that does not come without its weaknesses 
as the hot temperatures used to melt the wax can have negative impacts on the samples, such 
as denaturing proteins. These experiments would benefit from being repeated on slices of 
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cochlea tissue sections where the spiral ligament is dissected and embedded in agarose gel 
before then being sectioned (Jagger et al, 2000), this may provide the optimal protein 
expression. 
3.4.4 Conclusion 
 
To conclXde, KiU5.1 poWaVViXm channelV aUe e[pUeVVed in boWh naWiYe and cXlWXUed SLFV, boWh 
poinWing WoZaUdV Whe confiUmaWion of WhiV channel being poWenWiall\ e[pUeVVed in W\pe III 
SLFV, a noYel finding. The BK poWaVViXm channel ZaV Zeakl\ e[pUeVVed in WheVe cXlWXUeV and 
conne[in gap jXncWion pUoWein e[pUeVVion ZaV VWUong in boWh cXlWXUed and naWiYe SLFV, 
eVpeciall\ in Whe baVal WXUn of Whe VpiUal ligamenW. ThiV e[pUeVVion ZaV inWenVified aW poinWV 
ZheUe gap jXncWion coXld be moUe concenWUaWed. OYeUall, Whe findingV VhoZ WhaW WheVe SLF 
cXlWXUeV haYe a VimilaU pUoWein e[pUeVVion pUofile aV naWiYe SLFV. TheUefoUe WheVe cXlWXUed 
cellV ma\ noW e[peUience a loVV of fXncWion Zhen compaUed Wo naWiYe SLFV, fXUWheU bXilding 
Whe caVe of WheiU XVe in a cell-UeplacemenW WheUap\ Wo WUeaW age-UelaWed heaUing loVV. 
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4. Chapter 4- Electrophysiology of Spiral Ligament Fibrocytes 
 
4.1 Introduction 
 
The maintenance of the ionic balance within and between the unique fluids of the cochlea is 
key to the functioning of the auditory system. The homeostasis of potassium is particularly 
important as K+ is the main cation carrying the acoustic transduction MET currents in the 
sensory hair cells (Corey & Hudspeth, 1979; Zidanic & Brownell, 1990). K+ concentration is 
low in the perilymph (~5mM) and high in the endolymph (~150mM) under normal conditions 
(Smith et al, 1954) and it is this gradient and the highly positive EP (~80mV) that provides 
the driving force for K+ influx into the hair cell through the MET channels to 
mechanoelectrical transduction in the mammalian cochlea. The active secretion of K+ from 
the stria vascularis maintains the high concentration of K+ in the endolymph (Wangemann, 
2002). However, there is accumulating evidence that non-sensory cells, including highly 
specialised subpopulations of the spiral ligament fibrocytes, are active in this process (Spicer 
& Schulte, 1996; Minowa et al, 1999; Steel, 1999). The reason for the lack of information in 
this area is due to difficulties in establishing pure subpopulations of healthy SLFs, as well as 
the challenges when attempting to access SLFs in vivo. In this study we investigate the 
electrophysiological and molecular characterisation of voltage-dependent K+ channels in 
native and a culture of predominantly type III mixed phenotype SLFs. 
The difference in electrical potential between the interior and exterior of the fibrocyte network 
enables the movement of ions; it has been found in vivo this membrane potential difference is 
maintained between +5 and +12 mV with respect to outside (Nin et al, 2008; Adachi et al, 
2013; Yoshida et al, 2015; 2016).  Yoshida et al (2016) found that fibrocyte membranes were 
significantly more permeable to sodium than to potassium or chloride. However, previous 
findings show type I SLFs cultures have a membrane conductance dominated largely by 
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potassium and a RMP of ~-40mV (Shen et al, 2004). The variance within these experiments 
could be due to a variety of reasons such as fibrocyte types, as some work exploring the 
electrophysiology of SLFs has been conducted on type I cultures specifically, and other work 
on the spiral ligament as a whole. Another potential reason for variance could be between the 
environments in terms of cultures or in vivo recordings, in addition to the difference in 
techniques used ranging from single or double-barrelled electrode insertion to whole-cell 
patch clamping. The inconsistencies may also be related to difference in the efficiency of the 
perilymphatic perfusion. 
 
A BK channel has been identified and characterised in cultured type I SLFs using both the 
patch-clamp technique and reverse transcription polymerase chain reaction (Liang et al, 
2003). It is thought that this channel significantly influences the cell membrane properties and 
it was demonstrated that BK channels are the dominant force responsible for regulating 
membrane conductance in type I SLFs. This suggests they have a critical role in the 
establishment of a proper electrochemical gradient for the potassium recycling in the cochlea 
(Liang et al, 2002; 2003; Shen et al, 2002; 2004). 
 
TEA+ is a small organic cation, about the size of a hydrated K+ ion that blocks most 
K+ channels. Presumably, it occupies a vestibule that is large enough to accept a hydrated 
K+ ion, but TEA+, unlike K+, cannot pass through a narrower part of the pore and thus blocks 
rather than permeating. The effects of the non-specific K channel blocker that reversibly 
blocks most K channels by binding to the K+- permeable pore,  has also been shown to almost 
completely reduce the current in type I SLFs (Liang et al, 2003; 2005; Shen et al, 2004). It is 
found intracellular application of 4mM TEA had no effect on single channel activity; 
however, extracellular application of 1mM TEA inhibited channel activity completely (Liang 
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et al, 2003). They produced a dose-response curve of the opening probability in response to 
extracellular TEA showing the opening probability significantly decreased with increasing 
TEA concentration. 
Some fibrocyte types aUe belieYed Wo be inYolYed in Whe cochlea¶V inflammaWoU\ UeVponVe Wo 
trauma induced by disease, noise and ageing (Hequembourg and Liberman, 2001; Ohlemiller, 
2009). The type III SLFs in vitro have been suggested to be involved with tension regulation 
in the spiral ligament-basilar membrane complex as they possess muscle and non-muscle 
filaments and display a mechanically contractile phenotype by cells inducing contraction of a 
collagen lattice. Therefore these cells are a crucial component in determining auditory 
sensitivity (Kelly et al, 2012). However, due to their inaccessibility in vivo direct 
experimental evidence to investigate these cells further is limited. 
Here we compare the electrophysiological properties of cell cultures of predominantly type III 
mixed phenotype SLFs, type III being the µWenVion¶ fibUoc\WeV, obWained fUom fUeVhl\ iVolaWed 
primary spiral ligament explants, to that of native SLFs from freshly sectioned cochlea, 
revealing an active potassium channel in both. This is the first work directly comparing the 
physiological properties between a predominantly type III mixed phenotype culture of SLFs 
and native SLFs, and exploring the K+ transport in these cultured SLFs which could provide 
new insight into a way to treat age-related hearing loss. We report the electrophysiological 
characterisation of voltage-dependent K+ channels in these cells. 
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4.2 Methods  
 
4.2.1 Preparation of fresh cochlea sections 
 
Cochlear slices were taken from P7-9 CD/1 mice, as this was the optimal age for slicing of the 
cochlea and used the technique provided by Jagger et al (2000). The bullae were excised and 
the cochlear bones exposed. Additional dissection was performed in 4 ஈC artificial 
cerebrospinal fluid (ACSF, table 4.1), bubbled with 5% CO2 and 95% O2. The cochlear bone 
was mounted on a vibratome (Leica VT1000) using superglue and slices were cut horizontally 
from apical to basal end in a mid-modiolar plane at 300 µm using a vibrating blade at a speed 
of 1.5 mm/sec and frequency of 8Hz. The slices were then submerged in the cold ASCF and 
transferred into a recording chamber and positioned in such a way as to expose the spiral 
ligament to perform electrophysiology on SLFs. 
Another technique for the native fibrocytes access for patch clamping was employed when 
vibratome produced sub-optimal results. Dissection of the spiral ligament was used following 
the same microdissection procedure as that for the dissection prior to cell culture using a 
dissection microscope (Leica, Wild M8), however, once a section of spiral ligament was 
dissected it was held down in the recording chamber by two pieces of teased dental floss (fig. 
4.1) to enable the tissue to be held securely and allow access of the recording electrodes to the 
fibrocytes.  
4.2.2 Whole cell recording set up and preparation 
 
The set-up used for the patch clamping utilized a microscope (Upright, Olympus BXWI) 
supported on a vibration-isolation table. On the left of the patch rig a micromanipulator held 
the puffer pipette and on the right a second micromanipulator held the patch pipette. The 
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microscope image was also displayed on the computer screen through a monochromatic video 
camera (fig. 4.1).  
Figure 4. 1Rig set-up 
 
 
 
 
 
 
 
 
 
 
 
At the start of the recordings, the pump was set to perfuse artificial perilymph @RT, bubbled 
with 5% CO2 95% O2 (BOC gas), through the recording chamber. The experimental chamber 
contained a petri dish with the hydrogel central in the recording chamber with the cells facing 
up (on top of the gel) for the cultured fibrocyte recordings. A set up containing two strings of 
dental floss in a cross pattern to hold the spiral ligament in place for the native fibrocyte 
recordings, both could be transferred from the dissection microscope to the patch clamping 
microscope. A constant supply of ACSF was delivered to one side of the sample set up and 
this ACSF was removed at an average rate of 0.2mL per min.  
 
A glass capillary puller (Narishige PC-10) was used to make recording electrodes from 
borosilicate glass capillaries (GC120TF-10, Harvard apparatus) with a ~1µm wide tip and 
Figure 4.1 Photo of the setup 
of the rig. At the top of the 
image the inverted camera 
can be seen. To the left of the 
stage the micromanipulator 
for the puffer can be seen and 
to the right the recording 
pipette with the fine 
manipulators either side and 
coarse directly on top of the 
air table.  
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resistance of around 4 Mȍ Zhen filled ZiWh inWUacellXlaU VolXWion (KCl solution, table 4.2) pH 
adjusted to 7.3 with KOH and tip of electrode dipping in the bath. Prior to filling with 
intracellular solution, patch pipettes were gently fire polished at the rear end of the recording 
electrode and then insulated with wax to reduce pipette capacitance (avoiding the very tip of 
the electrode). 
 
4.2.3 Dextran 3000  
 
The patch pipette was filled with fluorescent Dextran 3000 (Thermofisher, UK) diluted in the 
intracellular solution to enable the cell to be visualised once whole cell patching was 
successful. A stock at 10mM dissolved in dH2O was diluted to a final concentration of 
0.1mM.  
 
4.2.4 TEA (potassium channel blocker)  
 
100mM TEA (Sigma Aldrich, UK) stock solution was diluted in the ACSF solution to a final 
concentration of 10mM in dH2O. The TEA was applied by pressure ejection (controlled by a 
PV 820 pneumatic picopump, World Precision Instruments, FL, USA) through a glass pipette 
electrode (opening diameter 1-3µm) approaching the cell from the left, with a variable 
pressure of between 14 and 70kPa. Once the pipette was in position the pressure was adjusted 
to obtain clear solution exchange without producing large movements of the cell body. The 
pipette was kept about 5 to 10µm from the cell. The TEA was usually applied for 0.6s every 
2s approximately, with a pause between each sweep.  
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4.2.5 Whole cell patch clamp recording  
 
Fibrocytes were identified visually. A syringe linked to a filter and micro-loader tip was used 
Wo fill a boUoVilicaWe pipeWWe ZiWh inWUacellXlaU VolXWion. PipeWWeV ZeUe µflicked¶ genWl\ Wo 
remove air bubbles and then placed in a pipette holder attached to the head stage of the patch 
clamp amplifier. The amplifier was set to voltage-clamp mode and the pipette voltage offset 
was adjusted so the currents measured 0 pA. The electrode tip was directed towards the 
chosen isolated fibrocyte using a precision micromanipulator whilst simultaneously 
monitoring the height of the pipette on the video. Once the cells were in focus the pipette tip 
was kept just above the focus level of the cells, using the fine manipulator controls when 
proceeding. 
 
The electrode was directed towards the cell body moving using the axial control until the tip 
touched the cell and a small dimple was observed in the surface of the membrane. Positive 
pressure was then UeleaVed and VXcWion applied Wo obWain a 1 Gȍ Veal. The holding command 
voltage was slowly set to negative (-50mV). To form a seal and break through the membrane, 
suction pulses were applied using the mouth syringe. Following break-in, voltage steps from 
different holding potentials were delivered to characterise the membrane currents. Recordings 
were acquired and analyzed using Signal 2.16 software. Voltages were corrected for the 
uncompensated series resistance and junction potential before plotting of I±V curves. RMPs 
were measured in voltage-clamp by reading the voltage value where the current was 0nA. 
Conductance is  ூ
௏
  (inverse of resistance). 
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Table 4. 1 Extracellular solution 
 
KCl 
NaCl 
CaCl2 
MgCl2 
NaH2PO4 
NaHCO3 
Glucose  
mM 
2.5 
 
124 
 
1.3 
 
2 
 
1.25 
 
26 
 
17 
 
 
 
 
Table 4. 2 Intracellular solutions 
 
KCl 
NaCl 
MgCl2 
EGTA 
HEPES 
Glucose 
mM 
140 
 
10 
 
2 
 
0.5 
 
5 
 
5 
 
4.2.6 Statistics 
 
 
Table 4.1 Components of extracellular solution (ACSF) made up 
with dH2O and adjusted to pH7.3 with NaOH. Source of 
components from Sigma, UK. 
Table 4.2 Components of intracellular solution made up with dH2O 
and adjusted to pH7.3 with KOH (as from Kelly et al, 2012). 
Dextran 3000 diluted in solution at 0.1mM. Source of components 
from Sigma, UK.  
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Data were analysed using GraphPad Prism statistical analysis software (version 5.0). All data 
are expressed as mean ± standard error of the mean (S.E.M.). Tests for normal distribution 
and equal variance were conducted to determine the suitable parametric or un-parametric test 
to be used. The number of experiments (n) refers to the number of cultured or native SLFs 
recorded from, with multiple primary cultures established from different mouse litters. The 
analysis of variance and t-tests used to examine the significance of these data were calculated 
using GraphPad prism. Unless otherwise stated, significance was assessed at the 5% level (p< 
0.05*); p<0.01**; p<0.001***; p<0.0001 indicate significance, shown across groups by bars.   
 
4.3 Results 
 
4.3.1 Whole-cell voltage clamp experiments 
 
Cells in cultures derived from spiral ligament explants were grown on 3-D collagen gels and 
accessed successfully by electrodes from electrophysiology (fig. 4.2). SLFs were grown on a 
gel (fig 4.2a) and individual cells targeted for patch-clamping the cell was immediately filled 
with Dextran 3000 which fluoresced (figs 4.2b-g). Native SLFs within the spiral ligament of a 
cochlear slice were also accessed successfully (fig. 4.3). Turns of the cochlea revealed the 
lateral wall containing the SLFs (fig 4.3a). Individual SLFs within the spiral ligament were 
also identified and targeted for patch-clamping and once whole-cell were filled with Dextran 
3000 (fig 4.3b-g).  
 
 
 
E 
B C D 
F G 
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Figure 4. 2 Recording from 3-D cultured SLFs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Whole-cell recordings of 3-D cultured spiral ligament fibrocytes on a 3-D 
collagen gel. A shows overview of cells on gel. B-D show light microscope images of SLFs 
and E-G the corresponding cell filled with Dextran 3000 once whole cell via the recording 
pipette. Left electrode is recording pipette and right electrode is puffer (filled with 10mM 
TEA). Scale bar in A indicates 25µm and B-G indicate 10µm. 
A 
B C D 
E F G
A 
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Figure 4. 3 Recording from native SLF  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Whole-cell recordings of native spiral ligament fibrocytes. A shows cochlea 
slices revealing spiral ligaments containing the fibrocytes. B-D show light microscope 
images of SLFs and E-G the corresponding cell filled with Dextran 3000 once whole cell via 
the recording pipette. Left electrode is recording pipette and right electrode is puffer (filled 
with 10mM TEA). Scale bar in A indicates 25µm and B-G indicate 10µm.  
 
E 
B C D 
F G 
A 
 128 
 
With a KCl-based pipette solution and a NaCl based bath solution two main characteristic 
groups arose from the recordings in the cultured and native SLFs, linear responses and 
outwardly rectifying whole-cell currents induced by depolarising membrane potentials. Cells 
were filled with the fluorescent dye Dextran 3000 in order to locate and see the exact cells 
being recorded from. The electrophysiological recordings are shown from SLFs grown in 3-D 
culture on collagen gels (n=25), where whole-cell voltage-clamp recordings of intrinsic 
membrane conductances were obtained (fig. 4.4). A cultured SLF was filled with Dextran 
3000 and exhibited a linear response (non-rectifying) in an IV plot (figs 4.4a-c), the average 
group IV plot for linear responses shown in figure 4.4d (n=17). A cultured SLF recorded from 
and immediately filled with Dextran 3000, exhibiting an outwardly rectifying response in an 
IV plot (figs 4.4e-g), the average group IV plot for outwardly responses shown in figure 3.3h 
(n=8). 
The electrophysiological recordings from native SLFs (n=38), where again whole-cell 
voltage-clamp recordings of intrinsic membrane conductances were obtained. As with the 
cultured SLFs two main groups arose from the recording responses, linear and outwardly 
rectifying.  
Native SLFs were recorded from and immediately filled with Dextran 3000, exhibiting a 
linear response (non-rectifying) in an IV plot (figs 4.5a-c), the average group IV plot for linear 
responses shown in figure 4.5d (n=27). A native SLF was filled with Dextran 3000 and 
exhibited an outwardly rectifying response in an IV plot (figs 4.5e-g), the average group IV 
plot for outwardly responses shown in figure 4.5h (n=11). It appears from the trace data 
shown in figure 4.5e &f that there may be multiple cells contributing to the recording as 
opposed to a singular cell, the use of tracer dyes could have confirmed this. 
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Inward current was induced by hyperpolarisation and outward current by depolarisation and 
in voltage clamp are plotted as negative values and shows downward deflection whilst 
outward are plotted at positive values and shows upward deflection. 
The linear current in both the cultured and native fibrocytes is very similar, however, when 
comparing the outwardly rectifying groups the current is much greater in the native fibrocytes 
than the cultured as the total current through the range of voltage steps in the cultured SLFs in 
the outwardly rectifying group was 0.42 nA, and in native SLFs was 1.77nA, which is x4.2 
greater than the current in the cultured SLFs.  
 
4.3.1.1 Resting membrane potential and conductance values in native and 
cultured fibrocytes 
 
Certain characteristics of the cells (RMP, conductances and reversal potentials values) were 
deduced from the IV graphs to giving insight into the functions of these cells and the 
similarities or differences in them between native and cultured fibrocytes. The resting 
membrane potential tells us the electrical potential when the cell is not stimulated, so the 
current when there is no voltage injected- what the cell rests at. The RMPs of cultured and 
native fibrocytes show linear and outwardly rectifying responses (fig. 4.6). In the outwardly 
rectifying responses the mean RMP was -8.63mV (±4.75, n=8) and -16.73mV (±7.01, n=11) 
in the cultured and native fibrocytes respectively; this means the RMP in the native SLFs for 
the outwardly rectifying group is almost twice as negative than the cultured, however there 
was no significant difference between the RMPs in the culture and native SLFs. In the mean 
linear responses the RMP in cultured fibrocytes was -8.13mV (±2.77, n=17) and -10.78mV 
(±3.00, n=27) in the native fibrocytes which are relatively similar RMPs and they were not 
significantly different.   
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 Figure 4. 4 IV plot of responses in 3-D
 cultured fibrocytes 
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 Figure 4. 5 IV plot of responses in native fibrocytes  
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Figure 4. 6 RMP of native and 3-D cultured fibrocytes  
 
 
 
 
 
 
 
 
The condXcWance of Whe membUane Wo Whe ion UefeUV Wo Whe UaWio of Whe ion¶V neW floZ WhUoXgh 
the cell to the driving force. Figure 4.7 shows the conductance of native and 3-D cultured 
fibrocytes. The conductance values of cultured and native fibrocytes with linear responses 
show a very similar mean conductance (0.021µS ±0.004, n=17; versus 0.023µS ±0.003, n=27 
respectively), therefore there was no significant difference in conductance between the 
cultured and native fibrocytes showing a linear response. In the outwardly rectifying 
responses the conductance values at negative voltage steps (-60mV to -80 mV) in cultured 
fibrocytes was 0.002µS (±0.001, n=8) and 0.009µS (±0.003, n=11) in native fibrocytes which 
is X4.5 greater than in cultured SLFs. Despite this there were no significant differences in 
these values between the native and cultured fibrocytes. There was, however, a significant 
difference (p=0.026) in the conductance values in the outwardly rectifying responses between 
native and cultured fibrocytes at positive voltage steps (10mV to 20mV), 0.006µS (±0.003, 
n=8) in cultured and 0.02µS (±0.007, n=11) in native fibrocytes, over three times greater than 
in cultured SLFs. 
FLJXUH 4.6 BaU gUaph VhoZing Whe aYeUage UeVWing membUane 
poWenWialV (RMP) of 3-D cXlWXUed fibUoc\WeV (a) and naWiYe fibUoc\WeV 
(b). The WZo UeVponVe gUoXpV: oXWZaUdl\ UecWif\ing (cXlWXUed n=8; 
naWiYe n=11); and lineaU (cXlWXUed n=17; naWiYe n=27) (mean  SEM). 
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Figure 4. 7 Conductance of native and 3-D cultured fibrocytes  
 
 
 
 
 
 
 
 
 
The capacitance of a cell corresponds to the surface area of a cell. The capacitance of 3-D 
cultured and native SLFs were found to not be significantly different, although higher in 
cultured fibrocytes (11.67pF±1.424 and 8.225pF±1.272, respectively, p=0.1329) (fig. 4.8).  
Figure 4. 8 Capacitance of 3-D cultured and native SLFs 
 
 
 
 
 
 
 Figure 4.8 Bar graph showing the capacitance of 3-D cultured 
(n=3) and native (n=4) SLFs. (mean  SEM).  
FLJXUH 4.7 BaU gUaphV VhoZing Whe aYeUage condXcWance YalXeV in 3-D cXlWXUed 
and naWiYe fibUoc\WeV. The gUaph VhoZV Whe condXcWance aW negaWiYe (-80 Wo -
60mV) and poViWiYe VWepV (10 Wo 20mV) in Whe lineaU and oXWZaUdl\ UecWif\ing 
gUoXpV, ZiWhin Whe WZo gUoXpV, (mean  SEM). OR= oXWZaUdl\ UecWif\ing, 
lineaU= none UecWif\ing cXUUenW. 
Ύ 
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4.3.2 TEA experiments/ Effect of TEA on current in 3-D cultured and 
native spiral ligament fibrocytes 
 
The effect of the non-specific K channel blocker TEA was evaluated with extracellular 
application. TEA is widely used for reversible blockade of K channels in many preparations 
and was used in these experiments to assess the presence of potassium currents. It has been 
shown to reversibly block most K channels by binding to the K+-permeable pore (Hille, 
1991). TEA eliminates the delayed K+ current measured in voltage clamp experiments. Effect 
of TEA is almost immediate showing a response after approximately 20msec. Also resistance 
increases after TEA application as ion channels are closing. 
10mM TEA was puffed onto a fibrocyte during a whole-cell recording showing an immediate 
effect after the TEA puff was applied (fig. 4.9). It then continues to increase resistance where 
channels have started to close, showing a time dependent block that increases with time. TEA 
appears to block/reduce the holding current at -50mV, presumably through an effect of an 
unknown cation channel.   
Control TEA experiments were conducted with the puffer electrode to confirm the effect 
would be due to the TEA itself and not any other confounding variables such as mechanical 
effects. An example in a native SLFs of the control TEA experiment where ACSF was loaded 
into the puffer electrode and puffed onto the cell in replacement of TEA (fig. 4.10). TEA has 
no effect on the current neither in a time dependent of voltage dependent manner (fig. 4.10). 
Before all experiments the puffer was checked for working by aiming at any lose debris to 
check if it moved when puffer was released.  
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 Figure 4. 9 Effect of TEA
 on a current trace response in a native spiral ligam
ent fibrocyte 
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 Figure 4. 10 Effect of AC
SF control on a current trace response in a native spiral ligam
ent fibrocyte 
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The averaged effect of TEA on current is shown in the native SLFs (n=8), cultures 
established from P9 mice (n=3) and cultures established from P28 mice (n=7) (fig. 4.11). In 
all cases TEA reduced the current, but produced a greater reduction in native SLFs and 
cultured SLFs derived from P28 mice. TEA reduced the current in native SLFs by ~1nA (fig. 
4.11a) and TEA in the cultures from P9 mice reduced the current to a lesser extent, by 
~0.25nA (fig. 4.11b). TEA in cultured SLFs from P28 mice had a similar effect to that of the 
native SLFs by reducing the current to a similar degree of ~1nA (fig 4.11c). Controls for these 
experiments in native (a, n=6) and cultured (b, n=6) SLFs were undertaken by replacing TEA 
with ACSF in the puffer electrode (fig. 4.11 d & e). ACSF had no effect in either the native or 
cultured SLFs (fig. 4.11d & e). This means the effect on current was purely due to TEA and 
not any confounding mechanical stimuli.  
The IV plot shown in figure 4.12a shows the effect of TEA on current in native SLFs. TEA 
had a greater effect at negative voltages than at positive voltages, as the greatest effect of TEA 
occurred at around -90mV reducing the current by approximately ~1nA (fig. 4.12a). The 
effect of TEA is reduced as the steps become more positive. An IV plot showing the effect of 
TEA on the current in cultured SLFs from P9 mice shows TEA had a small effect at negative 
voltages with the greatest effect reducing the current by approximately ~-0.25nA at around -
70mV (fig. 4.12b).  An IV plot showing the effect of TEA on the current in cultured SLFs 
from P28 mice shows TEA has a small effect at around -70mV and 30mV (fig 4.12c).  
TEA partially blocked the current in native (fig. 4.12a), cultured fibrocytes from P9 mice (fig. 
4.12b) and cultured fibrocytes from P28 mice (fig. 4.12c), but had a greater effect at the 
negative voltages in native fibrocytes, reducing the current more so. TEA appears to block a 
non-specific cation channel. Prior to TEA application in this experiment there was generally a 
greater current in the cultured fibrocytes, contradictory to earlier data, this could be due to 
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linear and rectifying responses being averaged together or a difference in the protocol due to 
the application of the TEA. 
Figure 4. 11 Effect of TEA on current trace in native and 3-D cultured SLFs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B A 
FLJXUH 4.11 Whole-cell cXUUenWV ZeUe inhibiWed b\ e[WUacellXlaU TEA, Whe K channel blockeU. 
AYeUaged WUaceV VhoZing Whe cXUUenW befoUe and afWeU TEA in naWiYe (a, n=8); and 3-D cXlWXUed 
SLFV fUom P9 mice (E, n=3); and 3-D cXlWXUed SLFV fUom P28 mice (F, n=7). Black lineV VhoZ 
conWUol, and Ued lineV in a Wo F UepUeVenW Whe UeVponVeV afWeU TEA applicaWion (10mM) and in G 
& H UepUeVenW UeVponVeV afWeU TEA ZaVh-off (ACSF applicaWion). ConWUol TEA e[peUimenWV 
pXffing ACSF onWo cellV in UeplacemenW of TEA (G & H). AYeUaged WUaceV VhoZing Whe cXUUenW 
befoUe and afWeU ACSF applicaWion in naWiYe (G, n=6); and cXlWXUed SLFV (H, n=6). All cellV aW a 
holding YolWage of -50mV and VhoZn aW +30mV VWep.  
 
C 
D E 
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Figure 4. 12  Average IV plots of effect of TEA on native and 3-D cultured SLFs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B A 
FLJXUH 4.12 AYeUaged IV ploW gUaphV in naWiYe (a, n=8); and 3-D cXlWXUed SLFV fUom P9 
mice (b, n=3); and 3-D cXlWXUed SLFV fUom P28 mice (c, n=7). VolWage VWepV Uan fUom -
90mV Wo 30mV. Black lineV VhoZ conWUol UeVponVe (noUmal cXUUenW UeVponVe Wo diffeUenW 
YolWage VWepV), and Ued lineV UepUeVenW Whe UeVponVeV afWeU TEA applicaWion (10mM).  
C 
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4.3.2.1 Effect of TEA on resting membrane potential, conductance and 
reversal potential values in native and 3-D cultured fibrocytes 
 
Resting membrane potential 
In both the native and cultured fibrocytes TEA block results in a more negative RMP (fig. 
4.13). In the 3-D culture SLFs TEA experiments were carried out on cultures derived from P9 
mice and P28 mice. Both of these groups were compared to native SLFs to see if cultures 
from one of the ages showed responses similar to the native. There was no significant 
difference between the RMPs in the control and TEA group in either the P9 (p=0.214) or P28 
(p=0.135) derived culture, however, there was a significant difference between the RMPs in 
the control group and TEA group in the native SLFs with the effect of TEA on the native 
SLFs reducing the mean current by over 13 times (-0.85mV ±0.866, n=8, versus, -11.84mV 
±1.84, n=8, respectively, p=0.0012). 
There was no significant difference between the RMPs between native and P9 cultured SLFs 
in the control group (p=0.971) or TEA group (p=0.195). There was a significant difference in 
the RMPs between native and P28 cultured SLFs in the control group (-0.85mV ±0.866, n=8, 
versus, -5.62mV ±0.915, n=7, respectively, p=0.0023) with the RMP being over six times 
greater in the cultured SLFs, as well as a significant difference in the TEA group (-11.84mV 
±1.84, n=8, versus, -4.00mV ±1.38, n=7, respectively, p=0.0079) with the RMP being nearly 
three times greater in the native SLFs. There was also a significant difference in RMP 
between the P28 and P9 cultures in the control group (-5.62mV ±0.915, n=7, versus, -0.80mV 
± 0.095, n=3, respectively, p=0.0103), but not in the TEA group (p=0.418). 
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Figure 4. 13 RMPs in 3-D cultured and native SLFs before and after TEA application 
 
 
 
 
 
 
 
 
 
Conductance 
The effect of TEA on the conductance, as expected, is reduced in both native and cultured 
fibrocytes (fig. 4.14). In the P9 derived culture there was no significant difference in the 
conductance between the control and TEA group (p=0.305), however, there was a significant 
difference in conductance between the control and TEA group in the native SLFs (0.0306µs 
±0.0142, n=8, versus 0.0215µs ±0.0033, n=8, respectively, p=0.0011), and the P28 cultures 
(0.0675µs ±0.00529, n=7, versus 0.0617µs ±0.0543, n=7, respectively, p=0.0214). 
There was no significant difference in the conductance between P9 cultured and native SLFs 
in the control group (p=0.840), nor the TEA group (p=0.442). Furthermore there was a 
significant difference in the conductance between P28 cultured and native SLFs in the control 
group (0.0675µs ±0.00529, n=7, versus 0.0306µs ±0.0142, n=8, p=0.0002) as well as in the 
FLJXUH 4.13 BaU gUaph VhoZing Whe aYeUage UeVWing membUane poWenWialV (RMPV) of 3-D 
cXlWXUed (n=10) and naWiYe (n=8) fibUoc\WeV befoUe and afWeU applicaWion of TEA. GUoXpV 
VhoZ cXlWXUed SLFV fUom P9 mice (n=3), cXlWXUed SLFV fUom P28 mice (n=7), and naWiYe 
SLFV (n=8). (mean  SEM) 
** 
** 
** 
* 
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TEA group (0.0617µs ±0.0543, n=7, versus 0.0215µs ±0.00333, n=8, p<0.0001). Finally, 
there was a significant difference in conductance between the cultures from P28 and P9 mice 
in the control group (0.0675µs ±0.00529, n=7, versus 0.0329µs ±0.0134, n=3, p=0.0172) and 
in the TEA group (0.0617µs ±0.0543, n=7, versus 0.0293µs ±0.00475, n=3, versus 
p=0.0277). 
 
Figure 4. 14 Conductance in 3-D cultured and native SLFs before and after TEA 
application 
 
 
 
 
 
 
 
 
 
 
 
 
 
FLJXUH 4.14 BaU gUaph of Whe aYeUage condXcWance of 3-D cXlWXUed (n=10) and naWiYe (n=8) 
fibUoc\WeV befoUe and afWeU applicaWion of TEA. GUoXpV VhoZ cXlWXUed SLFV fUom P9 mice 
(n=3), cXlWXUed SLFV fUom P28 mice (n=7), and naWiYe SLFV (n=8), beWZeen VWepV -20mV Wo 
-40mV befoUe and afWeU applicaWion of TEA. (mean  SEM).  
** * 
*** 
**** 
* 
* 
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Reversal potential 
In the apparent reversal potential of TEA in native SLFs and SLFs derived from P9 and P28 
mice (fig. 4.15), there was no significant difference between the P9 derived cultured SLFs and 
native SLFs (-15.72mV±27.32, n=3 versus 18.75mV±3.602, n=8 respectively, p=0.06 ). 
There was a significant difference in the reversible potential between the P28 derived cultured 
SLFs and the native (-22.13mV±9.911, n=7, p=0.0013). Finally, there was no significant 
different in the reversal potential between the P28 and P9 cultured SLFs (p=0.784).  
Figure 4. 15 Reversal potential of TEA- sensitive current in 3-D cultured and native SLFs 
 
 
 
 
 
 
 
 
 
 
Overall, the results from the TEA experiments show that the responses to TEA in terms of its 
effect on the RMP, conductance and reversal potential show that the P9 derived SLFs cultures 
show more similar trends to native SLFs, when compared to the P28 derived cultures.   
FLJXUH 4.15 BaU gUaph VhoZing Whe aYeUage UeYeUVal poWenWial of naWiYe and 3-D 
cXlWXUed SLFV befoUe and afWeU applicaWion of TEA. GUoXpV VhoZ cXlWXUe SLFV 
deUiYed fUom P9 mice (n=3), cXlWXUed SLFV deUiYed fUom P28 mice (n=7), and 
naWiYe SLFV (n=8). (mean  SEM).  
** 
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4.4 Discussion 
 
There are voltage-gated channels in all living systems and these K+ channels segregate into at 
least two main functional groups ± hyperpolarised-activated, inwardly rectifying, and 
depolarised activated, outwardly-rectifying (Riedelsberger et al, 2015). In excitable cells they 
serve the crucial function of repolarising the membrane to its resting voltage after an action 
potential.  
Indeed, dominant K+ membrane conductance has been reported in all cell types studied in the 
lateral wall syncytium (Takeuchi et al, 2000; Liang et al, 2001; 2002). This is consistent with 
the generation of a concentration gradient enabling the hypothetical movement of K+ through 
SLFs to the cells of the stria vascularis, as the concentration of extracellular K+ in perilymph 
surrounding SLFs (∼5 mM) is slightly higher than that in the intrastrial fluid bathing strial 
basal and intermediate cells (∼1.5±3 mM, Salt et al., 1987, Ikeda & Morizono, 1989). The 
involvement of potassium channels and transporters function in the potassium recycling. 
The main findings here that an outwardly rectifying current dominates the voltage-dependent 
membrane conductance in native and cultured SLFs suggests that they potentially play a 
major role in generating and regulating the electrochemical gradient inside the lateral wall 
syncytium, an essential process to K+ recycling (Kikuchi et al, 1995; 2000; Spicer & Schulte, 
1996;1998; Wangermann, 2002). It is also consistent with previous research stating the 
presence of an outward large conductance voltage-gated potassium current carried by the BK 
channel in cultured SLFs (Liang et al, 2003; 2004; 2005; Shen et al, 2004). 
Additionally, there were a few recordings showing inward rectifying currents (n=2 in cultured 
and n=1 in native, data not shown). The reason, therefore, why not much inward current was 
detected could be due to the developmental expression of Kir5.1 as it has been seen in mice in 
the lower part of the spiral ligament at P10 (Hibino et al, 2004). In the cultures the exact 
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maturity of the cells are unclear due to the lack of external cues that would be present in vivo 
but the native recordings were from mice between P7-9. It may be that at older post P10 ages 
of the mouse more frequent inward rectification would have been seen, however, this would 
have made the sectioning of the cochlea much more problematic due to the hardness of the 
bone as the mouse gets older, causing the slice to crumble.  
4.4.1 Similar electrophysiological signature in native and cultured SLFs  
 
The most notable outcome of the electrophysiology work is that both native and cultured 
showed voltage-dependent potassium currents. This is crucial to the point of cultured SLFs 
being functional making them a useful target to be used as a cell replacement. Both native and 
cultured SLFs both show similar responses, they both showed predominantly linear and 
outwardly rectifying responses. The linear group the current responses were very similar 
between the native and cultured fibrocytes; however the outwardly rectifying responses in 
native SLFs were much greater than the outwardly rectifying responses in cultured SLFs. 
These cultured fibrocytes seemed connected through processes forming a lattice-like structure 
and label for connexin proteins (data shown in previous chapter) but not connected to the 
density level as they would be natively. Therefore, these cells possess a greater current as they 
most likely have more channels for current to pass through.  
4.4.2 Similar RMPs and conductance between native and cultured SLFs  
 
In general, the plasma membrane of cells in a resting state is permeable predominantly to K+ 
and so their RMPs relative to the neighbouring extracellular solution are negative (-30 to -
90mV, Elmslie, 2001; Hille, 2001; Jaye et al, 2010). However, it has been found in 
microelectrode studies that these fibrocytes in vivo show a positive membrane potential of +5 to 
+12 mV (Nin et al, 2008; Ikeda & Morizono, 1989). It is believed this electrical component is 
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required for the highly positive EP of around +80mV. It has been demonstrated that the 
membrane of fibrocytes are more permeable to Na+ than K+ or Cl- and this may explain their 
positive RMP (Yoshida et al, 2016).  It may be that this characteristic accounts for the RMP in 
type I, II, IV and V SLFs as it is these types that express cation channels that are permeable to 
Na+, the Na+ transporters NKCC and Na+ K+ ATPase, whereas type III (and type I) express the 
K+ Cl- transporter (KCC3, Hibino et al, 2004; Mahendrasingam et al, 2011a). Also the native 
SLFs recordings were mainly from the area of the ligament whereby the type III fibrocytes 
reside due to them being more easily assessable for patch-clamp recordings then the other types 
as the previous in vivo microelectrode studies would not distinguish between fibrocyte types as 
it is just known that it is in the fibrocyte region in the spiral ligament. It may be that type I, II, 
IV and V have a positive RMP and type III slightly negative. 
Here native and cultured fibrocytes show similar RMPs as there is no significant difference 
between any of the RMPs in the linear or outwardly rectifying groups. This means both the 
native and cultured SLFs share some similar trends in terms of their membrane properties 
indicating cultured SLFs may be a suitable cell replacement therapy. 
Despite research stating the RMP of SLFs is positive, there has been research which has 
found the membrane potential of fibrocytes to be approximately -5mV (Salt et al, 1987; Von 
Bekesy, 1951). The average RMP here in this study was around -10mV, therefore, Kir5.1 
could stimulate Na+K+ATPase and NKCC1 by providing K+ for their K+ site in the narrow 
extracellular space surrounded by the infolded plasma membrane of the fibrocytes. The 
localised K+ recycling would reduce the uptake of K+ released from outer sulcus cells by the 
K+ -transport apparatuses as the K+ is taken up through the hair cells then passed through the 
epithelial gap junction network to the connective-tissue gap junction network. Thus the K+- 
recycling mechanism by Kir5.1 could negatively regulate cochlear K+ circulation and prevent 
EP overshoot (Hibino et al, 2006). It is worth noting that Kir5.1 is slightly expressed on the 
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surface of the membrane but abundantly distributed in the cytoplasm, presumably on the 
transport vesicles. Therefore, Kir5.1 may be actively recycled between cytoplasm and 
membrane surface, and this recycling system could dynamically regulate the activity of the 
Kir5.1 in the fibrocytes, although its regulatory mechanism is still unknown. 
Moreover, the conductance in the native and cultured SLFs is similar, particularly in the linear 
responses and at the negative voltage steps in the outwardly rectifying responses. The native 
SLFs had a significantly greater conductance compared to cultured fibrocytes at positive steps 
in the outwardly rectifying responses. This could possibly be due to the cells being more 
electronically connected natively therefore more channels contributing, compared to the 
cultured environment where the cells are sparser and more isolated showing fewer 
connections. It could be that there may be a loss of cell-cell interactions and truncation of 
projections in the process of acute dissociation and this may alter the electrical activity of the 
cells. However, the capacity was found to be slightly greater in the cultured SLFs, which is 
consistent with these cells appearing larger than the native SLFs as shown in the bright field 
and fluorescent images seen in figures 4.2 and 4.3 with the average cell dimension of cultured 
fibrocytes being 4.41µm and native 2.01µm. It may be that cells are typically larger in culture, 
and there may be an association between the size of a cell and the characteristics of those 
cells. This could be related to cell density as the density of cells in vivo is greater than that in 
vitro and it has been found that cells seeding density affects the diameter of the cells as with 
lower densities the cell diameter was 62-73% larger than those seeded at higher densities 
(Awad et al, 2000). 
4.4.3 TEA reduces potassium currents in native and cultured SLFs 
 
In the TEA experiments the magnitude of the currents are greater in the cultured SLFs derived 
from the P28 cultures, whereas the currents appear to be similar between the native and P9 
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derived cultured SLFs. One possible explanation for this is a developmental effect in that the 
native SLFs (P7-P9 mice) and the cultures derived from P9 mice, the SLFs may not be fully 
matured and specialised. Even though in this case it is not known how mature the cells are in 
culture, the fact that they are from a P9 mouse could mean they cells lack in specialisation 
when compared to the cultured SLFs from the P28 mice. The cultures from the older mice 
may be more developed for hearing and therefore possess a greater current for K+ recycling 
and generation of the EP as in mice it develops between 5 and 17 days after birth (DAB) 
increasing abruptly 7 DAB and reaches 80mV 14 DAB (Sadanaga & Morimitsu, 1995). This 
idea is consistent with findings in whole brain slices from mice of varying maturity which 
found cultures from neonatal mouse tissue survive longer and continuously express 
progenitor-like cells but do not retain the cellular and cytoarchitectural features of mature 
tissue cultures (Staal et al, 2011). 
Furthermore, TEA has the same effect on the native and cultured SLFs; it decreases the 
inZaUd holding cXUUenW (µleak cXUUenW¶). HoZeYeU, iW appeaUV Wo UedXce Whe cXUUenW moUe 
dramatically in native SLFs the more negative the voltage. Reducing the current by ~1nA 
between around -50mV to -90mV and in P28 mice derived cultures at most positive voltages 
reducing the current by ~0.5nA between around 20mV to 30mV and also most negative 
voltages reducing the current by ~0.5nA between around -60mV to -70mV. In comparison the 
P9 derived cultures current was reduced by ~0.25nA between around -50mV to -70mV but 
only at the more negative voltages. It is to be expected that TEA would block the current but 
to a more significant degree as it has been found that extracellular application of 1mM almost 
completely inhibits channel activity in cultured type I SLFs (Liang et al, 2003; 2005; Shen et 
al, 2004). It could be that TEA could be blocking a non-specific cation channel. 
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4.4.4 TEA affects the RMP and conductance of P9 derived cultured and 
native SLFs similarly  
 
Moreover, TEA affects the RMPs similarly between the native and P9 derived cultures by 
making them more negative. The RMP prior to TEA in the native and P9 derived cultures are 
relatively close to zero at -0.85mV and -0.795mV respectively, after TEA application the 
RMPs becomes more negative -11.38mV and -6.437mV respectively. However, the RMP in 
the P28 group there was significant difference between the cultured SLFs and native SLFs 
both before and after TEA application. Also, the RMP in P28 derived SLFs became less 
negative after TEA application, the opposite effect as to that of the P9 derived cultures and 
native SLFs. Even though this effect of TEA is the same in both sets of cells, although to 
different magnitudes, it is unusual for TEA to make the RMP more negative as it blocks the 
potassium channels so depolarisation would be expected to make the RMP more positive 
(Barrett et al, 1988). It could be that some channels are insensitive to TEA under these 
conditions. It seems TEA appears to block current that depolarises the P9 cultured SLFs and 
native SLFs; this could be a novel finding. 
Again the effect of TEA on conductance is similar in native and P9 derived cultured SLFs, as 
it reduced the conductance in both P9 cultured and native SLFs, significantly so in the native. 
This is consistent with what would be expected as TEA blocks or reduces the flow of current. 
However, not only did the TEA significantly reduced the conductance in the P28 cultures and 
native SLFs but there was a significant difference between the conductance in the cultures and 
native SLFs both before and after TEA application. Likewise, the reversal potential of TEA in 
these cells was not significantly different between cultures derived from P9 mice at -15.72 
mV and the native SLFs at 18.75 mV; again however, native SLFs was significantly different 
to that of the cultured SLFs derived from P28 mice at -22.13mV. These results were not due 
to a change in the relative permeability of the channels to potassium or sodium, but could be 
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explained by a change in driving force for the permeant intracellular ions (K+ and/or Cs+) on 
their substitution with the impermeant TEA+ ion. 
These results could suggest TEA affects fibrocytes differently depending on age of the mouse, 
again meaning the older mice cultures may be more mature than that of the P9 mice derived 
cultures and P7-9 native SLFs which may have less mature cells with a more negative RMP 
and a greater conductance capacity in order for these cells to fulfil their K+ recycling function 
essentials to the maintenance of the EP. It appears in this case the SLFs derived from P9 mice 
seem to have comparable TEA response characteristics to native SLFs of mice within an age 
range of P7-9, and different characteristics to that of cultured SLFs derived from older mice 
of the age P28. Whether these cells are not yet specialised for function in vitro is unknown in 
either cultures so conclusions on this matter cannot be certain, but one would think those in an 
older mice may be more mature and differentiated with the ready features necessary for 
maintenance of the EP and function of hearing.   
The overall discrepancies between the results found in this study, when compared to previous 
research, could be accounted for by numerous other factors such as the use of different 
species as CD/1 mice were used here but many other animals such as rats, gerbils and guinea 
pigs where used in other studies (Liang et el, 2003; 2005; Shen et al, 2004; Yoshida et al, 
2016). CD/1were chosen in this study as they displayed a similar pathology to human age-
related hearing loss on an accelerated time period. Additionally, the difference in 
electrophysiological techniques may also be a variable for consideration as the techniques for 
establishing the RMP of type I cultured SLFs where microelectrode work compared to the 
whole-cell patch clamp method used here which could potentially be specific to each 
fibrocyte type. The use microelectrodes could cast a possible doubt as to whether the area of 
recording was definitely that of the SLFs.  
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The fact that here both the cultures and slices used to explore the properties of SLFs are both 
in vitro techniques compared to the in vivo work finding positive RMPs could also be a 
variable in the difference between the results (Yoshida et al, 2016). It could be that the cells 
are not as they would be naturally in vivo; however patch-clamp electrophysiology would be 
extremely difficult in an in vivo setting. It must be remembered here in this case that this is 
the first attempt at whole-cell voltage clamp recordings from cultured SLFs grown in a 3-D 
environment and being that of a potentially type III mixed phenotype, as other work exploring 
the electrophysiological characteristics on these cells has been from possible type I SLFs 
cultures in a 2-D environmental setting. This again could be another reason for this difference 
in findings between the cultured SLFs studies as it could be that the different types of SLFs 
have different properties such as RMPs. 
4.4.5 Conclusion  
 
In conclusion, this is the first whole-cell voltage-clamp recordings of and established culture 
of predominantly a type III mixed phenotype SLF culture grown in a 3-D environment. These 
recordings were compared to those of native SLFs and in this case functional and comparable 
potassium currents were found to be present in both the native SLFs and cultured SLFs. 
Cultures derived from P9 mice responded to TEA more similarly to native SLFs than cultures 
derived from P28 mice. Overall, this means this could be a unique cell type that may 
potentially fulfil the functions of the native cells. This is also the first evidence that potentially 
type III SLFs are involved in K+ recycling in the spiral ligament additional to their in their 
tension regulation function of the cochlea lateral wall. In combination, this work strengthens 
the argument in the case of cultured SLFs being suitable replacement for the degenerating 
fibrocytes in vivo to treat age-related hearing loss.  
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5. Chapter 5- General Discussion  
 
It is generally accepted that K+ is released from cochlear hair cells and cycles from the 
perilymph, through the cochlea lateral wall, to the endolymph. The lateral wall is made up of 
the spiral ligament containing SLFs, and the stria vascularis. SLFs are one of the crucial 
components in mediating K+ circulation.  
This study was undertaken to determine if these crucial cells of the spiral ligament could be 
successfully cultured in a 3-D environment, and investigate whether they possessed the 
features and characteristics to fulfil the function of native SLFs, building the case for them to 
be used as a cell replacement therapy to treat age-related hearing loss. 
5.1 Successful 3-D cultures of a type III mixed phenotype SLF culture  
 
Firstly, SLFs were successfully cultured in a 3-D collagen gel, enabling the cells to possess a 
more rounded, interconnected morphology when compared to 2-D cultures which exhibited a 
more flat, stretched out morphology. The 3-D cultured SLFs were found to be more elongated 
compared to 2-D cultured cells, and were found to form a network of cell-cell connections. 
This 3-D environment, potentially, more closely represents the in vivo environment of the 
spiral ligament, and therefore would be a more promising target for a cell replacement as 
opposed to 2-D cultures. Additionally, these SLFs cultures were found to be that of a type III 
mixed phenotype culture.  
In vivo, type I SLFs are lateral to the stria vascularis and are connected via gap junction 
proteins connexin26 and connexin30 to strial basal cells (Forge et al, 2003; Liu and Zhao, 
2008). They are also connected through similar gap junctions to type II SLFs located under 
the stria vascularis and type V above. This connective syncytium is thought to be the main K+ 
circulation pathway (Kelly et al, 2011). Type IV SLFs reside underneath type II fibrocytes but 
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have not been found to express connexin26/connexin30 channels, and consequently are not 
thought to be contributing to the recirculation pathway (Adams, 2009). However, it is thought 
they may possibly play crucial roles in perilymphatic Cl- transport (Que et al, 2007). 
Type III SLFs are present at the back lining of the ligament and express connexin31 
intracellularly, but do not appear to be connected cytoplasmically to the gap junction network 
(Kelly et al, 2012). This is consistent with the findings of this study whereby the SLF cultures 
were observed to be positive for the type III SLF marker (AQP1) and also the connexin 31 
and conne[in26 gap jXncWion pUoWeinV. T\pe III fibUoc\WeV aUe alVo WeUmed µWenVion fibUoc\WeV¶ 
(Henson et al, 1984; 1985, Henson and Henson, 1988). Analysis of type III fibrocytes in vitro 
has identified a role for these cells in setting basilar membrane tension and auditory 
sensitivity (Kelly et al, 2012).  
AqXapoUin labelling in Whe W\pe III µbone-lining¶ cellV in all WXUnV of Whe cochlea (SWankoYic eW 
al, 1995) suggests that type III fibrocytes contribute to normal hearing in all tonotopic 
locations. It is reported that AQP1-null mice retain normal hearing sensitivity (Li & Verkman, 
2001), making it unclear as to the role of AQP1 in type III SLFs. Aquaporins facilitate water 
permeability in sensory and non-sensory tissues, and this may be critical in maintaining the 
mechanics of tissue and the ionic balance of fluids. In the eye, cells express AQP1 and are 
associated with regulating volume and pressure of fluids in this network (Verkman , 2003; 
Lin et al, 2007). It is suggested that additionally to the basilar membrane tensioning in the 
basal region of the cochlea (Naidu & Mountain, 2007), type III SLFs could regulate 
hydrostatic pressure within the whole ligament though AQP1.    
Mounting evidence suggests that the cochlear fibrocytes may have a regenerative capacity, 
pointing towards a potential therapeutic target for regeneration of the lateral wall and 
associated deafness. Cochlear fibrocytes divide continuously until an advanced age where the 
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proliferation capacity decreases (Lang et al, 2003). This proliferation capacity increases after 
damage (Roberson & Rubel, 1994; Hirose & Liberman, 2003; Lang et al, 2003). It has further 
been revealed that the slow cycling, or potential stem cells, is found more often in type III 
SLFs and that these fibrocytes repopulate the type I area where the most significant decrease 
in fibrocytes is  observed when exposed to intense noise (Li et al, 2017). It is therefore 
thought that type III SLFs contain the stem cell population in the lateral wall and may be a 
potential target for a regenerative therapy. 
This is consistent with the findings here of a predominantly type III mixed phenotype culture. 
It may be that this fibrocyte type specifically contains a regenerative capacity that exceeds the 
other SLF types in culture. It could also be suggested that the cultured cells are of a hybrid 
phenotype due to the strong labelling for AQP1 and less intense labelling for S-100, 
indicating the expression of two different markers of fibrocytes in one cell. This could be an 
effective culture, as expression of two different fibrocyte phenotypes within one cell culture 
would enable the cells to possess multiple fibrocyte characteristics, thus increasing the 
likelihood of the cells retaining the ability to function as the fibrocytes of the spiral ligament 
natively following in vivo transplantation.  
This study went on to investigate whether this culture of a type III mixed phenotype may also 
play a part in cochlea K+ recycling, through determining a protein profile and 
electrophysiological signature of these cells.  
5.2 Cultured SLFs possess potassium transport functions 
 
The immunolabelling and electrophysiology conducted on the 3-D cultured and native SLFs 
showed similar characteristics. Both showed expression for Kir5.1 and connexin proteins, and 
showed predominately outward rectifying potassium currents as opposed to inwardly 
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rectifying. The only discrepancy was the BK labelling as there was weak labelling in the 
cultured SLFs and inconclusive labelling in the native sections of cochlea.  
Kir4.1 and Kir5.1 subunits are expressed in epithelial tissues and glial cells and may form a 
heteromeric assembly (Tanemoto et al, 2000; Lourdel et al, 2002). Both homomeric 
Kir4.1channels and heteromeric Kir4.1/Kir5.1 channels can be regarded as the major Kir 
channels responsible for K+ transport in glial and epithelial cells. A previous study observed 
that Kir5.1 and Kir4.1 subunits are expressed in different types of cells in the cochlea (Hibino 
et al, 2004).  This suggests the possibility that Kir5.1 expressed in cochlear fibrocytes is that 
of a homomeric assembly. Kir5.1 subunit expression has been found specifically in type II 
and IV fibrocytes in the spiral ligament, and it seems probable that this Kir channel is 
involved in the control of K+ transport in this region (Hibino et al, 2004).  
In support of this interpretation is the observed developmental time-course of Kir5.1 
expression in the ligament. The EP starts to rise at P8 and reaches the adult level at 2 weeks 
after birth (Anniko, 1985). In the stria vascularis the immunoreactivity of Kir4.1 is first 
observed at P8 when the EP starts to become positive and increases rapidly between P10 and 
P14 (Hibino et al, 1997). This indicates that Kir4.1- expression may be required for the 
initiation and establishment of the highly positive EP.  This is further supported by a study 
which demonstrated that the loss of Kir4.1 using Kir4.1 knockout mice resulted in the loss of 
EP (Marcus et al, 2002). In contrast, Kir5.1 is thought to have an important role in the rapid 
phase of EP elevation. Kir5.1 is detected in the lower part of the spiral ligament at around 
P10, and increases to plateaus at P15-P16 (Hibino et al, 2004). During this stage of 
development EP rises concurrently (Xia et al, 1999), thus suggesting that Kir5.1 plays a role 
in EP elevation. 
 157 
 
Previous studies have also demonstrated that type I SLFs exhibit a dominant BK channel 
conductance that likely contributes to establishing and maintaining an electrochemical 
gradient essential for K+ recycling (Shen et al, 2004). BK channels in type I SLFs have a 
voltage-dependent incomplete inactivation. This enables the cells to maintain their membrane 
potential whilst conserving intracellular K+, a biophysical property similar to that observed in 
cardiac myocytes (McManus et al, 1995; Wallner et al, 1995; 1999; Brenner et al, 2000). This 
regulatory mechanism is crucial to the function of type I SLFs, as these cells are believed to 
transmit K+ intracellularly through gap junction-coupled SLFs network to return to the stria 
vascularis (Schulte and Steel, 1994; Spicer and Schulte, 1996). 
The main findings from the electrophysiology in this study showed that the predominant 
characteristic groups in both the cultured and native SLFs were linear (non-rectifying) 
responses and outwardly rectifying responses, whilst there was very little inward rectification 
seen (some inward rectifying currents can be seen in the current traces in cultured SLFs in 
fig.3f and native SLFs in fig.4f). However, there was weak labelling for the BK channel in 
cultured SLFs and inconclusive labelling in the native. This was unexpected as the BK 
channel is an important negative feedback system linking increases in intracellular calcium to 
outward hyperpolarizing potassium currents therefore is thought to invoke an outward current 
in SLFs.   
This is also the case for the Kir5.1 labelling as positive labelling for this inward-rectifier was 
observed in both the cultured and native SLFs, but very little inward rectification was seen in 
the electrophysiology. The potential homomeric Kir5.1 expression in the cytoplasm and not 
membrane could explain why little inward rectification was detected in electrophysiology. It 
could be that the Kir5.1 inward-rectifier may actually impose an outward current due to the 
resting membrane properties of the SLFs. Outward current through inward rectifier K+ 
channels play a vital role in the determination of cells RMP and controlling cell excitability. 
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Thus, regulation of outward Kir current is important for appropriate physiological functions. 
It is known that outward Kir currents increase with increasing extracellular K+ concentration, 
in a driving force dependent manner (Hagiwara et al, 1976; Lopatin & Nichols, 1996; 
Matsuda et al, 2010). Previous studies have shown that outward Kir current is increased at 
higher extracellular K+ concentrations as a consequence of single channel conductance being 
elevated at higher extracellular K+ concentrations.  
Despite the discrepancy in the BK labelling between the native and cultured SLFs, in general, 
the protein expression and electrophysiological results found here are relatively similar 
between the 3-D cultured and native SLFs. This, therefore, strengthens the case for cultured 
SLFV being µfiW foU fXncWion¶ in a cell UeplacemenW WheUap\ Wo WUeaW age-related metabolic 
hearing loss, where the SLFs that reside in the ligament in vivo degenerate with age. 
5.3 Case for transplantation of cultured SLFs 
 
The degeneration and change in cochlear SLFs has been reported to cause hearing loss 
(Delprat et al, 2005; Minowa et al, 1999). Brain-4 (Brn-4) deficient mice, for example, 
display a reduced EP and hearing loss, and also show ultrastructural alterations, particularly in 
SLFs such as cellular atrophy and mitochondrial reduction (Minowa et al, 1999; Xia et al, 
2002). In mice deficient in otospiralin, type II and IV SLF degeneration is the main 
pathological change seen, with the appearance of hair cells and the stria vascularis being 
normal (Delprat et al, 2005). It has also been found that age-related degeneration of cochlea 
SLFs precedes that of any other type of cells within the cochlea, with the most significant 
pathological changes seen in type II, IV and V fibrocytes, where they have been found to 
degenerate in aged gerbil models, aged C57BL/6 mice, and aged CD/1 mice (Spicer & 
Schulte, 2002; Hequembourg & Liberman, 2001; Wu & Marcus, 2003; Mahendrasingam et 
al, 2011).  
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MSC transplantation has been used to treat multiple sclerosis and amyotrophic lateral 
sclerosis (Giordano et al, 2007; Devine, 2002; Karussis et al, 2010; Uccelli et al, 2011). A 
novel rat model developed for acute sensorineural hearing loss attributable to fibrocyte 
dysfunction induced by a mitochondrial toxin, found that active regeneration of the cochlear 
fibrocytes occurred following extreme focal apoptosis, without any changes observed in the 
Organ of Corti (Kamiya et al, 2007). Moreover, following transplantation of MSCs into the 
lateral semi-circular canal of the rats some of the MSCs were detected in the injured area of 
the lateral wall, and those that received MSC transplantation displayed significantly increased 
hearing recovery compared to the control mice (Kamiya et al, 2007). The MSCs also showed 
connexin26 and connexin30 immunostaining indicating gap junctions between these cells. 
This research suggests that regeneration of cells within the spiral ligament of the cochlea 
leads to hearing recovery after acute sensorineural hearing loss, and that the transplantation of 
these cells may be a promising therapy.  
More recently, a similar study transplanted MSCs into the cochlea in an attempt to explore 
whether it would be an effective therapy for stopping or delaying the progression of 
sensorineural hearing loss in childhood (Kasagi et al, 2013).  Kasagi et al transplanted MSCs 
into the semi-circular canal of young mice of 2-3 weeks and adult mice of 24-26 weeks. In the 
young mice they found the transplanted MSCs had differentiated into fibrocyte-like cells and 
were detected in cochlea tissue. There were no adverse effects on auditory function by the 
MSC transplantation, and the auditory brain stem responses threshold did not significantly 
change after surgery. However, no MSC migration or differentiation was observed in the 
adult mice after transplantation. The problems of migration and differentiation of the MSCs 
within these studies, where ectopic cells grew and were not completely differentiated into 
SLFs, highlight the potential of a cell-replacement therapy of those cells that are fully 
diffeUenWiaWed and µfiW foU fXncWion¶.  
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The use of collagen gels for transplantation of stem cells is a particularly explored technique 
for the regeneration of tissues and organs. It has recently been found MSCs seeded collagen 
gels can be delivered into injured intervertebral discs and maintained safely in live sheep to 6 
weeks (Hussain et al, 2019). Another technique when transplanting cells in collagen gels is to 
use soluble gels or dissolve the gels after transplantation, as it has been found intradermal 
injection of cells in pepsin-solubilized collagen is a simple and reliable technique for 
transplanting normal primary cells and preneoplastic cells (Zhang et al, 2002). 
The genetic, structural and functional alterations in cochlea SLFs related to deafness signify 
the importance of these cells in the maintenance of normal hearing. In this study, SLFs 
displaying a predominantly type III mixed phenotype were successfully cultured on 3-D 
collagen gels. This technique was found to be advantageous over 2-D culture methods as it 
resulted in the generation of rounder cells that were more interconnected and formed a 
network of cells much like those in vivo. These cultures also expressed gap junction proteins 
and potassium channels, as well as having functioning potassium currents. The concept of 
using the 3-D cultured, fully differentiated SLFs that possess similar characteristics to that of 
native SLFs, and transplanting them directly into the spiral ligament would avoid the 
previously experienced problems of migration and differentiation into this area when 
exploring a cell replacement therapy to treat hearing loss. 
5.4 General Conclusion 
 
Overall, the findings from this study support the idea of cultured SLFs being suitable as a cell 
replacement therapy to treat age-related hearing loss. The cultures generated in this study 
were found to be that of a type III mixed SLF phenotype as the cells express AQP1 and S-
100, with type III believed to possess the regeneration capacity. When grown in a 3-D 
transplantable collagen matrix these cells were found to display a morphology which 
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resembles that in vivo.  The cultured SLFs were demonstrated to express channels found to be 
expressed in native SLFs, such as the inwardly rectifying Kir5.1 channel, the large 
conductance BK channel and the gap junction connexin proteins, connexin26 and 
connexin31. Electrophysiological analysis of the cultured SLFs revealed similarities with that 
of native SLFs possessing outwardly rectifying potassium currents. Despite some differences 
in findings to those previously founded by others, the robust techniques such as patch-
clamping enabled better access to the inside of cells, and therefore a closer analysis of the 
characteristics of SLFs when compared to other techniques previously used to explore these 
cells.  
In combination, these findings demonstrated that the cultured SLFs possess active potassium 
currents and associated protein channels pointing towards the possibility of them being able to 
fulfil their function as they would in vivo. Transplantation strategies should be explored to 
further these cultured SLFs being used to replace degenerating SLFs in the ageing cochlea, 
and consequently preventing or restoring associated metabolic hearing loss. 
5.5 Future work 
 
Although there were numerous significant challenges experienced throughout the project, 
such as problems with starting up cultures and testing times trying to retrieve 
electrophysiological data, the work here uses robust laboratory techniques that have made it 
possible to conduct a comprehensive comparison of 3-D cultured SLFs to native SLFs. All the 
work was in aid of investigating whether these cells are fit for transplantation. Reflecting on 
the project reveals strengths and weakness, as well as areas to explore further which will only 
benefit the limited knowledge of these cells and their involvement in hearing. 
Continuation of this work would involve further investigations into the possibility of using 
novel cell replacement therapy to treat age-related hearing loss, for example exploring the 
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viability of the cultured SLFs for long periods on the 3-D gels. The density of SLFs on these 
gels slowly decline over a 5 day period (data not shown). Long-term survival rates of SLFs 
cultured of 3-D gels would therefore need to be investigated prior to the implementation of 
transplantation strategies, as it would be more ideal for the cells to remain viable for a longer 
period of time. This could involve the use of growth factors such as transforming growth 
factor beta (TGF-ȕ) and plaWeleW-derived growth factor (PDGF-BB) during cultivation of the 
cells. This would enable the cells to survive for longer periods of time in the gels so the 
success rate of cell survival for transplantation would likely be more successful. Future work 
could also attempt to successfully generate a cell culture containing all of the five SLF types. 
This is the most desirable and optimal culture as it would more effectively enable 
regeneration of a degenerated SL, as all the fibrocytes would be present and carry out their 
individual functions. 
Another point for future work is the use of electron microscopy as this was something that 
was unable to be carried out due to time constraints. This would enable more in-depth look at 
the morphology and ultrastructure of the cells, giving a more detailed comparison between the 
native and cultured SLFs. FXWXUe ZoUk coXld compaUe Whe diffeUenceV beWZeen Whe denViW\ and 
diVWUibXWion of labelled membUane pUoWeinV beWZeen naWiYe and cXlWXUed fibUoc\WeV XVing 
poVWembedding immXnogold labelling foU elecWUon micUoVcop\ Wo qXanWif\ Whe leYelV of WheVe 
channelV and WUanVpoUWeU pUoWeinV b\ Whe nXmbeU of immXnogold paUWicleV labelled. ThiV 
WechniqXe ZoXld alVo make iW poVVible Wo idenWif\ ZheWheU Whe pUoWein ZaV localiVed on Whe 
cellV membUane oU c\WoplaVm. The XVe of elecWUon micUoVcop\ coXld alVo eliminaWe a poWenWial 
flaZ of Whe cXUUenW UeVeaUch, in WhaW iW ZoXld confiUm Whe WaUgeW cellV in Whe naWiYe ligamenW Wo 
be fibUoc\WeV. TheVe pXWaWiYe fibUoc\WeV of Whe spiral ligament XVed foU Zhole-cell UecoUdingV 
ZeUe idenWified b\ Whe XVe of de[WUan 3000 Zhich enabled Whe geneUal moUpholog\ and 
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locaWion of Whe filled cell. HoZeYeU, elecWUon micUoVcop\ ZoXld make iW poVVible Wo confiUm 
WhiV b\ Whe XlWUaVWUXcWXUe of Whe cellV. 
Furthermore, another area for exploration is the use of more agonists and antagonists as this 
would allow the ability to distinguish differences in the carrying of the currents. Future work 
could explore this by applying specific agonists and antagonists to fibrocytes directly in order 
to isolate and characterise the potassium channels, such as Kir5.1 and the BK channel, and ion 
pumps, including the Na+ K+ ATPase and the Na+ K+ Cl- cotransporter, all of which 
contribute to the EP. 
In this study the predominant phenotype in the established cultures were those of a mixed 
phenotype with type III properties. Although the type III SLFs have been found to possess a 
regeneration capacity that enables them repopulate in area where other fibrocyte types have 
degenerated (Li et al, 2017), a culture population containing a mixture of all five types of 
SLFs would be most optimal as they could potentially fulfil all of their individual functions.  
The next step of future work would involve human work, as although mouse models exhibit a 
similar morphology to that of a human, there are always differences across species. The 
accelerated pathology of CD/1 mice is significantly more rapid when compared to humans, 
and even other animal models. Therefore, this work should be explored in other mice models 
such as the C57BL/6 strain and other species such as guinea pigs beforehand. To therefore 
understand the function of SLF in humans, future work in this area should also work towards 
the exploration of these cells in trial transplantation studies into live CD/1 mice initially to 
examine the success of cell survival after transplantation into a living organism.  
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Appendix 
Appendix 1- video of cells included separately with electronic submission of thesis to Keele 
University library. 
